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  Abstract	  	   	  	   Nucleotides,	   the	   building	   blocks	   for	   nucleic	   acids,	   are	   essential	   for	   cell	   growth	  and	   replication.	   In	  E. coli	   the	  enzyme	  responsible	   for	   the	   regulation	  of	  pyrimidine	  nucleotide	   biosynthesis	   is	   aspartate	   transcarbamoylase	   (ATCase),	  which	   catalyzes	  the	   committed	   step	   in	   this	   pathway.	  ATCase	   is	   allosterically	   inhibited	  by	  CTP	   and	  UTP	  in	  the	  presence	  of	  CTP,	  the	  end	  products	  of	  the	  pyrimidine	  pathway.	  ATP,	  the	  end	   product	   of	   the	   purine	   biosynthetic	   pathway,	   acts	   as	   an	   allosteric	   activator.	  ATCase	  undergoes	  the	  allosteric	  transition	  from	  the	  low-­‐activity	  and	  low-­‐affinity	  T	  state	  to	  the	  high-­‐activity	  and	  high-­‐affinity	  R	  state	  upon	  the	  binding	  of	  the	  substrates.	  In	   this	   work	  we	  were	   able	   to	   trap	   an	   intermediate	   ATCase	   along	   the	   path	   of	   the	  allosteric	  transition	  between	  the	  T	  and	  R	  states.	  Both	  the	  X-­‐ray	  crystallography	  and	  small-­‐angle	   X-­‐ray	   scattering	   in	   solution	   clearly	   demonstrated	   that	   the	   mutant	  ATCase	   (K164E/E239K)	   exists	   in	   an	   intermediate	   quaternary	   structure	   shifted	  about	   one-­‐third	   toward	   the	   canonical	   R	   structure	   from	   the	   T	   structure.	   	   The	  
structure	  of	  this	  intermediate	  ATCase	  is	  helping	  to	  understand	  the	  mechanism	  of	  the	  allosteric	   transition	   on	   a	  molecular	   basis.	   In	   this	   work	  we	   also	   discovered	   that	   a	  metal	   ion,	   such	   as	  Mg2+,	  was	   required	   for	   the	   synergistic	   inhibition	  by	  UTP	   in	   the	  presence	   of	   CTP.	   	   Therefore,	   the	  metal	   ion	   also	   had	   significant	   influence	   on	   how	  other	   nucleotides	   effect	   the	   enzyme.	   A	   more	   physiological	   relevant	   model	   was	  proposed	   involving	  the	  metal	   ion.	  To	  better	  understand	  the	  allosteric	   transition	  of	  ATCase,	   time-­‐resolved	   small-­‐angle	   X-­‐ray	   scattering	   was	   utilized	   to	   track	   the	  conformational	   changes	   of	   the	   quaternary	   structure	   of	   the	   enzyme	   upon	   reaction	  with	  the	  natural	  substrates,	  PALA	  and	  nucleotide	  effectors.	  The	  transition	  rate	  was	  increased	   with	   an	   increasing	   concentration	   of	   the	   natural	   substrates	   but	   became	  over	  one	  order	  of	  magnitude	  slower	  with	  addition	  of	  PALA.	  Addition	  of	  ATP	  to	  the	  substrates	   increased	   the	  rate	  of	   the	   transition	  whereas	  CTP	  or	   the	  combination	  of	  CTP	  and	  UTP	  exhibited	  the	  opposite	  effect.	   	  	   In	   this	  work	  we	  also	   studied	  E. coli	   dihydroorotase	   (DHOase),	  which	   catalyzes	  the	  following	  step	  of	  ATCase	  in	  the	  pyrimidine	  biosynthetic	  pathway.	  A	  virtual	  high	  throughput	   screening	   system	   was	   employed	   to	   screen	   for	   inhibitors	   of	   DHOase,	  which	  may	   become	   potential	   anti-­‐proliferation	   and	   anti-­‐malarial	   drug	   candidates.	  Upon	  the	  discovery	  of	  the	  different	  conformations	  of	  the	  100’s	  loop	  of	  DHOase	  when	  substrate	   or	   product	   bound	   at	   the	   active	   site,	   we’ve	   genetically	   incorporated	   an	  unnatural	   fluorescent	   amino	   acid	   to	   a	   site	   on	   this	   loop	   in	   the	   hope	   of	   obtaining	   a	  better	  understanding	  of	   the	   catalysis	   that	  may	   involve	   the	  movement	  of	   the	  100’s	  loop.	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Aspartate	  Transcarbamoylase	  
Brief	  Overview	  of	  E. coli	  Aspartate	  Transcarbamoylase	  	   Many	   biochemical	   reactions	   in	   a	   living	   cell	   can	   go	   both	  ways,	   for	   example,	  mammalian	  cells	  both	  synthesize	  and	  catabolize	  glucose.	  The	   rates	  at	  which	   these	  reactions	  proceed	  must	  be	   regulated	   to	  maintain	  homeostasis	   of	   cell.	   The	  de	  novo	  biosynthesis	   of	   pyrimidine	   nucleotides	   in	  E. coli	   starts	  with	   carbamoyl	   phosphate	  (CP),	  which	  is	  derived	  from	  glutamine,	  and	  subsequently	  proceeds	  through	  a	  series	  of	  reactions	  catalyzed	  by	  enzymes	  to	  produce	  the	  pyrimidine	  nucleotides,	  UTP	  and	  CTP.	   The	   enzyme	   that exerts control	   over	   the	   rate	   of	   this	   pathway	   is	   a	   classic	  allosteric	   enzyme,	   aspartate	   transcarbamoylase	   (EC	   2.1.3.2,	   ATCase),	   which	  catalyzes	  the	  first	  step	  in	  this	  pathway:	  CP	  reacted	  with	  L-­‐aspartate	  (Asp)	  to	  form	  N-­‐carbamoyl-­‐L-­‐aspartate	   (CA)	   and	   inorganic	   phosphate	   (Pi)	   (see	   Figure	   1.1).1-­‐3	  ATCase	   exists	   as	   a	   single	   monofunctional	   enzyme	   in	   bacteria,	   such	   as	   E. coli,	  whereas	   in	   higher	   organisms	   ATCase	   exists	   as	   part	   of	   a	   multifunctional	   enzyme	  complex.	   For	   example,	   in	  mammals	  ATCase	   contributes	   as	   a	   functional	   domain	   in	  the	  CAD	  enzyme	  complex,	  which	  is	  composed	  of	  the	  first	  three	  enzymes,	  carbamoyl	  phosphate	   synthetase,	   aspartate	   transcarbamoylase	   and	   dihydroorotase,	   in	   the	  pyrimidine	  biosynthetic	  pathway.4	   	   Allosteric	  control	  is	  a	  type	  of	  enzyme	  regulation	  that	  results	  from	  the	  binding	  of	  an	  effector	  at	  a	  site	  (allosteric	  site)	  other	  than	  the	  active	  site	  of	  the	  enzyme.	  An	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Figure	   1.1.	   The	   reaction	   catalyzed	   by	   aspartate	   transcarbamoylase	   (ATCase):	  condensation	   of	   carbamoyl	   phosphate	   (CP)	   and	   L-­‐aspartate	   (Asp)	   to	   form	   N-­‐carbamoyl-­‐L-­‐aspartate	  and	  inorganic	  phosphate	  (Pi).	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effector	  that	  causes	  an	  increase	  in	  the	  activity	  of	  the	  enzyme	  is	  called	  an	  allosteric	  activator,	  and	  an	  effector	  that	  causes	  a	  decrease	  in	  the	  activity	  of	  the	  enzyme	  is	  an	  allosteric	   inhibitor.	   The	   influence	   of	   an	   allosteric	   effector	   on	   the	   activity	   of	   the	  enzyme	   is	   called	   an	   heterotropic	   effect.	   Unlike	   a	   heterotropic	   effect,	   homotropic	  effect	   is	  caused	  by	  the	  same	  molecule	  as	   the	  one	  that	  will	  be	  affected	  (such	  as	   the	  substrate).	  Both	  effects	  together	  allow	  allosteric	  enzymes	  to	  greatly	  vary	  the	  rate	  of	  catalysis	   in	   response	   to	   small	   changes	   in	   substrate	   or	   allosteric	   effector	  concentration.	  ATCase,	  which	  is	  regulated	  both	  homotropically	  by	  its	  substrate	  Asp	  and	   heterotropically	   by	   the	   pyrimidine	   and	   purine	   nucleotides,	   becomes	   an	  archetypal	  example	  of	  allosteric	  modulation	  of	  control	  of	  metabolism.5 	  	   ATCase	  controls	  the	  rate	  of	  the	  pyrimidine	  biosynthesis	  by	  altering	  its	  rate	  of	  catalysis	   in	  response	  to	  the	  cellular	   levels	  of	  both	  pyrimidines	  and	  purines.6	  When	  the	  end-­‐product	  of	  the	  pyrimidine	  pathway,	  CTP,	  is	  in	  excess,	  the	  rate	  of	  catalysis	  is	  reduced	   due	   to	   feedback	   inhibition	   by	   allosteric	   inhibitors	   CTP	   and	   UTP7	   in	   the	  presence	  of	  CTP.	  When	   the	  end-­‐product	  of	   the	  parallel	  purine	  pathway,	  ATP,	   is	   in	  excess,	  the	  rate	  of	  catalysis	  is	  enhanced	  by	  the	  allosteric	  activator	  ATP.	  In	  addition,	  the	   substrate	   Asp	   binds	   cooperatively	   to	   the	   enzyme	   to	   increase	   activity	   at	   high	  concentrations	  when	   the	  end-­‐products	  accumulate.	  These	  regulatory	  properties	  of	  ATCase	   thus	   contribute	   to	   maintain	   a	   balanced	   pool	   of	   pyrimidine	   and	   purine	  nucleotides	  for	  the	  biosynthesis	  of	  nucleic	  acids	  in	  the	  cell. 
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Structure	  of	  ATCase	  
	   Based	  on	  the	  molecular	  size,	  Bethell	  and	  Jones8	   first	  proposed	  to	  divide	  the	  bacterial	   ATCases	   into	   three	   classes,	   namely	   Class	   A,	   Class	   B	   and	   Class	   C.	   E. coli	  ATCase	  is	  a	  representative	  for	  Class	  B	  ATCases,	  which	  include	  the	  enzymes	  from	  the	  enteric	   bacteria.	   Class	   B	   ATCases	   have	   a	   molecular	   weight	   of	   approximately	   300	  kDa,	   which	   are	   composed	   of	   the	   34	   kDa	   and	   17	   kDa	   polypeptide	   chains.	   The	  structural	   details	   of	   this	   class	   are	   described	   below	   in	   detail	   using	  E. coli	   ATCase.	  Class	   A	   ATCases	   are	   the	   largest	   in	   size	   with	   a	   molecular	   weight	   of	   480	   kDa	   and	  mostly	   found	   in	   the	  pseudomonads.	   In	  addition	  to	   the	  34	  kDa	  polypeptides,	   larger	  polypeptides	   of	   45	   kDa	   are	   found	   to	   form	   the	   enzymes	   in	   this	   class.9,10	   Class	   C	  ATCases	  only	  consist	  of	  three	  identical	  monomers	  of	  the	  34	  kDa	  polypeptides,	  giving	  a	   total	  molecular	   weight	   of	   100	   kDa.	   Unlike	   ATCases	   in	   Class	   A	   and	   B	   under	   the	  regulation	  of	  nucleotides,	  Class	  C	  enzymes	  are	  not	  regulated	  and	  mostly	  found	  from	  Gram	   positive	   bacteria,	   such	   as	   Bacillus subtilis,	   and	   some	   from	   Gram	   negative	  bacteria.11	  	  The	   E. coli	   ATCase	   is	   an	   oligomeric	   protein	   complex	   composed	   of	   12	  polypeptide	  chains,	  which	  are	  grouped	  into	  two	  distinct	  types	  of	  subunits,	  catalytic	  (c)	   and	   regulatory	   (r).	   Treatment	   by	   heat	   or	   reacting	   with	   certain	   mercurial	  compounds	   can	   breakdown	   the	   enzyme	   into	   these	   subunits.	   The	   catalytic	   subunit	  contains	  the	  active	  sites,	  but	  is	  not	  influenced	  by	  CTP	  or	  ATP.	  The	  regulatory	  subunit	  is	  able	  to	  bind	  the	  allosteric	  effectors	  but	  has	  no	  catalytic	  activity.12	  The	  composition	  of	  the	  holoenzyme	  is	  c6r6,	  which	  was	  proved	  from	  the	  analysis	  of	  the	  sequence	  of	  the	  
	   6	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  
Figure	  1.2.	  Schematic	  representation	  of	  the	  quaternary	  structure	  of	  ATCase	  viewed	  along	   the	   three-­‐fold	   axis.	   The	   two	   catalytic	   trimers	   (C1-­‐C2-­‐C3	   and	   C4-­‐C5-­‐C6)	   are	  shown	  in	  blue.	  The	  three	  regulatory	  dimers	  (R1-­‐R6,	  R2-­‐R4	  and	  R3-­‐R5)	  are	  shown	  in	  yellow.	  The	  three	  red	  lines	  indicate	  the	  three	  two-­‐fold	  axes.15	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regulatory	   chain13	   and	   also	   independently	   from	   crystallographic	   symmetry	  determinations.14	   The	   ATCase	   holoenzyme,	   with	   a	   total	   molecular	   weight	   of	   310	  kDa,	  is	  made	  up	  of	  two	  catalytic	  trimers	  (Mr	  34,000	  Da/chain)	  that	  are	  held	  together	  by	   three	   regulatory	   dimers	   (Mr	   17,000	   Da/chain).	   The	   catalytic	   trimers	   and	  regulatory	  dimers	  are	  related	  to	  one	  another	  by	  one	  three-­‐fold	  axis	  and	  three	  2-­‐fold	  axes	  as	  shown	  in	  Figure	  1.2.15 Each	   catalytic	   chain	   is	   composed	  of	   two	   structural	   domains,	   the	   carbamoyl	  phosphate	  (CP)	  domain,	  which	  contains	  most	  of	  the	  residues	  responsible	  for	  binding	  CP	  (residues	  1-­‐135	  and	  292-­‐310),	  and	  the	  L-­‐aspartate	  (Asp)	  domain,	  which	  contains	  most	   of	   the	   residues	   responsible	   for	   binding	   Asp	   (residues	   136-­‐291).	   Each	  regulatory	   chain	   is	   also	   composed	   of	   two	   structural	   domains,	   the	   allosteric	   (AL)	  domain	  (residues	  1-­‐100),	  which	  contains	  the	  binding	  site	  for	  the	  allosteric	  effectors,	  and	   the	   zinc	   (Zn)	   domain	   (residues	   101-­‐153),	  which	   has	   the	   binding	   site	   for	   zinc	  atom	  coordinated	  with	  four	  cysteine	  residues	  (see	  Figure	  1.3).16	  	  
Allosteric	  Transition	  of	  ATCase	  Most	   allosteric	   properties	   can	   be	   explained	   by	   the	   concerted	   model	   of	  Monod,	   Wyman,	   Changeux	   (MWC),17	   or	   by	   the	   sequential	   model	   of	   Koshland,	  Nemethy,	  Filmer	  (KNF).18	  Both	  models	  are	  built	  on	  the	  same	  basic	  assumption	  that	  enzyme	  subunits	  exist	  in	  one	  of	  two	  extreme	  conformational	  states,	  the	  low-­‐activity,	  low-­‐affinity	   tense	   (T)	  state	  or	   the	  high-­‐activity,	  high-­‐affinity	   relaxed	  (R)	  state.	  The	  two	   models	   differ	   most	   in	   their	   assumption	   about	   the	   process	   of	   the	   T-­‐to-­‐R	  transition.	  In	  the	  MWC	  model,	  the	  conformational	  change	  in	  one	  subunit	  induced	  




Figure	  1.3.	  Structural	  domains	  of	  catalytic	  chain	  and	  regulatory	  chain.	  Each	  of	  the	  six	  catalytic	  chains	  contains	  two	  domains:	  the	  CP	  and	  Asp	  domains.	  Each	  regulatory	  chain	   is	  also	  composed	  of	   two	  domains:	   the	  Al	  domain	  and	  Zn	  domain.	  The	  active	  site	  is	  shown	  with	  substrate	  analogs	  phosphonoacetamide	  and	  malonate	  bound,	  and	  the	  allosteric	  site	  is	  shown	  with	  the	  nucleotide	  effector	  CTP	  bound.	  This	  figure	  was	  redrawn	  with	  Pymol19	  using	  data	  from	  PDB	  ID	  8AT1.20	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upon	   ligand	  binding	  propagates	   to	   all	   other	   subunits	   such	   that	   all	   subunits	   of	   the	  enzyme	  must	   exist	   in	   the	   same	   conformation.	   Thus,	   the	   enzyme	   is	   assumed	   to	   be	  either	  in	  the	  T	  state	  or	  the	  R	  state,	  and	  the	  transition	  between	  the	  states	  is	  concerted.	  As	   seen	   in	   Figure	  1.4	   in	   the	   absence	   of	   ligands,	   the	   two	   states	   are	   in	   equilibrium,	  which	  favors	  the	  T	  state.	  The	  equilibrium	  can	  be	  shifted	  to	  the	  T	  or	  R	  state	  upon	  the	  binding	  of	  one	  ligand.	  	  	   Different	   from	   the	  MWC	  model,	   the	   KNF	  model	   assumes	   that	   the	   progress	  from	  the	  T	  to	  R	  state	  is	  a	  sequential	  process.	  Thus,	  all	  enzyme	  subunits	  can	  exist	  in	  different	  conformations	  and	  there	  is	  no	  dramatic	  switch	  from	  one	  state	  to	  another.	  As	  a	  result	   for	  the	  KNF	  model,	   in	  the	  absence	  of	   ligands,	  the	  enzyme	  exists	  only	   in	  one	  state	  and	  there	   is	  no	  pre-­‐equilibrium	  between	  the	  two	  states	  (see	  Figure	  1.5).	  The	   KNF	   model	   uses	   a	   series	   of	   tertiary	   structural	   changes	   during	   the	   T-­‐to-­‐R	  transition,	  whereas	  the	  MWC	  model	  uses	  a	  quaternary	  structural	  change. ATCase	  has	  been	  shown	  to	  undergo	  an	  allosteric	  transition	  from	  the	  T	  to	  the	  R	   state	   upon	   the	   binding	   of	   substrates	   as	   well	   as	   substrate	   analogs	   such	   as	   N-­‐phosphonacetyl-­‐L-­‐aspartate	   (PALA).21	   Studies	  using	   a	   variety	  of	  methods22-­‐25	   have	  shown	   that	   the	   holoenzyme	   is	  more	   swollen	   in	   the	   R	   state	   as	   compared	   to	   the	   T	  state.	  Molecular	  details	  of	  this	  structural	  change	  are	  revealed	  from	  the	  comparison	  of	   the	   X-­‐ray	   structures	   of	   ATCase	   in	   the	   absence	   and	   presence	   of	   PALA.25-­‐27	   The	  enzyme	  expands	  11	  Å	  along	  the	  3-­‐fold	  axis	  during	  the	  T-­‐to-­‐R	  allosteric	  transition,	  at	  the	   same	   time	   the	   catalytic	   trimers	   rotate	   12°	   relative	   to	   one	   another	   and	   the	  regulatory	  dimers	  rotate	  by	  15°	  about	  the	  approximate	  2-­‐fold	  axes	  (see	  Figure	  1.6).	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Figure	   1.4.	   The	  MWC	  model17	   for	   a	   tetrameric	   allosteric	   protein	   upon	  binding	   of	  ligands.	  Protein	   subunits	   in	   the	  T	   state	   and	   the	  R	   state	   are	   shown	  as	   squares	   and	  circles,	   respectively.	   Unligated	   protein	   exists	   in	   the	   equilibrium	   between	   the	   two	  states.	  “L”	  represents	  ligands.	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Figure	   1.5.	   The	   KNF	  model18	   for	   a	   tetrameric	   allosteric	   protein	   upon	   binding	   of	  ligands.	  Protein	   subunits	   in	   the	  T	   state	   and	   the	  R	   state	   are	   shown	  as	   squares	   and	  circles,	  respectively.	  Protein	  transits	  from	  the	  unligated	  T	  state	  conformation	  to	  the	  ligand-­‐bound	   R	   state	   conformation	   through	   a	   sequential	   process.	   “L”	   represents	  ligands.	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  These	  quaternary	  changes	  are	  accompanied	  by	  the	  tertiary	  structural	  alterations	  in	  both	   the	   catalytic	   and	   regulatory	   chains,	   the	   most	   significant	   of	   which	   involve	  movement	  of	  domains	  and	  loops.25,28	  In	  particular，the	  Asp	  domain	  and	  CP	  domain	  of	   the	   catalytic	   chain	  moves	   toward	   each	   other	   by	  ~7°	   bringing	   the	   substrates	   in	  close	  proximity	  while	  the	  AL	  domain	  and	  Zn	  domain	  of	  the	  regulatory	  chain	  open	  by	  1.7°.29	   Besides	   the	   motions	   of	   domain,	   there	   is	   also	   a	   major	   reorientation	   of	   the	  240’s	  loop	  (residue	  230	  to	  245	  of	  the	  catalytic	  chains).	  In	  the	  T	  state,	  side	  chains	  of	  residues	   in	   the	   240’s	   loop	   are	   involved	   in	   the	   intersubunit	   interactions	   which	  stabilizing	   the	   compact	   form，such	   as	   interactions	   exist	   at	   the	   interfaces	   c1	  (Glu239):c4	   (Lys164	   and	   Tyr165),	   c1	   (Asp236):r4	   (Lys143),	   c1	   (Ser238):r4	  (Asn111)	  and	  their	  symmetry	  related	  interfaces.	  (c1,	  c4	  are	  catalytic	  chains	  and	  r4	  is	  regulatory	   chain	   as	   shown	   in	   Figure	   1.2)	   These	   interactions	   are	   lost	   after	   the	  enzyme	  expands	  to	  the	  R	  state,	  though	  the	  salt	  links	  of	  Glu239	  to	  both	  Lys164	  and	  Tyr165	   change	   from	   interchain	   interactions	   to	   intrachain	   interactions.	   Therefore	  the	  allosteric	  transition	  involves	  both	  the	  global	  and	  local	  conformational	  changes,	  which	  contribute	  to	  breaking	  the	  interactions	  that	  stabilize	  the	  T	  state	  and	  replace	  with	  those	  stabilizing	  the	  R	  state.	  	  Extensive	   studies	   on	  ATCase	   have	   proved	   that	   the	   allosteric	  mechanism	   of	  the	  enzyme	  can	  be	  explained	  by	  the	  MWC	  model.	  Recently	  Fetler	  et	  al.30	  were	  able	  to	  detect	   the	   pre-­‐existence	   of	   the	   T	   to	   R	   equilibrium	   using	   a	   mutant	   ATCase.	  Furthermore,	  Macol	  et	  al.31	  provided	  direct	  structural	  evidence	   that	   the	  binding	  of
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Figure	   1.6.	   Allosteric	   transition	   of	   ATCase	   from	   the	   T	   state	   (top)	   to	   the	   R	   state	  (bottom).	  The	  structure	  of	  ATCase	   in	   the	  T	  state	   is	  drawn	  using	  data	   from	  PDB	  ID	  1ZA1.32	  The	  structure	  of	  ATCase•PALA	  complex	   in	   the	  R	  state	   is	  drawn	  using	  data	  from	  PDB	  ID	  1D09.33	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PALA	   to	   just	   one	   of	   the	   six	   catalytic	   sites	   of	   ATCase	   was	   sufficient	   to	   bring	   the	  enzyme	   from	   the	   T	   to	   the	   R	   state,	   which	   demonstrated	   a	   concerted	   allosteric	  transition.	  
Catalytic	  Mechanism	  and	  Homotropic	  Cooperativity	  for	  Aspartate	  The	   active	   sites	   are	   located	   at	   the	   interface	   between	   two	   neighboring	  catalytic	   chains	   in	   the	   same	   trimer.	   Details	   of	   the	   active	   site	   residues	   involved	   in	  substrates	   binding	  were	   revealed	   from	   the	   structural	   studies	   of	   enzyme	  with	   the	  bisubstrate	  transition	  state	  analog	  PALA	  bound	  (see	  Figure	  1.7).33	    The	   reaction	   catalyzed	   by	   ATCase	   proceeds	   through	   an	   ordered	   mechanism	   in	  which	   CP	   binds	   before	   Asp	   and	   the	   product	   CA	   leaves	   before	   Pi.34	   X-­‐ray	  crystallography	   has	   been	   used	   to	   obtain	   snapshots	   of	   enzyme	   at	   each	   step	   in	   the	  catalytic	  cycle	  to	  understand	  not	  only	  the	  catalysis	  but	  also	  the	  ordered	  binding	  and	  release	   on	   a	  molecular	   basis.32,35-­‐37	  When	   CP	   binds,	   the	   enzyme	   remains	   in	   the	   T	  state	  but	  local	  conformational	  changes	  occur	  which	  allow	  the	  binding	  of	  the	  second	  substrate	  Asp.32	  The	  80’s	   loop	   from	  the	  adjacent	  catalytic	  chain	  moves	   toward	  the	  active	  site,	  which	  positions	  Ser80	  and	  Lys84	  for	  Asp	  binding.	  Along	  with	  the	  motions	  of	   50’s	   loop	   and	   240’s	   loop,	   these	   conformational	   changes	   create	   a	   positively	  charged	  binding	  pocket	  for	  Asp,	  which	  does	  not	  exist	  in	  the	  absence	  of	  CP.	  When	  Asp	  binds	   to	   the	  ATCase·CP	  complex,	  more	   conformational	   changes	  occur	   to	  make	   the	  active	   site	   more	   electropositive.	   The	   binding	   of	   Asp	   induces	   a	   significant	  reorientation	   of	   the	   240’s	   loop	  which	   not	   only	   assists	   in	   the	   establishment	   of	   the	  high-­‐affinity	  high-­‐activity	  R-­‐state	  active	  site,	  but	  also	  weakens	  the	  T-­‐state	  stabilizing	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Figure	   1.7.	   Active	   site	   of	   ATCase	   with	   PALA	   bound.	   All	   residues	   involved	   in	   the	  active	  site	  are	  labeled	  and	  those	  from	  the	  adjacent	  catalytic	  chain	  are	  marked	  with	  asterick.	  This	  figure	  was	  redrawn	  with	  Pymol19	  using	  data	  from	  PDB	  ID	  1D09.33	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intersubunit	   interactions,	   promoting	   the	   quaternary	   conformational	   changes	  required	  for	  the	  enzyme	  to	  go	  to	  the	  R	  state.38	  Thus	  the	  binding	  of	  Asp	  to	  one	  active	  site	   favors	   the	   conversion	   of	   the	   entire	   enzyme	   into	   the	   R	   state,	   resulting	   in	   the	  increased	  affinity	  and	  activity	   for	   the	  other	  active	  sites.	  The	  cooperativity	   induced	  by	  Asp	  binding	  reflects	  the	  sigmoidal	  kinetics	  of	  the	  ATCase	  reaction	  as	  a	  function	  of	  Asp	   concentration.	   The	   sigmoidal	   Asp	   saturation	   curve	   for	   ATCase	   is	   shown	   in	  Figure	  1.8.	  	  
Nucleotide	  Regulation	  of	  ATCase 
	   The	   nucleotide	   effectors	   (such	   as	   ATP,	   CTP	   and	   UTP)	   exhibit	   heterotropic	  regulation	  of	  ATCase	  by	  binding	  at	  the	  allosteric	  sites.	  CTP	  inhibits	  the	  enzyme	  while	  ATP	  shows	  the	  opposite	  effect,	  increasing	  the	  catalytic	  activity.	  UTP	  by	  itself	  has	  no	  effect	   on	   the	   enzyme	   activity,	   but	   in	   the	   presence	   of	   CTP,	   UTP	   causes	   a	   further	  decrease	  in	  enzyme	  activity	  than	  CTP	  alone.7	  The	  nucleotide	  binding	  sites	  of	  ATCase	  are	  located	  in	  the	  AL	  domain	  of	  the	  regulatory	  chains	  near	  the	  N-­‐terminus	  and	  the	  interface	   between	   two	   regulatory	   chains	   in	   the	   same	   dimer.	   Each	   active	   site	   is	   at	  least	   60	   Å	   away	   from	   where	   the	   nucleotides	   bind	   (see	   Figure	   1.3).	   How	   can	   the	  nucleotide	  effectors	  influence	  the	  catalytic	  activity	  at	  a	  site	  60	  Å	  from	  the	  active	  site?	  	  According	  to	  the	  MWC	  model,	  ATCase	  exists	  in	  equilibrium	  between	  the	  low	  activity	  T	  state	  and	  the	  high	  activity	  R	  state.	  In	  the	  absence	  of	  any	  ligand,	  the	  T	  state	  is	   favored	   by	   a	   factor	   of	   250	   or	   more.39	   To	   explain	   the	   heterotropic	   effect	   of	  nucleotides,	   it	   has	   been	   suggested	   that	   the	   binding	   of	   nucleotides	   shift	   the	  equilibrium	  between	  the	  two	  states,	  thus	  changing	  the	  net	  enzyme	  activity.	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Figure	  1.8.	  Asp	  saturation	  curves	  ()	  of	  ATCase	  in	  the	  absence	  of	  nucleotides	  at	  25	  °C.	   In	   the	   presence	   of	   4	  mM	  ATP	   ()	   the	   curve	   shifts	   to	   the	   left	   as	   the	  R	   state	   is	  stabilized	  by	  ATP.	  In	  the	  presence	  of	  2	  mM	  CTP	  ()	  the	  curve	  shifts	  to	  the	  right	  as	  the	  T	   state	   is	   stabilized	  by	  CTP.	  All	  measurements	  were	  made	   in	   the	  50	  mM	  Tris-­‐acetate	  buffer,	  pH	  8.3.	  Specific	  activity	  is	  reported	  in	  mmoles	  of	  CA	  formed	  per	  hour	  per	  mg	  of	  ATCase.	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  CTP	  shifts	  the	  equilibrium	  towards	  the	  T	  state,	  increasing	  the	  [T]/[R]	  to	  1250.39	  The	  binding	  of	  CTP	  moves	   the	  sigmoidal	  Asp	  saturation	  curve	   to	   the	  right,	   resulting	   in	  more	  substrate	  needed	  to	  reach	  the	  same	  reaction	  rate	  in	  the	  absence	  of	  nucleotides.	  Conversely,	   allosteric	   activator	   ATP	   shifts	   the	   equilibrium	   towards	   the	   R	   state,	  decreasing	   the	   [T]/[R]	   to	   70.39	   The	   Asp	   saturation	   curve	   in	   the	   presence	   of	   ATP	  shifts	   to	   the	   left	   and	   shows	   less	   sigmoidal	   characteristic	   as	   ATP	   concentration	  increasing	  (See	  Figure	  1.8).	  X-­‐ray	  crystal	  structures	  of	  ATCase	  in	  the	  T	  and	  R	  states	  with	  ATP	  and	  CTP	  bound	  were	  solved	  by	  Lipscomb	  and	  coworkers.	  The	  binding	  of	  ATP	   to	   the	   T	   state	   was	   found	   to	   increase	   the	   vertical	   separation	   between	   the	  catalytic	  trimers	  by	  ~0.5	  Å	  towards	  the	  R	  state,40	  while	  CTP	  had	  the	  reverse	  effect	  of	  reducing	  the	  vertical	  separation	  by	  ~0.5	  Å	  towards	  the	  T	  state.35	  	   Though	  ATP	   and	  CTP	   cause	   opposite	   effects,	   kinetic6	   and	  binding	   studies41 suggest	   that	   ATP	   and	   CTP	   bind	   competitively	   to	   the	   same	   site.	   However	   the	   six	  allosteric	  sites	  on	  the	  enzyme	  do	  not	  all	  have	  the	  same	  affinity	  for	  ATP	  and	  CTP.	  The	  asymmetry	   binding	   of	   both	   nucleotides	   have	   been	   interpreted	   in	   terms	   of	   two	  distinct	  classes	  of	  binding	  sites:	  three	  high-­‐affinity	  sites	  and	  three	  low-­‐affinity	  sites,	  differing	  in	  affinity	  by	  about	  20-­‐fold.42-­‐44	  Furthermore,	  this	  asymmetry	  of	  binding	  is	  also	   observed	   for	   the	   isolated	   regulatory	   subunits.	   Besides	   CTP,	   UTP	   can	   also	  synergistically	   inhibit	   the	   enzyme	   in	   the	  presence	  of	   CTP,	   decreasing	   the	   catalytic	  activity	   lower	   than	  that	  by	  either	  nucleotide	  alone. To	  understand	  this	  synergistic	  effect,	   more	   binding	   studies	   have	   been	   performed	   for	   CTP	   and	   UTP.45-­‐47	   These	  results	   indicate	   that	  UTP	  binds	   to	  ATCase	   in	   the	  absence	  of	  CTP,	  but	  not	   inducing	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any	   inhibition	   unless	   CTP	   is	   present.	   CTP	   enhances	   the	   affinity	   of	   UTP	   for	   the	  regulatory	  sites	  80-­‐fold,	  and	  UTP	  enhances	  CTP	  binding	  5-­‐fold.46	  Though	  CTP	  binds	  to	  all	  six	  sites	   in	  the	  absence	  of	  UTP,	  only	  three	  high-­‐affinity	  CTP	  binding	  sites	  are	  observed	  when	  UTP	  is	  present.45	  Thus	  the	  low-­‐affinity	  CTP	  binding	  sites	  have	  been	  suggested	  to	  be	  the	  UTP	  binding	  sites.45	  This	  asymmetry	  binding	  of	  nucleotides	  may	  be	   due	   to	   the	   pre-­‐existing	   structural	   asymmetry	   in	   the	   allosteric	   sites	   on	   the	  regulatory	  dimer	  which	  is	  revealed	  from	  the	  X-­‐ray	  crystallography	  studies.33 
Research	  Aspects 
	   Chapter	  2	   investigates	  the	  allosteric	  transition	  by	  time-­‐resolved	  small-­‐angle	  X-­‐ray	  scattering	  (TR-­‐SAXS)	  in	  the	  temperature	  range	  of	  5-­‐25°	  C.	  TR-­‐SAXS	  patterns	  of	  ATCase	  in	  the	  presence	  of	  substrates	  (carbamoyl	  phosphate	  and	  L-­‐aspartate)	  and	  bi-­‐substrate	   analogues	   (N-­‐phosphonacetyl-­‐L-­‐aspartate)	   are	   reported.	   The	   effects	   of	  allosteric	   effectors,	  ATP,	   CTP	   and	  UTP	  on	   the	   kinetics	   of	   the	  quaternary	   structure	  change	  of	  ATCase	  in	  the	  presence	  of	  substrates	  are	  investigated	  by	  TR-­‐SAXS	  as	  well.	  	  	   Chapter	   3	   uses	   X-­‐ray	   crystallography	   and	   small-­‐angle	   X-­‐ray	   scattering	   in	  solution	   to	   examine	   the	  K164E/E239K	  ATCase,	   revealing	   this	  mutant	   exists	   in	   an	  intermediate	  quaternary	  structure	  between	  the	  canonical	  T	  and	  R	  structures.	  	  These	  data	  indicate	  that	  this	  mutant	  is	  not	  a	  model	  for	  the	  R	  state	  as	  has	  been	  proposed,	  but	  rather	  represents	  the	  enzyme	  trapped	  along	  the	  path	  of	  the	  allosteric	  transition	  between	  the	  T	  and	  R	  states. 	   Chapter	  4	   systematically	   studies	   the	  nucleotide	   regulation	  of	  ATCase	   in	   the	  absence	  and	  presence	  of	  Mg2+	  as	  allosteric	  effectors,	  ATP,	  CTP	  and	  GTP,	  have	  shown	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Dihydroorotase	  
Brief	  Overview	  of	  Dihydroorotase	  
	   Dihydroorotase	  (EC	  3.5.2.3,	  DHOase)	   is	  a	  zinc	  metalloenzyme	  that	  catalyzes	  the	   reversible	   cyclization	   of	   N-­‐carbamoyl-­‐L-­‐aspartate	   (CA)	   to	   L-­‐dihydroorotate	  (DHO)	  in	  the	  third	  step	  of	  de	  novo	  pyrimidine	  biosynthetic	  pathway	  (Figure	  1.9).	  At	  lower	  pH,	  the	  reaction	  favors	  the	  biosynthetic	  direction	  to	  produce	  DHO.	  At	  higher	  pH,	   the	   formation	  of	  CA	   is	   favored.	  The	  equilibrium	  between	  CA	  and	  DHO	  reaches	  unity	  at	  pH	  6.2.48 In	   prokaryotes,	   DHOase	   is	   a	   monofunctional	   homodimeric	   enzyme.49	   In	  higher	  eukaryotes,	  DHOase	  is	  part	  of	  a	  trifunctional	  enzyme,	  carbamoyl	  phosphate	  synthetase-­‐dihydroorotase-­‐aspartate	   transcarbamylase	   (CAD),	  which	   catalyzes	   the	  first	   three	  reactions	   in	  the	  biosynthesis	  of	  pyrimidine	  nucleotides.50	  An	  analysis	  of	  the	   amino	   acid	   sequences	   of	   DHOase	   from	   multiple	   species	   reveals	   two	   major	  classes	   of	   this	   enzyme	   thought	   to	   have	   arisen	   from	   ancestral	   gene	   duplication.51	  Type	   I	   DHOases,	   found	   in	   higher	   organisms,	   are	   the	   most	   ancient	   and	   widely	  divergent	   form	   of	   the	   enzyme.	   There	   are	   three	   subgroups	   within	   the	   Type	   I	  DHOases:	   Type	   IA	   is	  monofunctional	   and	   independent	   (e.g.	   DHOase	   from	  Bacillus 
caldolyticus);52,53	  Type	  IB	  only	  functions	  when	  associates	  non-­‐covalently	  with	  one	  or	  more	   other	   enzymes	   in	   the	   pyrimidine	   pathway	   (e.g.	   DHOase	   from	   Aquifex 
aeolicus);54,55	   Type	   IC	   is	   found	   as	   part	   of	   the	   multifunctional	   proteins	   (e.g.	  mammalian	   CAD).	   Type	   II	   DHOases,	   found	   in	   many	   bacteria	   and	   fungi,	   are	   a	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Figure	   1.9.	   The	   reversible	   cyclization	   of	   CA	   to	   DHO	   catalyzed	   by	   DHOase.	   The	  reaction	  is	  pH	  dependent.	  At	  lower	  pH,	  the	  forward	  reaction	  to	  form	  DHO	  is	  favored	  and	  at	  higher	  pH,	  the	  reverse	  reaction	  to	  form	  CA	  is	  favored.	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more	  recent	  evolutionary	  development	  from	  significant	  changes	  in	  sequence.	  They	  are	  all	  monofunctional	  proteins,	  such	  as	  DHOase	  from	  E. coli. Type	  I	  DHOases	  have	  a	  larger	   size	   (~45	  kDa)	   than	   the	  Type	   II	   enzymes	   (~38	  kDa).	  Members	  of	   the	   same	  type	  of	  DHOase	  have	  a	  high-­‐level	  amino	  acid	  sequence	   identity	  of	  more	  than	  40%,	  while	   less	   than	  20%	  sequence	   identity	   is	  observed	   for	  members	  between	   the	   two	  types.	  	  Holm	   and	   Sander	   proposed	   that	   DHOase	   belongs	   to	   the	   amidohydrolase	  superfamily	  that	  comprises	  a	  diverse	  set	  of	  hydrolytic	  enzymes.56	  Members	  of	   this	  superfamily	  were	   predicted	   to	   have	   a	   common	   structural	   core	   consisting	   of	   eight	  alternating	   β-­‐sheet/α-­‐helices	   (or	   TIM-­‐barrel)	   and	   a	   signature	   pattern	   of	   four	  conserved	   histidine	   residues	   and	   one	   aspartate	   residue.	   There	   are	   two	   subsets	  within	  this	  superfamily:	  the	  first	  subset	  consists	  of	  enzymes	  with	  a	  binuclear	  metal	  center,	  where	  the	  two	  metal	  ions	  are	  bridged	  by	  a	  solvent-­‐derived	  hydroxide	  and	  a	  carboxylated	   lysine	   (e.g.	   urease);	   the	   second	   subset	   consists	   of	   enzymes	   with	   a	  single	  metal	   ion	   at	   the	   active	   site	   in	   the	   absence	   of	   the	   carboxylated	   lysine57	   (e.g.	  adenosine	   deaminase).	   DHOase	   was	   first	   thought	   to	   belong	   to	   the	   second	   subset	  because	   only	   one	   zinc	   atom	   was	   found	   at	   the	   active	   site.56	   However	   the	   first	  structure	  of	  a	  DHOase,	  that	  from	  E. coli,	  solved	  to	  a	  resolution	  of	  1.7	  Å	  by	  Thoden	  et	  
al.,58	  (PDB	  ID	  1J79)	  showed	  a	  binuclear	  zinc	  center	  at	  the	  active	  site,	  placing	  the	  E. 
coli enzyme	  in	  the	  first	  subset.	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Structure	  of	  E. coli	  DHOase	  
E. coli	  DHOase	  was	  first	  purified	  by	  Washabaugh	  et	  al.49	  The	  native	  molecular	  weight	   was	   determined	   to	   be	   80,900	   Da	   by	   equilibrium	   sedimentation	   while	  molecular	  weight	   of	   subunit	  was	   determined	   to	   be	   38,400	  Da	   by	   sodium	  dodecyl	  sulfate-­‐polyacrylamide	   gel	   electrophoresis.	   The	   enzyme	   was	   thus	   a	   dimer.	   More	  than	  15	  years	  later	  the	  first	  structure	  of	  E. coli	  DHOase	  was	  solved	  and	  reported	  by	  Thoden	  et	  al.,	  which	  was	  also	  the	  first	  structure	  of	  any	  DHOase	  (PDB	  ID	  1J79).58	  As	  proposed	  by	  Holm	  and	  Sander,56	   the	   architecture	  of	   the	  E. coli	  DHOase	   resembles	  the	   structure	   core	   of	   urease.	  As	   shown	   in	   Figure	  1.10	   each	   subunit	   of	   the	  protein	  folds	  into	  a	  TIM-­‐barrel	  motif,	  with	  eight	  strands	  of	  parallel	  β-­‐sheets	  flanked	  on	  the	  outer	  surface	  by	  α-­‐helices.	  	  The	  asymmetric	  unit	  contained	  a	  single	  homodimer.	  Though	  the	  enzyme	  was	  crystallized	   in	   the	  presence	  of	   racemic	   substrate	  D,L-­‐CA,	   the	   structure	   showed	   the	  substrate	   CA	   bound	   at	   the	   active	   site	   of	   one	   subunit	   (subunit	   B)	   and	   the	   product	  DHO	  bound	  at	  the	  active	  site	  of	  the	  other	  (subunit	  A).	  No	  explanation	  for	  the	  unusual	  structure	  was	   given	   and	   the	   residues	  B109-­‐B112	  were	   omitted.	   Later,	   Lee	   et	  al.59	  were	   able	   to	   resolve	   the	   conformations	   of	   residues	   109-­‐112	   for	   both	   subunits	   by	  solving	  the	  structure	  of	  E. coli	  DHOase	  crystallized	  in	  the	  presence	  of	  DHO	  (PDB	  ID	  1XGE).	   They	   found	   that	   the	   residues	   B109-­‐B112	   missing	   in	   the	   first	   structure	  comprised	   part	   of	   the	   100’s	   loop	   (residues	   105-­‐115),	   which	   adopted	   different	  conformations	   for	   each	   subunit	   of	   the	  dimer.	   For	   the	  CA-­‐bound	   subunit,	   this	   loop	  reached	  toward	  the	  active	  site	  and	  made	  direct	  contact	  with	  the	  substrate.	  For	  the	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Figure	  1.10.	  Structure	  of	  E. coli	  DHOase.	  Each	  monomer	  of	  the	  dimer	  folds	  into	  the	  TIM	  barrel.	  The	  substrate	  CA	  and	  product	  DHO	  are	   shown	   in	   the	  active	   sites	  with	  two	   zinc	   atoms	   shown	   as	   magenta	   spheres.	   This	   figure	   was	   drawn	  with	   Pymol19	  using	  data	  from	  PDB	  ID	  1J79.58 






















Figure	   1.11.	   Superposition	   of	   the	   100’s	   loop	   (residues	   105-­‐115)	   from	   subunit	   A	  (green)	  and	  subunit	  B	  (blue)	  of	  DHOase.	  In	  DHO-­‐bound	  subunit	  A,	  the	  loop	  has	  the	  “out”	  conformation.	  In	  CA-­‐bound	  subunit	  B,	  the	  loop	  has	  the	  “in”	  conformation.	  CA	  is	  shown	  with	  its	  carbon	  atoms	  in	  yellow.	  	  When	  loop	  reaches	  in	  toward	  the	  active	  site,	  Thr109	  and	  Thr110	  shown	  in	  thick	  lines	  have	  hydrogen-­‐bonding	  interactions	  with	  CA.	  The	  zinc	  atoms	  in	  the	  active	  site	  are	  shown	  as	  magenta	  spheres.	  This	  figure	  was	  redrawn	  with	  Pymol19	  using	  data	  from	  PDB	  ID	  1XGE.59 
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  DHO-­‐bound	  subunit,	  this	  loop	  moved	  away	  from	  the	  active	  site	  forming	  part	  of	  the	  protein	  surface	  (see	  Figure	  1.11).	  
Active	  Site	  of	  E. coli	  DHOase 
	   As	   a	   member	   of	   the	   amidohydrolase	   superfamily,	   the	   signature	   pattern	   of	  four	  histidine	  and	  one	  aspartate	  residues	  was	  observed	  in	  the	  active	  site.58	  Though	  DHOase	  was	  originally	  proposed	  to	  belong	  to	  the	  second	  subset	  of	  this	  superfamily,	  in	   the	   structure	   of	   E. coli	   DHOase	   it	   clearly	   showed	   that	   the	   active	   sites	   of	   both	  subunits	  contained	  a	  binuclear	  zinc	  center,	  which	  suggested	  this	  enzyme	  belong	  to	  the	  first	  subset.	  This	  was	  also	  consistent	  with	  the	  observation	  that	  the	  carboxylated	  Lys102	  served	  as	  a	  bridging	  ligand	  between	  the	  two	  metals.	  In	  the	  active	  site	  with	  DHO	  bound	  a	  water	  or	  hydroxide	  ion	  also	  served	  to	  bridge	  the	  two	  zinc	  ions.	  One	  of	  the	   zinc	   ions	  was	   tetrahedrally	   coordinated	  with	  His139,	  His177,	   Lys102,	   and	   the	  bridging	  hydroxide,	  while	   the	  other	  zinc	   ion	  was	  trigonal	  bipyramidal	  coordinated	  with	  His16,	  His18,	  Asp250,	  Lys102	  and	  the	  bridging	  hydroxide.	  The	  binuclear	  zinc	  center	  was	  arranged	  in	  the	  similar	   fashion	  in	  the	  active	  site	  with	  CA	  bound	  except	  the	   replacement	   of	   the	   bridging	   hydroxide	   with	   the	   carboxylate	   oxygen	   of	   the	  substrate	  CA.	  	  	   As	  can	  be	  seen	   in	  Figure	  1.12	  A,	  DHO	   is	   in	  close	  proximity	   to	   the	  binuclear	  metal	  center.	  Backbone	  atoms	  of	  Leu222	  and	  Ala266	  formed	  hydrogen	  bonds	  with	  DHO.	  The	   side	   chains	  of	  Arg20,	  Asn44	  and	  His254	  help	   to	   anchor	   the	   carboxylate	  group	  of	  DHO.	  CA	  also	  has	  interactions	  with	  these	  residues	  as	  shown	  in	  Figure	  1.12	  



























Figure	  1.12.	  Active	  sites	  of	  E. coli	  DHOase.	  (A)	  The	  active	  site	  of	  subunit	  A.	  DHO	  is	  shown	   with	   its	   carbon	   atoms	   in	   yellow.	   The	   oxygen	   atom	   of	   a	   water	   molecule	  bridging	  the	  two	  zinc	  atoms	  is	  shown	  as	  red	  sphere.	  (B)	  The	  active	  site	  of	  subunit	  B.	  CA	   is	   shown	  with	   its	   carbon	   atoms	   in	   yellow.	  Only	   the	   side	   chains	   of	  Thr109	   and	  Thr110	  are	   shown	  as	   thin	   lines.	  The	   zinc	   atoms	   in	  both	   active	   sites	   are	   shown	  as	  magenta	   spheres.	   This	   figure	   was	   drawn	   with	   Pymol19	   using	   data	   from	   PDB	   ID	  1XGE.59 
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B.	  In	  addition,	  Thr109	  and	  Thr110,	  the	  tip	  of	  the	  100’s	  loop	  hydrogen	  bond	  to	  both	  carboxylate	  groups	  of	  CA.59	  	  	  
Catalytic	  Mechanism 
	   The	  detailed	  reaction	  mechanism	  of	  E. coli	  DHOase	  was	  first	  proposed	  based	  on	   the	   three-­‐dimensional	   crystal	   structure	   of	   the	   enzyme	   in	   the	   presence	   of	   an	  equilibrium	   mixture	   of	   the	   reaction	   products.58	   The	   proposed	   mechanism	   was	  improved	   later	  on	   the	  basis	  of	   an	  analysis	  of	   the	  effects	  of	  pH,	  metal	   substitution,	  solvent	  isotope	  effects,	  mutant	  proteins,	  and	  alternative	  substrates.60	  	  Presented	   in	   Figure	   1.13	   is	   the	   mechanism	   of	   the	   reversible	   reaction	  catalyzed	  by	  DHOase	   involving	   the	  binuclear	  metal	   center	  and	   the	  proton	   transfer	  facilitator	  Asp250	  in	  the	  active	  site.60	  For	  the	  biosynthesis	  of	  DHO	  which	  is	  favored	  at	  lower	  pH,	  the	  substrate	  CA	  binds	  to	  the	  protonated	  form	  of	  the	  enzyme	  with	  the	  release	   of	   a	   bound	   water	   molecule,	   which	   results	   from	   the	   protonation	   of	   the	  bridging	   hydroxide	   associated	   with	   the	   binuclear	   metal	   center.	   The	   reaction	   is	  initiated	   by	   the	   abstraction	   of	   a	   proton	   from	   the	   amide	   nitrogen	   of	   CA	   by	   the	  carboxylate	   of	   Asp250	   residue.	   Meanwhile	   the	   ring	   closure	   occurs	   with	   the	  nucleophilic	  attack	  on	  the	  carbon	  center	  of	  the	  carboxylate	  of	  CA	  by	  the	  same	  amide	  nitrogen	  to	  form	  the	  product	  DHO.	  The	  binuclear	  metal	  center	  is	  recharged	  with	  the	  bridging	   solvent	   hydroxide.	   In	   the	   reverse	   direction	   to	   form	   CA,	   the	   hydroxide	  bridging	   the	   two	  divalent	   cations	   is	   required	   for	   the	   catalysis.	   The	  polarization	  of	  the	  carbonyl	  oxygen	  of	  DHO	  through	  the	  interaction	  with	  the	  β-­‐metal	  promotes	  the	  nucleophilic	  attack	  of	  the	  bridging	  hydroxide	  on	  the	  carbon	  center.	  Asp250	  transfers
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Figure	  1.13.	  Proposed	  mechanism	  of	  the	  catalysis	  by	  E. coli	  DHOase.	  This	  figure	  was	  redrawn	  with	  modification	  of	  the	  scheme	  presented	  by	  Porter	  et	  al.60 	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the	  proton	  from	  the	  bridging	  hydroxide	  to	  the	  amide	  nitrogen	  via	  the	  formation	  of	  the	   tetrahedral	   intermediate.	   Formation	   of	   CA	   takes	   place	   when	   the	   tetrahedral	  intermediate	  collapsed	  with	  the	  cleavage	  of	  the	  carbon-­‐nitrogen	  bond.	  
Research	  Aspects	  Chapter	  5	  uses	  a	  virtual	  high-­‐throughput	  screening	  (vHTS)	  system	  developed	  in	  our	   lab	  to	   identify	   inhibitors	  of	  DHOase,	  which	  may	  become	  lead	  compounds	  as	  potential	   drug	   candidates.	   In	   particular,	   we	   first	   screened	   about	   3,000,000	  compounds	  from	  the	  ZINC	  database	  using	  the	  docking	  program	  Surflex	  through	  this	  system.	   The	   top	   five	   hundred	   compounds	   were	   then	   docked	   and	   scored	   using	   3	  other	   docking	   tools:	   AutoDock3.0,	   DOCK5.0,	   and	   GOLD.	   An	   independent	   scoring	  program	  XScore	  was	  used	  to	  rank	  the	  docking	  poses	  from	  all	  4	  tools.	  Among	  the	  top	  fifty	  poses,	  five	  candidates	  were	  purchased	  and	  their	  inhibitory	  effects	  against	  E. coli	  DHOase	  were	  tested.	  Chapter	  6	  uses	  unnatural	  amino	  acid	  mutagenesis	  to	  genetically	  incorporate	  a	   fluorescent	   amino	   acid	   into	   the	   100’s	   loop	   (residue	   105-­‐115)	   of	   DHOase	   to	  investigate	  the	  role	  of	  loop	  motion	  for	  catalysis	  and	  cooperativity.	  5-­‐fluoroorotate,	  a	  known	  inhibitor	  of	  DHOase,	  was	  used	  to	  probe	  the	   fluorescence	  change	  upon	   loop	  movement.	  The	  inhibition	  curve	  of	  FOA	  against	  fluorescent	  DHOase	  was	  determined	  by	  colorimetric	  assay.	  The	  fluorescence	  response	  was	  measured	  upon	  the	  binding	  of	  FOA	  and	  examined	  with	  comparison	  to	  the	  inhibition	  curve.	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Time	  Evolution	  of	  the	  Quaternary	  Structure	  of	  Escherichia coli	  
Aspartate	  Transcarbamoylase	  upon	  Reaction	  with	  the	  Natural	  
Substrates	  and	  a	  Slow	  Tight	  Binding	  Inhibitor	  An	  article	  published	  in	  Journal	  of	  Molecular	  Biology	  by	  Jay	  M.	  West,	  Jiarong	  Xia,	  Hiro	  Tsuruta,	  Wenyue	  Guo,	  Elizabeth	  M.	  O’Day	  	  and	  Evan	  R.	  Kantrowitz	  	  	  	  	  	  	  	  	  	  *Contribution	  to	  work:	  Purified	  wild-­‐type	  ATCase	  holoenzyme	  and	  carried	  out	  the	  kinetic	  study	  of	  ATCase	  in	  the	  absence	  and	  presence	  of	  ethylene	  glycol,	  and	  at	  both	  25°	  C	  and	  5°	  C.	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Introduction	  Aspartate	   transcarbamoylase	   (ATCase)	   catalyzes	   one	   of	   the	   first	   steps	   in	  pyrimidine	  nucleotide	  biosynthesis,	  the	  reaction	  of	  carbamoyl	  phosphate	  (CP),	  with	  
L-­‐aspartate	   (Asp)	   to	   form	  N-­‐carbamoyl-­‐L-­‐aspartate	   and	   inorganic	   phosphate	   (Pi).1	  In	  many	  prokaryotes	  such	  as	  Escherichia coli	  this	  reaction	  is	  the	  committed	  step	   in	  pyrimidine	   nucleotide	   biosynthesis.	   E. coli	   ATCase	   is	   composed	   of	   two	   types	   of	  subunits.	  The	  two	  larger	  or	  catalytic	  subunits	  are	  each	  composed	  of	  three	  identical	  polypeptide	  chains	  (Mr	  34,000),	  while	  the	  three	  smaller	  or	  regulatory	  subunits	  are	  each	   composed	   of	   two	   identical	   polypeptide	   chains	   (Mr	   17,000).	   Each	   of	   the	   six	  active	   sites	   is	   located	   at	   the	   interface	   between	   two	   adjacent	   catalytic	   chains,	   and	  side	  chains	  required	  for	  catalysis	  are	  recruited	  to	  the	  active	  site	  from	  both	  chains.2	  The	   enzyme	   demonstrates	   homotropic	   cooperativity	   for	   the	   substrate	   Asp	   and	   is	  heterotropically	   regulated	  by	   the	   effectors	  ATP,	   CTP,3	   and	  UTP	   in	   the	   presence	   of	  CTP.4	  	   The	  structures	  of	  the	  low-­‐activity	  T	  state	  (in	  the	  absence	  of	  substrates)5,6	  and	  high-­‐activity	  R	  state	  (in	  the	  presence	  of	  substrates	  or	  substrate	  analogues	  such	  as	  N-­‐phosphonacetyl-­‐L-­‐aspartate,	   PALA)7-­‐9	   have	   been	   determined	   by	   X-­‐ray	  crystallography.	  	  A	  comparison	  of	  the	  T	  and	  R	  structures	  reveals	  that	  during	  the	  T	  →	  R	  transition,	  the	  two	  catalytic	  trimers	  increase	  their	  separation	  along	  the	  3-­‐fold	  axis	  by	  about	  11	  Å	  and	  rotate	  about	  5˚	  around	  the	  same	  axis,	  while	  the	  regulatory	  dimers	  rotate	   about	   15˚	   around	   their	   respective	   2-­‐fold	   axes.10	   The	   11	  Å	   expansion	   of	   the	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enzyme	  observed	  during	  the	  T	  →	  R	  transition	  is	  easily	  monitored	  by	  small-­‐angle	  X-­‐ray	  scattering	  (SAXS).11	  Thus,	   the	  SAXS	  pattern	   is	  a	  sensitive	  and	  specific	  probe	  to	  study	  the	  quaternary	  conformational	  changes	  of	  the	  enzyme.	  	  	  By	  using	  SAXS	  as	  a	  structural	  probe	   in	  stopped-­‐flow	  experiments,	   the	  time-­‐evolution	   of	   the	   quaternary	   conformational	   changes	   of	   ATCase	   have	   been	  monitored.12,13	  These	  studies	  showed	  that	  the	  enzyme	  when	  mixed	  with	  substrates	  is	   very	   quickly	   converted	   from	   the	  T	   to	   the	  R	   state,	   the	   enzyme	   remains	   in	   the	  R	  state	   until	   substrates	   are	   exhausted,	   and	   then	   the	   enzyme	   reverts	   back	   to	   the	   T	  state.	   These	   early	   studies	   required	   integration	  of	   the	   signal	   over	   time	   intervals	   of	  100	  -­‐	  200	  ms	  and	  averaging	  over	  many	  runs	  to	  improve	  the	  signal	  to	  noise	  ratio.12,13	  Because	  of	  the	  relatively	  long	  time	  window	  for	  each	  point	  it	  was	  necessary	  to	  slow	  the	   reaction	   rate,	  which	  was	  done	  by	  performing	   the	   reaction	  at	   –5°	  C	   in	   a	  buffer	  containing	  20%	  ethylene	  glycol.	  Dreyfus	  et	  al.14	  showed	  that	  a	  variety	  of	  alcohols	  such	  as	  methanol,	  ethanol,	  1-­‐propanol,	   2-­‐propanol,	   1-­‐butanol,	   and	   2-­‐methyl-­‐2-­‐propanol	   have	   a	   significant	  influence	   on	   the	   activity	   and	   homotropic	   cooperativity	   of	   ATCase.	   	   For	   example,	  20%	  methanol	   or	   ethanol	   reduced	   the	   activity	   of	   ATCase	   by	   approximately	   90%.	  	  Additional	   studies	   with	   15%	   ethanol	   showed	   a	   shift	   in	   the	   pH	   optimum	   of	   the	  reaction	   and	   an	   alteration	   in	   the	   Hill	   coefficient.	   	   Their	   interpretation	   of	   these	  solvent	  effects	  was	  that	  the	  cosolvent	  preferentially	  stabilized	  the	  T	  or	  R	  state	  of	  the	  enzyme	   depending	   upon	   the	   relative	   concentration	   and	   polarity	   of	   the	   cosolvent.	  	  For	  the	  simple	  alcohols,	  the	  primary	  effect	  was	  stabilization	  of	  the	  T	  state.	  	  Although	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ethylene	   glycol	   was	   not	   investigated	   by	   Dreyfus	   et	   al.,14	   one	   would	   predict	   that	  ethylene	   glycol	  with	   its	   two	  hydroxyl	   groups	  would	   behave	   similarly	   to	  methanol	  and	  ethanol.	  	  	  Here	  we	   reinvestigate	   the	   time-­‐evolution	  of	   the	  quaternary	   conformational	  changes	   of	   ATCase	   in	   the	   absence	   of	   ethylene	   glycol.	   This	   was	  made	   possible	   by	  significant	   instrumental	   developments	   including	   a	   fast	   CCD	   X-­‐ray	   detector	   and	   a	  high-­‐flux	  X-­‐ray	  beam	  via	  a	  multilayer	  monochromator15,	  with	  an	   increase	   in	  beam	  brightness	   due	   to	   the	   update	   of	   the	   synchrotron	   storage	   ring	   at	   Stanford	  Synchrotron	   Radiation	   Laboratory	   (SSRL)	   to	   SPEAR3,	   a	   third	   generation	   source.	  	  These	   improvements	   allowed	   the	   collection	   of	   time-­‐resolved	   SAXS	   data	   at	   a	   time	  resolution	  as	  short	  as	  5	  ms.	  Using	  this	  system	  we	  were	  able	  to	  study	  the	  quaternary	  conformational	   changes	   of	   ATCase	   in	   the	   temperature	   range	   of	   5-­‐22°	   C	   in	   the	  absence	  of	  ethylene	  glycol.	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Results	  
Kinetics	  of	  the	  ATCase	  Reaction	  In	  the	  Presence	  of	  Ethylene	  Glycol	  Since	  previous	  TR-­‐SAXS	  experiments	  were	  performed	  in	  the	  presence	  of	  20%	  ethylene	   glycol,12,13	   and	   Dreyfus	   et	   al.14	   showed	   that	   a	   variety	   of	   alcohols	   at	  concentrations	  of	  20%	  or	  less	  can	  dramatically	  alter	  the	  catalytic	  turnover	  rate	  and	  cooperativity	  of	  ATCase,	  kinetic	  assays	  were	  performed	  in	  the	  presence	  of	  ethylene	  glycol	   to	   determine	   if	   it	   had	   any	   influence	   on	   the	   ATCase	   reaction.	   As	   shown	   in	  Figure	  2.1	  (a),	  ethylene	  glycol	  dramatically	  reduced	  the	  activity	  of	  ATCase	  at	  5°	  C.	  In	  the	  presence	  of	  20%	  ethylene	  glycol	  the	  activity	  of	  the	  enzyme	  was	  reduced	  by	  75%.	  In	   addition	   to	   reducing	   the	   activity	   of	   the	   enzyme,	   ethylene	   glycol	   had	   a	   small	  influence	  on	  homotropic	  cooperativity	  (data	  not	  shown).	  Ethylene	  glycol	  also	  has	  a	  significant	  influence	  on	  the	  ability	  of	  the	  heterotropic	  effectors	  to	  modulate	  enzyme	  activity.	   	   As	   shown	   in	   Figure	   2.1	   (b)	   at	   5°	   C	   the	   presence	   of	   20%	   ethylene	   glycol	  increased	  the	  activation	  of	  the	  enzyme	  by	  ATP,	  while	  reducing	  the	  inhibition	  by	  CTP.	  The	  maximal	   activation	  by	  ATP	   increased	   from	  220%	   to	  274%	   in	   the	  presence	  of	  20%	  ethylene	  glycol.	  The	  residual	  activity	  at	  a	  saturating	  concentration	  of	  CTP	  was	  29%	  as	  compared	  to	  48%	  in	  the	  presence	  of	  ethylene	  glycol.	  The	  value	  of	  KATP	  (K	  is	  the	   nucleotide	   concentration	   required	   at	   50%	  maximal	   activation	   or	   inhibition	   of	  the	  enzyme)	  increased	  from	  0.47	  mM	  to	  0.72	  mM	  in	  the	  presence	  of	  20%	  ethylene	  glycol.	  The	  value	  of	  KCTP	  increased	  from	  7.8	  µM	  to	  14.5	  µM	  in	  the	  presence	  of	  20%	  ethylene	  glycol.	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Figure	   2.1.	   (a)	   The	   dependence	   of	   activity	   of	   ATCase	   on	   the	   concentration	   of	  ethylene	  glycol.	  All	  measurements	  were	  made	  at	  5°	  C	  in	  the	  presence	  of	  50	  mM	  Tris,	  2	  mM	  DTT,	   pH	   8.3.	   (b)	   Influence	   of	   the	   nucleotide	   effectors	   ATP	   and	   CTP	   on	   the	  activity	  of	  ATCase	  in	  the	  presence	  and	  absence	  of	  20%	  ethylene	  glycol.	  Colorimetric	  assays	   were	   performed	   at	   5°	   C	   in	   50	   mM	   Tris	   acetate	   buffer	   (pH	   8.3)	   at	   a	  subsaturating	  concentration	  of	  L-­‐Asp	  (2.4	  mM)	  and	  saturating	  CP	  concentration	  (4.8	  mM),	  in	  the	  presence	  of	  ATP	  and	  20%	  ethylene	  glycol	  (v/v)	  (),	  in	  the	  presence	  of	  ATP	   and	   in	   the	   absence	   of	   ethylene	   glycol	   (),	   in	   the	   presence	   of	   CTP	   and	   20%	  ethylene	   glycol	   (v/v)	   (),	   in	   the	   presence	   of	   CTP	   and	   in	   the	   absence	   of	   ethylene	  glycol	  (v/v)	  ().	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The	  ability	  of	  UTP	  to	  act	  as	  a	  synergistic	  inhibitor	  of	  ATCase	  in	  the	  presence	  of	  CTP4	  was	  also	  tested	  at	  5°	  C	  in	  the	  absence	  and	  presence	  of	  20%	  ethylene	  glycol.	  In	   the	   absence	   of	   ethylene	   glycol	   the	   combination	   of	   4	   mM	   CTP	   and	   4	   mM	   UTP	  (CTP/UTP)	   yielded	   a	   residual	   activity	   of	   the	   enzyme	   of	   22%,	   whereas	   in	   the	  presence	  of	  ethylene	  glycol	  the	  combination	  of	  CTP/UTP	  yielded	  a	  residual	  activity	  of	  the	  enzyme	  of	  28%.	  	  
Kinetics	  of	  the	  ATCase	  Reaction	  at	  5°	  C	  Because	   the	   TR-­‐SAXS	   experiments	   reported	   here	   were	   performed	   at	  temperatures	   as	   low	   as	   5°	   C,	   the	   kinetic	   properties	   of	   ATCase	   were	   fully	  characterized	  at	  5°	  C	  in	  the	  same	  buffers	  used	  for	  the	  TR-­‐SAXS	  experiments	  (Figure	  2.2).	   As	   shown	   in	   Table	   2.1,	   many	   aspects	   of	   catalysis	   at	   25°	   C	   are	   not	   only	  quantitatively	  different	  at	  5°	  C,	  but	  in	  some	  cases	  qualitatively	  different.	   	  As	  would	  be	   expected,	   the	   maximal	   observed	   velocity	   was	   reduced	   by	   nearly	   5-­‐fold.	   This	  reduction	   in	   velocity	   was	   accompanied	   by	   an	   almost	   3-­‐fold	   decrease	   in	   the	  concentration	  of	  Asp	  required	  for	  half-­‐maximal	  activity	  ([Asp]0.5),	  and	  a	  decease	  in	  the	  Hill	  coefficient	  (nH)	  from	  2.6	  to	  2.0.	  	  The	  observed	  changes	  in	  [Asp]0.5	  and	  nH	  are	  similar	  to	  the	  changes	  observed	  when	  Asp	  saturating	  curves	  are	  determined	  in	  the	  presence	  of	  ATP,	  suggesting	  that,	  like	  ATP,	  lower	  temperatures	  shift	  the	  equilibrium	  towards	  the	  R	  state.	  	  This	  phenomenon	  was	  demonstrated	  in	  a	  previous	  SAXS	  study	  by	   the	   shift	   in	   the	   structural	   equilibrium	   of	   the	   mutant	   D236A	   enzyme	   in	   the	  direction	  of	  the	  R	  state	  with	  decreasing	  temperature.16	  At	  5°	  C	  the	  [Asp]0.5	  decreased	  nearly	  2-­‐fold	  in	  the	  presence	  of	  ATP;	  increased	  20%	  in	  the	  presence	  of	  UTP;	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a	  All	  experiments	  were	  performed	  in	  50	  mM	  Tris-­‐acetate	  buffer	  (pH	  8.3)	  at	  a	  saturating	  CP	  concentration	  (4.8	  mM)	  
b	  The	  maximal	  observed	  velocity	  (mmol•h-­‐1•mg-­‐1	  )	  
c	  The	  observed	  concentration	  of	  L-­‐Asp	  (mM)	  which	  produces	  one-­‐half	  the	  observed	  maximal	  velocity	  
d	  Hill	  coefficient	  	  	  
Conditionsa	   Vmax	  b	   [Asp]0.5	  c	  25	  °C	   nH	  d	   Vmax	  b	   [Asp]0.5	  c	  5	  °C	   nHd	  No	  NTPs	   19.1	  ±	  0.3	   12.7	   2.6	  ±	  0.2	   4.2	  ±	  0.5	   5.1	   2.0	  ±	  0.1	  5mM	  ATP	   19.8	  ±	  0.7	   6.1	   1.4	  ±	  0.1	   5.4	  ±	  0.2	   2.9	   1.6	  ±	  0.2	  4mM	  CTP	   17.9	  ±	  0.9	   21.2	   2.4	  ±	  0.1	   3.6	  ±	  0.2	   11.3	   3.0±	  0.1	  4mM	  UTP	   18.4	  ±	  0.2	   13.5	   2.3	  ±	  0.1	   4.1	  ±	  0.6	   5.9	   2.2	  ±	  0.1	  4mM	  CTP/UTP	   17.3	  ±	  0.4	   28.6	   2.9	  ±	  0.1	   3.0	  ±	  0.4	   12.5	   3.0	  ±	  0.1	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Figure	  2.2.	  L-­‐Asp	  saturation	  kinetics	  in	  the	  absence	  and	  presence	  of	  the	  nucleotide	  effectors	  at	  (a)	  5°	  C	  and	  (b)	  25°	  C.	  	  Reactions	  were	  carried	  out	  in	  50	  mM	  Tris	  buffer,	  pH	  8.3.	  	  The	  kinetic	  curves	  were	  determined	  in	  the	  presence	  of	  5	  mM	  ATP	  (Δ),	  4	  mM	  CTP	   (),	   4	   mM	   UTP	   (),	   4	   mM	   CTP	   and	   4mM	   UTP	   ()	   as	   compared	   to	   the	  saturation	  kinetics	   in	  the	  absence	  of	  nucleotide	  ().	  Specific	  activity	   is	  reported	  in	  units	  of	  mmoles	  of	  carbamoyl	  aspartate	  formed	  per	  mg	  per	  hr.	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increased	  over	  2-­‐fold	  in	  the	  presence	  of	  CTP;	  and	  increased	  by	  a	  factor	  of	  2.5	  	  in	  the	  presence	   of	   CTP/UTP.	   A	   similar	   trend	   was	   also	   observed	   at	   25°	   C.	   The	   [Asp]0.5	  decreased	  over	  2-­‐fold	  in	  the	  presence	  of	  ATP;	  increased	  10%	  in	  the	  presence	  of	  UTP;	  increased	   nearly	   2-­‐fold	   in	   the	   presence	   of	   CTP;	   and	   increased	   by	   2.3-­‐fold	   in	   the	  presence	  of	  CTP/UTP.	  The	  kinetic	  data	  at	  5°	  C	  was	  plotted	  as	  v/Vmax	  vs.	  [Asp]	  as	  shown	  in	  Figure	  2.3	  and	  fitted	  by	  the	  theoretical	  curve	  of	  
€ 
Y Asp	  (fraction	  of	  active	  sites	  occupied	  by	  Asp)	  vs.	   αKR(Asp),	   which	   is	   derived	   from	   the	   equations	   of	   the	   theoretical	   two-­‐state	  allosteric	  transition	  model	  proposed	  by	  Monod	  et	  al.17,18	  
€ 
Y Asp= α(1+α)
n−1 + L'αcAsp (1+αcAsp )n−1
(1+α)n + L'(1+αcAsp )n
	  
where	  α	  =	  [Asp]	  /	  KR(Asp),	  L’	  is	  the	  allosteric	  equilibrium	  constant	  in	  the	  presence	  of	  saturating	   CP,	   and	   cAsp	   =	   KR(Asp)	   /	   KT(Asp).	   	   KT(Asp)	   	   and	   KR(Asp)	   are	   the	   dissociation	  constants	  of	  Asp	  for	  the	  T	  and	  R	  allosteric	  states,	  respectively.	  	  A	  value	  of	  L’	  =	  10	  was	  obtained	  from	  the	  static	  SAXS	  data	  shown	  in	  Figure	  2.4,	  according	  to	  the	  methods	  of	  Tsuruta	  et	  al.13	  The	  starting	  point	  used	  for	  KR(Asp)	   	  was	  the	  [Asp]0.5	  =	  5.1	  mM	  value	  obtained	  from	  the	  kinetic	  data.	  	  After	  obtaining	  a	  suitable	  fit	  for	  the	  data	  the	  values	  of	  KR(Asp)	  =	  3.5	  ±	  0.5	  mM	  and	  KT(Asp)	  =	  40	  ±	  10	  mM	  were	  derived.	  
Time-­Resolved	  X-­ray	  Scattering:	  Effect	  of	  Substrates	  and	  Substrate	  Analogues	  TR-­‐SAXS	  was	   used	   to	  monitor	   the	   quaternary	   conformational	   changes	   that	  ATCase	  undergoes	  when	  the	  enzyme	  is	  mixed	  with	  substrates.	  	  Using	  the	  high	  beam	  flux	  obtained	  by	  the	  multilayer	  monochromator	  and	  fast	  CCD	  detector	  at	  SSRL,	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Figure	  2.3.	  L-­‐Asp	  saturation	  kinetics	  at	  5°	  C	  fitted	  by	  a	  theoretical	  curve	  calculated	  from	   a	   modified	   Monod	   et	   al.	   equation	   and	   using	   parameters	   listed	   in	   the	   text.	  	  Reactions	  were	  carried	  out	  in	  50	  mM	  Tris	  buffer,	  pH	  8.3.	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Figure	  2.4.	  Steady-­‐state	  SAXS	  patterns	  of	  ATCase	  without	  ligands	  (),	  with	  50mM	  CP	  	  (),	  and	  with	  5mM	  PALA	  ().	  The	  allosteric	  equilibrium	  constant	  was	  calculated	  from	  these	  curves	  as	  L’	  =	  10.	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practical	   time	   resolution	  of	   the	  TR-­‐SAXS	  data	   collection	  was	   improved	   from	  100	   -­‐	  200	  ms19	  to	  as	  low	  as	  5	  ms	  in	  a	  single	  mixing	  event.	  	  However,	  the	  rate	  constants	  for	  the	  T	  →	  R	  transition	  presented	  here	  were	  obtained	  from	  19	  ms	  collection	  rate	  data,	  because	  at	  this	  rate	  the	  signal	  to	  noise	  ratio	  was	  significantly	  better	  and	  fast	  enough	  to	  record	  much	  of	  the	  transition.	  This	   improvement	  in	  detection	  allowed	  reactions	  to	  be	  monitored	  in	  the	  temperature	  range	  between	  5°	  C	  and	  22°	  C,	  rather	  than	  at	  –5	  °C	  as	  previously	  reported.19	  Shown	  in	  Figure	  2.5	  (a)	  are	  a	  series	  of	  SAXS	  patterns	  recorded	  upon	  mixing	  1.5	  mM	  ATCase	  (in	  active	  sites)	  plus	  50	  mM	  CP	  in	  one	  syringe	  with	  100	  mM	  Asp	  plus	  50	   mM	   CP	   in	   the	   second	   syringe	   at	   5°	   C.	   	   Immediately	   after	   mixing	   the	   enzyme	  concentration	   was	   0.75	   mM	   in	   active	   sites	   (37.5	   mg/ml),	   while	   the	   CP	   and	   Asp	  concentrations	  were	  each	  50	  mM.	  	  The	  SAXS	  patterns	  shown	  in	  Figure	  2.5	  (a)	  are	  at	  38	  ms,	  380	  ms,	  and	  3800	  ms.	  The	  scattering	  pattern	  at	  38	  ms	  does	  not	  correspond	  to	  either	  the	  T	  or	  R	  states	  as	  the	  enzyme	  population	  is	  in	  the	  process	  of	  undergoing	  the	  quaternary	  conformational	  change.	  The	  pattern	  at	  380	  ms	  is	  essentially	  identical	  to	  the	  curve	  of	  the	  enzyme	  in	  the	  presence	  of	  PALA	  (R	  state),	  while	  the	  curve	  at	  3800	  ms	   is	   essentially	   the	   same	   as	   that	   observed	   in	   the	   presence	   of	   D-­‐Asp	   and	   CP	   (T	  state).	   To	   determine	   if	   the	   curve	   at	   38	   ms	   corresponded	   to	   the	   formation	   of	   a	  transient	   intermediate	   on	   the	   pathway	   between	   the	   T	   and	   R	   states,	   a	   curve	   was	  generated	   from	   a	   sum	   of	   fractions	   of	   the	   T	   (33%)	   and	   R	   (67%)	   state	   curves	  corresponding	  to	  a	  value	  of	  L	  =	  0.5.13	  This	  generated	  curve	  is	  a	  near	  match	  to	  the	  X-­‐ray	  scattering	  curve	  recorded	  at	  t	  =	  38	  ms	  after	  mixing	  the	  enzyme	  with	  substrates.	  


















Figure	  2.5.	  (a)	  A	  time	  series	  of	  SAXS	  patterns	  of	  0.75	  mM	  ATCase	  (in	  active	  sites)	  mixed	  with	  50	  mM	  substrates	  (CP	  and	  L-­‐Asp),	  and	  50	  mM	  CP	  plus	  50	  mM	  D-­‐Asp	  as	  a	  T	   state	   control,	   at	  5°	  C.	   	  The	  SAXS	  patterns	  of	   the	  enzyme	  with	   the	   substrates	  are	  shown	  for	  38	  ms	  (),	  380	  ms	  (),	  and	  3800	  ms	  ()	  after	  mixing.	  	  The	  SAXS	  pattern	  of	  the	  enzyme	  with	  CP	  and	  D-­‐asp	  is	  shown	  for	  3800	  ms	  (Δ,	  short	  dashed	  curve)	  after	  mixing.	  	  The	  long	  dashed	  curve	  ()	  is	  calculated	  for	  an	  L	  =	  0.5,	  from	  the	  sum	  of	  0.33	  x	   (T	   state	   curve)	   and	   0.67	   x	   (R	   state	   curve).	   	   (b)	   Time-­‐courses	   of	   the	   quaternary	  structure	  change	  after	  mixing	  with	  substrates	  (solid	  line)	  and	  50	  mM	  CP	  plus	  50	  mM	  D-­‐Asp	  (short	  dashed	  line),	  as	  monitored	  by	  the	  scattering	  intensity	  integrated	  over	  the	  s-­‐range	  0.085-­‐0.152	  Å-­‐1.	  	  Inset:	  First	  300	  ms	  of	  the	  structural	  change	  after	  mixing	  with	  substrates	  shown	  along	  with	  the	  curve	  fit	  (two	  exponential)	  to	  the	  data.	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In	  order	   to	  help	  visualize	   the	   time	  course	  of	  structural	  change,	   the	  area	  under	   the	  curves	   between	   s	   =	   0.085	   Å-­‐1	   and	   s	   =	   0.152	   Å-­‐1	   was	   integrated	   and	   plotted	   as	   a	  function	  of	  time.	  This	  integration	  converts	  observed	  scattering	  intensity	  to	  relative	  concentration	  of	   the	  enzyme	  species	  on	  the	  basis	   that	  solution	  scattering	   intensity	  reflects	  relative	  concentration	  of	  each	  species	  linearly,	  in	  the	  absence	  of	  oligomeric	  state	   changes.	   	   Figure	   2.5	   (b)	   shows	   the	   time-­‐dependent	   change	   in	   the	   integrated	  intensity	  of	  the	  SAXS	  pattern	  for	  this	  experiment.	  At	  t	  ≅	  5	  -­‐	  10	  ms,	  (t	  =	  0	  as	  shown	  on	  the	  plot.	  The	  dead	  time	  of	   the	  stopped-­‐flow	  mixer	   is	  approximately	  5	  -­‐	  10	  ms)	  the	  enzyme	  population	  is	  nearly	  a	  equal	  mixture	  of	  T	  and	  R	  state	  molecules.	  Between	  t	  =	  100	  ms	   and	   t	   =	   1500	  ms	   95%	   of	   the	   enzyme	   population	   is	   in	   the	   R-­‐state	   as	   the	  enzyme	  catalyzes	  the	  reaction	  converting	  Asp	  and	  CP	  into	  carbamoyl	  aspartate	  and	  Pi.	   After	   t	   =	   1500	   ms	   the	   enzyme	   population	   is	   returning	   to	   the	   T	   state	   as	   the	  substrates	  are	  depleted,	  and	  after	  3000	  ms	  virtually	  the	  entire	  enzyme	  population	  is	  back	  in	  the	  T	  state.	  At	  5°	  C	  the	  turnover	  rate	  at	  maximal	  velocity	  of	  the	  holoenzyme	  is	   350	   ±	   40	   s-­‐1.	   	   At	   a	   substrate	   concentration	   of	   50	   mM	   and	   an	   active	   site	  concentration	  of	  0.75	  mM	  the	  substrate:holoenzyme	  ratio	  is	  400,	  so	  it	  should	  take	  1	  -­‐	   1.3	   seconds	   to	   consume	   the	   substrate.	   	   The	  R-­‐state	   plateau,	   defined	   here	   as	   the	  region	  of	  >95%	  of	  the	  peak	  amplitude	  of	  the	  integrated	  scattering	  curve,	  has	  a	  total	  duration	  of	  1.4	  seconds,	  which	  demonstrates	   that	  enzyme	  quickly	  reverts	   to	   the	  T	  state	  after	  depleting	  the	  substrates.	  	  When	   ATCase	   is	   mixed	  with	   D-­‐Asp	   and	   CP,	   (final	   concentrations	   0.75	  mM	  active	  sites,	  [D-­‐Asp]	  =	  [CP]	  =	  50	  mM)	  the	  TR-­‐SAXS	  curve	  showed	  virtually	  no	  change	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Figure	  2.6.	  Time-­‐course	  of	  the	  quaternary	  structure	  change	  of	  0.75	  mM	  ATCase	  (in	  active	   sites)	   as	  monitored	   by	   the	   scattering	   intensity	   integrated	   over	   the	   s-­‐range	  0.085-­‐0.152	  Å-­‐1.	  The	  final	  substrate	  or	  substrate	  analog	  concentrations	  after	  mixing	  were	  [CP]	  =	  [L-­‐Asp]	  =	  50	  mM	  	  (),	  [CP]	  =	  50	  mM	  and	  [PALA]	  =	  5	  mM	  (),	  and	  [CP]	  =	  [D-­‐Asp]	  =	  50	  mM	  ().	  	  Data	  displayed	  are	  from	  a	  36	  ms	  collection	  rate.	  Inset:	  First	  1000	  ms	  of	  the	  structural	  change	  after	  mixing	  with	  substrates	  or	  substrate	  analogs.	  	  Data	  displayed	  are	  from	  a	  19	  ms	  collection	  rate.	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(see	  Figures	  2.5	  and	  2.6).	   	  The	  use	  of	  D-­‐Asp	   thus	  provides	  a	   control	   for	   the	  L-­‐Asp	  experiments	  with	  a	   compound	  with	  equal	   scattering	  potential	   or	   electron	  density,	  and	   as	   a	   control	   for	   the	   T-­‐state	   scattering	   curve	   as	   previously	   described.19	   The	  integrated	   intensity	   at	   the	   end	   of	   experiment	  when	   L-­‐Asp	   and	   CP	   are	  mixed	  was	  practically	   identical	   to	   that	  observed	  when	  D-­‐Asp	  and	  CP	  are	  mixed	  with	  enzyme.	  	  Because	  the	  TR-­‐SAXS	  curve	  returns	  to	  the	   level	  observed	  in	  the	  presence	  of	  D-­‐Asp	  and	  CP,	   it	   is	  clear	  that	  virtually	  the	  entire	  enzyme	  population	  has	  reverted	  back	  to	  the	  T	  state	  after	  the	  substrates	  have	  been	  depleted.	  	  The	  initial	  time-­‐course	  of	  the	  structural	  change	  after	  combining	  the	  enzyme	  with	   substrates	   or	   substrate	   analogs	   appeared	   to	   fit	   to	   either	   a	   single	   or	   double	  exponential	   depending	   upon	   the	   experimental	   conditions.	   	   Therefore	   each	   set	   of	  data	  was	  fit	  to	  both	  exponential	  fits	  and	  the	  number	  of	  rate	  constants	  (represented	  as	  kT→R(1)	   for	  the	  first	  or	   fast	  phase	  and	  kT→R(2)	   for	  the	  second	  or	  slow	  phase,	  where	  applicable)	   reported	  reflects	  which	   fit	  was	  superior.	   	  As	  demonstrated	  by	   the	  rate	  constant	   data	   for	   the	   quaternary	   structural	   change	   in	   Table	   2.2,	   increasing	   the	  substrate	   concentration	   from	   25	   mM	   to	   50	   mM	   and	   doubling	   the	   enzyme	  concentration	  increased	  the	  rate	  of	  the	  fast	  phase	  of	  the	  transition	  from	  18.3	  s-­‐1	   to	  51	  s-­‐1.	   In	  this	  experiment	  it	  was	  necessary	  to	  use	  a	  lower	  enzyme	  concentration	  at	  the	  lower	  substrate	  concentration	  in	  order	  to	  observe	  the	  full	  T	  to	  R	  conversion	  of	  the	  enzyme	  population	  before	  significant	  depletion	  of	  the	  substrates.	  Lowering	  the	  enzyme	  concentration	  by	  one	  half,	   to	  18	  mg/ml,	  and	  half	  again	   to,	  9	  mg/ml,	  while	  keeping	  the	  substrate	  concentration	  at	  50	  mM	  did	  not	  change	  the	  rate	  of	  the	  fast	  or	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Table	  2.2.	  Kinetic	  parameters	  for	  the	  T	  to	  R	  allosteric	  transition	  of	  ATCase	  at	  5	  ºC	  	  Conditionsa	   	   kT→R1b	  (s-­‐1)	   kT→R2c	  (s-­‐1)	  25	  mM	  substratesd	   18.3	  ±	  0.6	   	  50	  mM	  substrates	   51	  ±	  4	   7.6	  ±	  1	  100	  mM	  substrates	   51	  ±	  5	   6.3	  ±	  0.9	  50	  mM	  substrates	  +	  5	  mM	  ATP	   89	  ±	  20	   7.9	  ±	  1	  50	  mM	  substrates	  +	  4	  mM	  UTP	   52	  ±	  8	   14.8	  ±	  1.8	  50	  mM	  substrates	  +	  4	  mM	  CTP	   12	  ±	  0.3	   	  50	  mM	  substrates	  +	  4	  mM	  CTP	  /	  4	  mM	  UTP	   10.3	  ±	  0.3	   	  50	  mM	  succinate	  +	  50	  mM	  CP	   38	  ±	  1	   	  5	  mM	  PALA	  +	  50	  mM	  CP	   1.53	  ±	  0.19	   0.31	  ±	  0.05	  
a	  These	  experiments	  were	  performed	  in	  50	  mM	  Tris	  acetate	  buffer	  (pH	  8.3),	  final	  enzyme	  concentration	  of	  37.5	  mg/ml	  after	  mixing,	  equal	  concentrations	  of	  substrates	  ([L-­‐Asp]	  =	  [CP])	  unless	  otherwise	  stated,	  and	  data	  points	  recorded	  at	  19ms	  intervals	  
b	  Rate	  constant	  of	  fast	  phase	  or	  first	  phase	  of	  two-­‐exponential	  fit	  
c	  Rate	  constant	  of	  slow	  phase	  or	  second	  phase	  of	  two-­‐exponential	  fit,	  where	  applicable	  
d	  Final	  enzyme	  concentration	  used	  was	  18.75	  mg/ml	  because	  at	  this	  low	  substrate	  concentration	  (and	  a	  relatively	  high	  enzyme	  concentration)	  the	  substrates	  were	  exhausted	  before	  the	  enzyme	  fully	  attained	  the	  R	  state	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slow	  phase,	  within	  error,	  of	   the	  T	  →	  R	   transition	   (data	  not	   shown).	   	  Therefore	  an	  enzyme	   concentration	   of	   37.5	   mg/ml	   was	   used	   for	   all	   experiments,	   with	   the	  previous	   exception,	   for	   a	   superior	   signal	   to	   noise	   ratio	   for	   the	   scattering	   data.	  	  Increasing	   the	   substrate	   concentration	   further	   to	   100	   mM	  while	   maintaining	   the	  same	  enzyme	  concentration	  (37.5	  mg/ml)	  did	  not	  change	  the	  rate	  of	  transition	  for	  the	   fast	   or	   slow	   phases,	   as	  might	   be	   expected	   since	   this	   concentration	  was	  much	  higher	  than	  the	  [Asp]0.5	  value	  of	  5.1	  mM.	  In	   order	   to	   establish	   the	   value	   for	   the	   integrated	   intensity	   and	   scattering	  pattern	   of	   the	   R-­‐state	   structure	   of	   ATCase	   in	   a	   TR-­‐SAXS	   experiment,	   PALA	   was	  mixed	  with	  enzyme	  and	  CP	  (final	  concentrations	  0.75	  mM	  active	  sites,	  5	  mM	  PALA,	  50	  mM	  CP).	  	  As	  seen	  in	  Figure	  2.6,	  the	  integrated	  intensity	  observed	  immediately	  	  after	  mixing	  was	  shifted	  towards	  the	  R-­‐state	  value.	   	  The	  rate	  constants	  for	  the	  fast	  and	   slow	   phases	   after	   mixing	   with	   PALA	   were	   both	   more	   than	   an	   order	   of	  magnitude	  slower	  than	  the	  corresponding	  T	  →	  R	  transition	  rate	  constants	  observed	  in	  the	  presence	  of	  a	  saturating	  concentration	  of	  the	  natural	  substrates,	  L-­‐Asp	  and	  CP.	  	  The	  single	  fast	  phase	  rate	  constant	  for	  the	  structural	  change	  with	  50	  mM	  succinate	  and	   50	   mM	   CP	   was	   38	   s-­‐1,	   similar	   to	   the	   rate	   of	   the	   fast	   phase	   with	   the	   natural	  substrates	  at	  a	  saturating	  concentration.	  	  
Effect	  of	  Nucleotides	  The	  time-­‐course	  of	  the	  quaternary	  structural	  change	  in	  the	  presence	  of	  ATP	  is	  shown	  in	  Figure	  2.7	  and	  is	  similar	  to	  that	  observed	  in	  the	  absence	  of	  nucleotides.	  However,	  in	  the	  presence	  of	  ATP,	  the	  duration	  that	  the	  enzyme	  remains	  in	  the	  R-­‐	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Figure	  2.7.	  Time	  evolution	  of	  the	  quaternary	  structure	  change	  of	  0.75	  mM	  ATCase	  (in	  active	  sites)	  as	  monitored	  by	  the	  scattering	  intensity	  integrated	  over	  the	  s-­‐range	  0.085-­‐0.152	   Å-­‐1	   after	   mixing	   with	   50	   mM	   substrates	   (Asp	   and	   CP)	   and	   without	  nucleotides	   ()	   and	  with	   [ATP]	  =	  5	  mM	  ().	   Inset:	   First	  300	  ms	  of	   the	   structural	  change	   after	   mixing	   with	   substrates	   shown	   along	   with	   the	   curve	   fits	   (two	  exponential)	  to	  the	  data.	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state	  plateau	  is	  shorter	  than	  in	  the	  absence	  of	  nucleotides	  and	  the	  kT→R(1)	  increased	  from	  51	   s-­‐1	   to	   89	   s-­‐1.	   	   The	   time-­‐course	   of	   the	   structural	   change	   for	  ATCase	   in	   the	  presence	   of	   the	   nucleotide	   inhibitors	   are	   shown	   in	   Figure	   2.8.	   The	   rate	   of	   T	  →	   R	  transition	   in	   the	  presence	  CTP	  and	  CTP/UTP	  decreased	  significantly,	   to	  12	  s-­‐1	  and	  10.3	  s-­‐1	  respectively.	  The	  integrated	  scattering	  intensity	  of	  the	  R-­‐state	  plateau	  in	  the	  presence	   of	   CTP	   and	   CTP/UTP	   is	   lower	   than	   that	   observed	   in	   the	   absence	   of	  nucleotides,	  and	  the	  duration	  of	  the	  plateau	  in	  the	  presence	  of	  CTP	  and	  CTP/UTP	  is	  much	  shorter	  than	  in	  the	  absence	  of	  nucleotides.	  	  The	  results	  with	  UTP	  alone	  were	  unexpected.	  The	  rate	  of	  the	  fast	  phase	  of	  the	  T	  →	   R	   transition	   in	   the	   presence	   of	   UTP	   was	   identical	   to	   that	   in	   the	   absence	   of	  nucleotides.	   The	   integrated	   scattering	   intensity	   of	   the	   R-­‐state	   plateau	   in	   the	  presence	   of	   UTP	   is	   also	   the	   same	   as	   in	   the	   absence	   of	   nucleotides.	   However,	   the	  duration	   of	   the	   R-­‐state	   plateau	   phase	   in	   the	   presence	   of	   UTP	   is	   only	   half	   of	   that	  observed	   in	   the	  absence	  of	  nucleotides,	  suggesting	  a	  slight	  destabilization	  of	   the	  R	  state	  by	  UTP.	  
Determination	  of	  the	  Activation	  Energy	  of	  ATCase	  	  The	  kinetics	  of	  the	  quaternary	  structural	  change	  were	  observed	  at	  a	  series	  of	  temperatures	  between	  5°	  C	  and	  22°	  C	  in	  order	  to	  calculate	  the	  activation	  energy	  of	  the	  quaternary	  conformational	  changes	  of	  ATCase	  both	  from	  the	  T	  to	  the	  R	  state	  and	  from	  the	  R	  to	  the	  T	  state.	  	  Unfortunately,	  above	  10°	  C	  the	  T	  →	  R	  transition	  rate	  is	  so	  fast	  that	  our	  instrumentation	  was	  unable	  to	  follow	  it.	   	  However,	  the	  rate	  constants	  for	  the	  R0	  →	  T0	  (unliganded	  states)	  transition	  after	  the	  substrates	  were	  exhausted	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Figure	  2.8.	  Time	  evolution	  of	  the	  quaternary	  structure	  change	  of	  0.75	  mM	  ATCase	  (in	  active	  sites)	  as	  monitored	  by	  the	  scattering	  intensity	  integrated	  over	  the	  s-­‐range	  0.085-­‐0.152	   Å-­‐1	   after	   mixing	   with	   50	   mM	   substrates	   (Asp	   and	   CP)	   and	   without	  nucleotides	  (),	  with	  [CTP]	  =	  4	  mM	  (◊),	  with	  [UTP]	  =	  4	  mM	  (,	  dashed	  curve),	  and	  with	  [CTP]	  =	  [UTP]	  =	  4	  mM	  (,	  dashed	  curve).	   	  Inset:	  First	  500ms	  of	  the	  structural	  change	  shown	  after	  mixing	  with	  substrates	  along	  with	  the	  curve	  fits	  to	  the	  data	  for	  without	   nucleotides	   (,two	   exponential)	   and	   with	   CTP	   and	   UTP	   (,	   one	  exponential).	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Figure	  2.9.	  Arrhenius	  plot	  of	  the	  temperature	  dependence	  of	  the	  R	  →	  T	  transition.	  	  The	  rate	  constants	  for	  the	  R	  to	  T	  transition	  (kR→T)	  at	  5,	  10,	  16,	  and	  22	  ˚C	  were	  2.08	  ±	  0.03,	  3.7	  ±	  0.1,	  5.1	  ±	  0.1,	  and	  8.3	  ±	  0.1	  s-­‐1,	  respectively.	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were	  obtained	  by	  fitting	  the	  lower	  half	  of	  the	  return	  phase	  to	  a	  single	  exponential	  fit.	  	  The	  rate	  constants	  for	  the	  R0	  →	  T0	  transition	  (kR→T)	  at	  5,	  10,	  16,	  and	  22°	  C	  were	  2.08	  ±	  0.03,	  3.7	  ±	  0.1,	  5.1	  ±	  0.1,	  and	  8.3	  ±	  0.1	  s-­‐1	  respectively.	  	  An	  Arhennius	  plot	  of	  these	  data	   is	   shown	   in	   Figure	   2.9,	   which	   yielded	   an	   activation	   energy	   for	   the	   R0	  →	   T0	  transition	  of	  13.0	  ±	  0.4	  kcal/mol.	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Discussion	  TR-­‐SAXS	   experiments	   investigating	   the	   time-­‐evolution	   of	   the	   quaternary	  structural	  change	  of	  ATCase	  induced	  by	  the	  binding	  of	  the	  natural	  substrates	  CP	  and	  L-­‐Asp	  were	  performed	  here	  in	  the	  absence	  of	  ethylene	  glycol.	  	  In	  previous	  studies19	  20%	   ethylene	   glycol	   was	   added	   to	   all	   solutions	   to	   allow	   the	   experiment	   to	   be	  performed	  at	  –5°	  C.	   	  Here	  we	  demonstrate	   that	  ethylene	  glycol	  dramatically	  alters	  the	  homotropic	  and	  heterotropic	  kinetics	  of	   the	  enzyme,	  as	   is	   the	   case	  with	  many	  other	   alcohols.14	   Therefore	   these	   new	   studies	   were	   important	   not	   only	   in	  monitoring	   the	   quaternary	   structural	   change	   at	   temperatures	   closer	   to	  physiological,	  but	  also	  because	  ethylene	  glycol	  was	  eliminated	  from	  the	  reaction.	  In	  order	  to	  better	  correlate	  the	  time-­‐resolved	  structural	  results	  reported	  here	  at	  5°	  C	  to	  the	  functional	  characteristics	  of	  ATCase	  at	  this	  temperature,	  a	  complete	  kinetic	  characterization	  of	   the	  enzyme	  was	  performed	  at	  5°	  C.	   	  As	  would	  be	  expected,	   the	  maximal	   velocity	   of	   the	   enzyme	   at	   5°	   C	   in	   the	   absence	   and	   presence	   of	   the	  nucleotide	   effectors	   was	   reduced	   nearly	   five-­‐fold	   as	   compared	   to	   the	   maximal	  velocity	  at	  25°	  C.	  	  The	  [Asp]0.5	  at	  5°	  C	  in	  the	  absence	  of	  nucleotides	  was	  also	  reduced	  nearly	  3-­‐fold,	  with	  a	  concomitant	  reduction	  in	  the	  cooperativity	  for	  Asp	  (see	  Table	  2.1).	   	  Similarly	   in	  the	  presence	  of	  nucleotides	  at	  5°	  C,	   the	  [Asp]0.5	  was	  reduced	  but	  with	   no	   change	   in	   cooperativity,	   except	   when	   CTP	   was	   present,	   where	   the	  cooperativity	   increased.	   	  The	   results	  of	   these	  kinetic	  experiments	   suggest	   that	   the	  structural	  results	  obtained	  from	  the	  TR-­‐SAXS	  experiments	  performed	  at	  5°	  C	  should	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strongly	   correlate	   with	   the	   structure	   and	   function	   of	   the	   enzyme	   at	   higher	  temperatures.	  	  In	  agreement	  with	  previous	  results,19	  when	  ATCase	  is	  mixed	  with	  its	  natural	  substrates,	  CP	  and	  L-­‐Asp,	   there	   is	  a	  rapid	  structural	   transition	  of	  the	  enzyme	  from	  the	  T	  to	  the	  R	  state.	  	  The	  preponderance	  of	  the	  enzyme	  population	  remains	  in	  the	  R	  state	  as	  the	  enzyme	  reacts	  with	  the	  substrates,	  and	  then	  reverts	  to	  the	  T	  state	  when	  the	  substrates	  are	  exhausted	  (see	  Figure	  2.5	  (b)).	  	  This	  clearly	  demonstrates	  that	  the	  allosteric	  transition	  is	  not	  the	  rate-­‐limiting	  step	  in	  catalysis,	  as	  has	  been	  previously	  suggested.20	   Therefore,	   under	   conditions	   of	   saturating	   substrates	   the	   enzyme	  remains	  in	  the	  R-­‐quaternary	  structure	  until	  the	  substrates	  are	  essentially	  exhausted	  and	  then	  reverts	  to	  the	  T-­‐quaternary	  structure.	  As	  shown	  in	  the	  inset	  to	  Figure	  2.5	  (b),	  the	  T	  →	  R	  structural	  transition	  upon	  addition	   of	   the	   natural	   substrates	   to	   the	   enzyme	   appears	   to	   be	   a	   biphasic	  exponential	   process,	   with	   a	   fast	   and	   slow	   phase.	   	   In	   this	   particular	   case	   the	   fast	  phase	   accounts	   for	   approximately	   75%	   of	   the	   total	   amplitude	   of	   the	   curve,	  representing	   the	   change	   in	   integrated	   intensity	   between	   the	   mixture	   of	   T	   and	   R	  states	  at	  the	  first	  recorded	  time	  point	  and	  R	  state	  at	  the	  curve	  plateau.	  	  Considering	  the	  evidence	  against	  the	  formation	  of	  a	  structural	  intermediate	  as	  demonstrated	  in	  Figure	  2.5	  (a),	  along	  with	  the	  structural	  transition	  being	  a	  single-­‐phase	  exponential	  process	   in	   the	   presence	   of	   allosteric	   inhibitors,	   as	   shown	   in	   Figure	   2.8,	   we	  determined	   that	   the	   curve	   monitoring	   the	   structural	   change	   may	   represent	   a	  composite	   of	   T-­‐state	   species	   with	   different	   ligation	   states,	   each	   with	   its	   own	  
	   68	  
particular	   rate	   of	   transition	   to	   the	   R	   state,	   as	   has	   been	   previously	   suggested	   in	  studies	  of	   the	   rate	  of	   the	   structural	   change	   in	   aspartate	   transcarbamoylase.13,21	   In	  the	   case	   of	   the	   allosteric	   protein	   hemoglobin,	   it	   is	  well	   documented	   that	   not	   only	  different	   ligation	   states	   but	   also	   configurational	   isomers,	   or	   asymmetric	   ligation	  states,	   exhibit	   a	   wide	   range	   of	   structural	   transition	   rates	   that	   originate	   from	  different	  activation	  energies	  for	  the	  structural	  change.22,23	  When	  all	  the	  CP	  binding	  sites	  of	  T-­‐state	  ATCase	  are	  saturated,	  as	  they	  are	  under	  our	  experimental	  conditions,	  there	  are	  thirteen	  possible	  species	  or	  ligation	  states	  with	  aspartate	  bound	  in	  the	  six	  binding	  sites	  when	  taking	  into	  account	  the	  T-­‐state	  interactions	  between	  the	  C1	  and	  C4	  chains	  on	  opposing	  catalytic	  trimers.	  	  Therefore	  the	  two	  rates	  we	  observe	  are	  the	  composites	  of	  up	  to	  thirteen	  or	  more	  individual	  rates	  for	  the	  T	  →	  R	  transition	  when	  accounting	   for	   these	   configurational	   isomers.	   	   The	   observed	   rate	   of	   the	   T	  →	   R	  transition	   increases	   about	  3-­‐fold	  when	  doubling	   the	   aspartate	   concentration	   from	  25	  mM,	  a	  concentration	  well	  in	  excess	  of	  the	  KR(Asp)	  value	  of	  3.5	  ±	  0.5	  mM,	  to	  50	  mM,	  while	  also	  doubling	  the	  enzyme	  concentration.	  	  Therefore,	  we	  are	  confident	  that	  the	  structural	   transition	   is	   triggered	   by	   aspartate	   binding	   to	   the	   T	   state,	   and	   is	   not	   a	  simple	  shift	  in	  the	  preexisting	  equilibrium	  between	  the	  T	  and	  R	  states	  towards	  the	  R	  state	  caused	  by	  aspartate	  binding	  only	  to	  that	  state	  and	  “locking”	  it	  into	  that	  state.	  	  If	  the	  structural	  transition	  were	  simply	  a	  population	  shift	  to	  the	  R	  state,	  then	  the	  rate	  would	  not	  change	  or	  change	  very	  little	  when	  increasing	  the	  aspartate	  concentration	  from	  25	  mM	  to	  50	  mM	  as	  both	  concentrations	  are	  well	  in	  excess	  of	  KR(Asp)	  .	  This	  can	  be	   accounted	   for	   using	   a	   kinetic	   version	   of	   the	   two-­‐state	   model,	   which	   would	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suggest	   14	   individual	   rates	   for	   the	   allosteric	   transition,	   defining	   the	   T	   to	   R	  equilibrium	  constants	  at	  the	  7	  ligation	  states.24	  In	  order	  to	  approximate	  the	  average	  number	  of	  aspartate	  molecules	  bound	  to	  the	  T	  state	  during	  the	  structural	  transition,	  we	   used	   the	   equation	   derived	   for	   the	   two-­‐state	   allosteric	   model	   of	   Monod	   et	   al.,	  simplified	  by	  assuming	  a	   saturating	   concentration	  of	  CP	   in	   the	  manner	  previously	  described	   to	   fit	   our	   aspartate	   saturation	   data	   at	   5°	   C.17,18	   After	   obtaining	   a	  reasonable	  fit	  of	  the	  data	  and	  extracting	  the	  appropriate	  parameters,	  we	  obtained	  a	  KT(Asp)	  value	  of	  40	  ±	  10	  mM.	   	  With	  an	  active	  site	  concentration	  of	  0.75	  mM	  and	  an	  aspartate	   concentration	   of	   25	  mM	   an	   average	   of	   33	   -­‐	   46%	   of	   the	   active	   sites	   are	  ligated	   with	   aspartate	   (2	   -­‐	   2.5	   per	   holoenzyme).	   	   Similarly,	   at	   an	   aspartate	  concentration	  of	  50	  mM	  an	  average	  of	  50	  -­‐	  67%	  of	  the	  active	  sites	  are	  ligated	  with	  aspartate	  (3	  -­‐	  4	  per	  holoenzyme)	  and	  at	  an	  aspartate	  concentration	  of	  100	  mM	  an	  average	   of	   67	   -­‐	   77%	   of	   the	   active	   sites	   are	   ligated	   with	   aspartate	   (4	   -­‐	   4.6	   per	  holoenzyme).	   	   These	   observations	   compare	   favorably	   with	   the	   previous	   SAXS	  studies	  of	  Fetler	  et	  al.25	  that	  two	  PALA	  molecules	  per	  ATCase	  holoenzyme	  molecule	  are	  necessary	  to	  shift	  the	  T	  to	  R	  equilibrium	  in	  favor	  of	  the	  R	  state,	  and	  four	  PALA	  molecules	  are	  necessary	  to	  shift	  the	  entire	  enzyme	  population	  to	  the	  R	  state.	  	  Macol	  
et	  al.26	  demonstrated	   that	   the	  binding	  of	  one	  PALA	  molecule	  could	  shift	   the	  entire	  holoenzyme	  population	  to	  the	  R	  state,	  however,	  the	  holoenzyme	  was	  comprised	  of	  five	   chains	  with	   the	  R105A	  mutation.	   	   In	   either	   case	   the	   enzyme	   clearly	   does	   not	  need	  to	  be	  saturated	  with	  substrate	  analogs	  or	  presumably	  substrates,	   in	  order	   to	  shift	   the	   equilibrium	   towards	   the	   R	   state.	   	   Our	   findings	   suggest	   that	   the	   faster	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observed	   rate	   is	   the	   composite	   of	   rates	   of	   the	   structural	   transition	   for	   the	   highly	  liganded	   species,	   with	   three	   or	   more	   active	   sites	   filled.	   	   Likewise,	   the	   slower	  observed	   rate	   may	   be	   the	   composite	   of	   structural	   transition	   rates	   of	   the	   least	  liganded	  species,	  with	  two	  or	  fewer	  active	  sites	  filled.	  	  At	  an	  aspartate	  concentration	  of	  25	  mM	  we	  observe	  only	  one	  exponential	   fit	   to	   the	  data,	  which	  according	   to	  our	  model	  would	  be	  the	  composites	  of	  rates	  of	  the	  least	  liganded	  species	  along	  with	  the	  rates	  of	  the	  highly	  liganded	  species	  containing	  three	  or	  more	  aspartate	  present	  as	  a	  small	  fraction	  of	  the	  mixed	  population.	  	  Increasing	  the	  aspartate	  concentration	  from	  50	  mM	  to	  100	  mM	  yielded	  identical	  rates	  for	  both	  observed	  phases,	  suggesting	  that	  once	   three	  or	  more	  aspartate	  molecules	  are	  bound	  to	   the	  holoenzyme	  the	  rate	   for	  the	   structural	   transition	   is	   near	   a	   maximum,	   or	   that	   highly	   liganded	   T-­‐state	  molecules	  bound	  with	  four	  or	  more	  aspartate	  are	  present	  as	  only	  a	  small	  fraction	  of	  the	   population	   even	   at	   high	   aspartate	   concentrations.	   	   Further	   evidence	   for	   this	  model	  is	  provided	  by	  comparison	  of	  the	  ratio	  of	  the	  fast	  phase	  amplitude	  to	  the	  slow	  phase	  amplitude	  at	  50	  mM	  aspartate	  and	  100	  mM	  aspartate	  concentrations;	  at	  the	  higher	  aspartate	  concentration	   the	   ratio	   is	  higher,	   suggesting	  a	   shift	   in	  population	  towards	  the	  highly	  liganded	  molecules.	  There	   are	   some	   substantial	   qualitative	   differences	   between	   these	   TR-­‐SAXS	  results	  and	  the	  data	  obtained	  previously	  in	  the	  presence	  of	  ethylene	  glycol,19	  such	  as	  the	  time-­‐course	  of	  the	  TR-­‐SAXS	  pattern	  of	  the	  enzyme	  in	  the	  presence	  of	  ATP,	  shown	  in	  Figure	  2.7.	   	  We	  observed	  that	  the	  R-­‐state	  plateau	  region	  in	  the	  presence	  of	  ATP,	  during	  which	  most	  of	  the	  substrates	  are	  being	  converted	  to	  products,	  is	  shorter	  than	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in	   the	   absence	   of	   ATP.	   This	   was	   not	   unexpected	   since	   ATP,	   an	   activator	   of	   the	  enzyme,	   at	   5°	   C	   increased	   the	   Vmax	   value	   from	   4.2	  mmol•h-­‐1•mg-­‐1	   to	   5.4	  mmol•h-­‐
1•mg-­‐1	   (Table	   2.1)	   and	   also	   the	   apparent	   binding	   affinity	   of	   L-­‐Asp,	   as	   the	   [Asp]0.5	  value	  decreased	  from	  5.1	  mM	  to	  2.9	  mM.	  	  However,	  in	  the	  presence	  of	  20%	  ethylene	  glycol,	   a	   longer	   R-­‐state	   plateau	   was	   observed	   in	   the	   presence	   of	   ATP	   than	   in	   its	  absence.19	  To	  explain	  this	  it	  was	  proposed	  that	  ATP,	  in	  addition	  to	  being	  an	  activator	  may	  possibly	  become	  an	  inhibitor	  by	  “increasing	  the	  chance	  of	  making	  L-­‐Asp	  bind	  to	  the	  active	  site	  before	  Pi	  leaves	  and	  locking	  the	  active	  site	  into	  an	  unproductive	  cycle	  with	  no	  alteration	  of	  the	  quaternary	  structure”.19	  In	  that	  experiment	  the	  activity	  of	  enzyme	  was	  dramatically	  reduced	  not	  only	  by	  the	  presence	  of	  20%	  ethylene	  glycol,	  which	   as	   demonstrated	   in	   Figure	   2.1(a)	   reduces	   the	   activity	   by	   75%,	   but	   also	   by	  performing	  the	  TR-­‐SAXS	  at	  –5°	  C.	  	  The	  similar	  phenomenon	  of	  “substrate	  inhibition”	  has	   been	   observed	   for	   the	   isolated	   catalytic	   subunit	   and	   for	   the	   incomplete	  complexes	   C6R4	   and	   C3R6,	   as	   well	   as	   for	   the	   holoenzyme	   C6R6,27-­‐29	   where	   a	   high	  aspartate	  concentration	  ostensibly	  acts	  as	  an	  inhibitor	  by	  binding	  to	  the	  CP	  binding	  site.	  	   As	   detailed	   in	   Table	   2.2,	   ATP	   increased	   the	   rate	   of	   the	   T	  →	   R	   transition,	  specifically	  the	  rate	  of	  the	  fast	  phase,	  by	  approximately	  75%.	  It	  should	  be	  noted	  that	  in	   the	   presence	   of	   ATP	   the	   allosteric	   transition	   is	   so	   rapid	   that	   with	   the	   current	  instrumentation	  the	  experimental	  error	  is	  somewhat	  large.	  	  As	  discussed	  previously,	  saturating	   the	   enzyme	   with	   aspartate	   beyond	   a	   concentration	   of	   50	   mM	   did	   not	  increase	  the	  rate	  of	  the	  structural	  transition.	  	  Therefore	  one	  possible	  interpretation	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is	   that	   ATP	   increases	   the	   on	   rate	   of	   aspartate	   to	   the	   T	   state,20	   suggesting	   that	  aspartate	  binding	  is	  a	  rate-­‐limiting	  step	  in	  the	  allosteric	  transition.	  	  However,	  a	  more	  elegant	   explanation,	  which	   is	   in	   accord	  with	   the	  data	   from	   the	   inhibitors	  CTP	  and	  CTP/UTP	  and	  numerous	  studies	  on	   the	  effects	  of	   the	  heterotropic	  nucleotides,30-­‐32	  can	  be	  derived	  using	  some	  aspects	  of	  the	  two-­‐state	  model	  of	  Monod	  et	  al.17,18	  At	  pH	  7.0	  Howlett	  et	  al.17,31	  observed	  that	  ATP	  increases	  the	  stability	  of	  the	  R	  state	  relative	  to	  the	  T	  state	  by	  0.8	  kcal	  and	  reduces	  the	  T	  to	  R	  equilibrium	  constant	  from	  250	  to	  7	  in	   the	  absence	  of	  substrates.	   	  The	  R	   to	  T	   transition	  rate	  with	  ATP	  was	  reduced	  by	  only	  approximately	  15%	  (Figure	  2.7),	  suggesting	  a	  slight	  stabilization	  of	  the	  R	  state,	  so	  therefore	  the	  large	  increase	  in	  the	  T	  →	  R	  rate	  would	  suggest	  a	  significant	  T	  state	  destabilization	   by	   ATP.	   	   Here	   the	   two-­‐state	  model	   suggests	   that	   ATP	   binds	  more	  tightly	  to	  the	  R	  state	  and	  therefore	  shifts	  the	  structural	  equilibrium	  in	  favor	  of	  the	  R	  state.17,31	  	  However,	  our	  observation	  of	  	  a	  possibly	  different	  mechanism	  for	  ATP	  was	  suggested	   by	   the	   crystal	   structures	   of	   the	   T	   and	   R	   states	   of	   the	   enzyme	   in	   the	  presence	  of	  ATP;	  	  the	  T	  state	  structure	  showed	  a	  slight	  shift	  towards	  the	  R	  state	  with	  ATP	  present,5	  whereas	  globally	  the	  R	  state	  structure	  was	  unchanged	  in	  the	  presence	  of	   ATP.33	   It	   should	   be	   noted	   that	   under	   these	   conditions	   with	   ATP	   the	   Vmax	   did	  increase	  even	  though	  the	  structural	  state	  at	  saturating	  substrate	  levels	  appears	  to	  be	  the	   same	   R	   state	   as	   with	   no	   ATP	   present,	   with	   the	   caveat	   that	   the	   Vmax	   value	   is	  difficult	   to	   obtain	   precisely	   from	   steady-­‐state	   kinetics	   curves	   which	   exhibit	  substrate	  inhibition.	  	  This	  suggests	  that	  the	  previously	  observed	  increase	  in	  the	  Asp	  to	  CA	  exchange	  rate	  with	  ATP	  may	   influence	   the	  catalytic	  mechanism	  to	  a	  modest	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degree.20	  However	  our	  time-­‐resolved	  structural	  study	  indicates	  that	  perturbation	  of	  T	  to	  R	  equilibrium	  specifically	  via	  T-­‐state	  destabilization	  may	  be	  the	  most	  significant	  mechanism	  of	  ATP	  activation	  of	  ATCase.	  The	  time-­‐courses	  of	  the	  quaternary	  structural	  change	  in	  the	  presence	  of	  CTP	  or	  CTP/UTP	  are	  similar	  in	  the	  presence	  and	  absence	  of	  ethylene	  glycol	  (see	  Figure	  2.8).	  	  For	  both	  cases,	  in	  the	  presence	  of	  CTP	  or	  CTP/UTP	  the	  duration	  of	  the	  R-­‐state	  shifted	  plateau	  is	  shorter	  and	  the	  integrated	  intensity	  of	  the	  plateau	  is	  lower	  than	  in	  the	   absence	   of	   nucleotides,	   and	   the	   observed	   return	   to	   the	   T-­‐state	   quaternary	  structure	  is	  a	  slow	  exponential	  decline	  as	  the	  remaining	  substrates	  are	  consumed	  as	  the	  enzyme	  population	   shifts	   towards	   the	  T	   state.	   	  The	   integrated	   intensity	  of	   the	  peak	  with	  CTP	  present	  and	  with	  CTP/UTP	  present	  was	  approximately	  80%	  and	  75%	  respectively	  of	  that	  when	  no	  nucleotides	  were	  present,	  indicative	  that	  the	  percent	  of	  high-­‐activity	  R-­‐state	  molecules	  at	  a	  saturating	  substrate	  concentration	  was	  reduced	  to	  a	  likewise	  value.	  	  This	  is	  in	  excellent	  agreement	  with	  the	  enzymatic	  kinetic	  data,	  in	  which	  the	  Vmax	  was,	  within	  error,	  reduced	  by	  the	  same	  amount	  as	  the	  integrated	  scattering	   peak	   in	   the	   presence	   of	   CTP	   and	   CTP/UTP	   as	   compared	   to	   when	   no	  nucleotides	  were	  present.	   	   These	   allosteric	   inhibitors	   also	   reduced	   the	   rate	   of	   the	  structural	   transition	  by	  over	  4-­‐fold.	   	   Similar	   to	   the	  condition	  when	  no	  nucleotides	  were	  present	  and	  the	  substrate	  concentration	  was	  25	  mM,	  the	  initial	  time-­‐course	  of	  the	   structural	   change	   fits	   to	   a	   single	   exponential.	   This	   suggests	   that	   the	   least	  liganded	  species	  have	  a	  rate	  that	  is	  so	  reduced	  that	  we	  do	  not	  observe	  them	  before	  the	  shortened	  plateau	  starts	  its	  reversion	  towards	  the	  T	  state,	  or	  that	  the	  R	  →	  T	  rate	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for	   these	  species	   is	  nearly	  equal	   to	   the	  T	  →	  R	   transition	  rate.	   	  As	  with	   the	  case	  of	  ATP,	  our	  experimental	  observations	  are	  not	  in	  complete	  agreement	  with	  some	  of	  the	  tenets	  of	  the	  two-­‐state	  model;	  the	  much	  reduced	  T	  →	  R	  transition	  rate	  suggests	  the	  nucleotide	   inhibitors	   stabilize	   the	   T	   state,	   and	   the	   incomplete	   conversion	   of	   the	  enzyme	  population	  to	  the	  R	  state	  at	  a	  saturating	  substrate	  concentration	  and	  shift	  in	  equilibrium	  towards	  the	  T	  state	  long	  before	  the	  substrates	  are	  exhausted	  caused	  by	  the	  collective	  R	  →	  T	  rates	  becoming	  greater	  than	  the	  T	  →	  R	  rates	  suggest	  that	  they	  destabilize	   the	   R	   state.	   	   Using	   the	   two-­‐state	   model	   as	   a	   theoretical	   framework,	  Howlett	  et	  al.17,31	  observed	  that	  CTP	  increases	  the	  stability	  of	  the	  T	  state	  relative	  to	  the	  R	   state	  by	  0.9	  kcal	   and	   increases	   the	  T	   to	  R	  equilibrium	  constant	   from	  250	   to	  1250	   in	   the	   absence	  of	   substrates.	   	   In	   addition,	   the	   two-­‐state	  model	   suggests	   that	  CTP	   (and	   UTP)	   exert	   their	   influence	   by	   binding	   more	   tightly	   to	   the	   T	   state	   and	  shifting	   the	  structural	  equilibrium	   in	   favor	  of	   the	  T	  state.	   	  However,	   again	  as	  with	  ATP	  our	  observations	  are	  somewhat	  at	  variance	  with	  this	  model,	  but	  are	  supported	  by	  the	  crystal	  structures	  of	  the	  T	  and	  R	  states	  of	  the	  enzyme	  in	  the	  presence	  of	  CTP;	  the	  T	   state	   structure	  globally	  was	  unchanged	   in	   the	  presence	  of	  CTP,5	  and	  R	  state	  structure	  was	  shifted	  slightly	  in	  the	  direction	  of	  the	  T	  state	  with	  CTP	  present.33	  In	  the	  case	  of	  UTP,	  by	  itself	  it	  had	  no	  influence	  on	  the	  kinetics	  of	  the	  enzyme	  with	   the	   exception	   of	   raising	   the	   [Asp]0.5	   slightly.	   	   It	   also	   had	   no	   influence	   on	   the	  kinetics	  of	  the	  T	  →	  R	  transition,	  except	  for	  increasing	  the	  rate	  of	  the	  slow	  phase	  for	  reasons	  that	  are	  unclear.	  	  However,	  UTP	  did	  have	  a	  noticeable	  effect	  on	  the	  length	  of	  time	  the	  enzyme	  spent	  in	  the	  R-­‐state	  plateau	  region,	  causing	  the	  enzyme	  population	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to	   begin	   reverting	   to	   the	   T	   state	   before	   the	   substrates	   were	   exhausted.	   	   This	  indicates	  that	  UTP	  may	  slightly	  destabilize	  the	  R	  state,	  but	  otherwise	  does	  not	  have	  an	  appreciable	  effect	  on	  the	  allosteric	  behavior	  of	  ATCase	  under	  these	  conditions.	  The	  activation	  energy	  of	  the	  R	  →	  T	  transition	  was	  determined	  by	  fitting	  the	  bottom	  half	  of	  the	  return	  curve,	  after	  the	  enzyme	  had	  exhausted	  the	  substrates,	  to	  a	  single	  exponential	  rate,	  as	  opposed	  to	  the	  upper	  half	  of	  the	  curve	  where	  presumably	  not	   all	   enzyme	  molecules	   have	   completely	   exhausted	   the	   substrate	   bound	   to	   the	  active	  sites.	  	  By	  fitting	  the	  bottom	  half	  of	  the	  return	  curve	  mainly	  the	  rate	  of	  R0	  →	  T0	  should	   be	   observed,	   which	   is	   supported	   by	   the	   very	   low	   error	   in	   the	   kR→T	   values	  obtained.	  	  As	  shown	  in	  Figure	  2.9,	  the	  EaR→T	  was	  calculated	  to	  be	  13.0	  ±	  1.4	  kcal/mol	  from	  the	  slope	  of	  the	  Arrhenius	  plot.	   	  At	  temperatures	  above	  10	  °C	  the	  T	  →	  R	  rate	  was	  so	  rapid	  that	  the	  data	  could	  not	  give	  rates	  with	  a	  reasonable	  error.	   	  Moreover	  these	   rates	   are	   composites	   of	   the	   multiple	   species	   with	   different	   ligation	   states,	  making	  interpretation	  of	  a	  single	  activation	  energy	  value	  problematic.	  	  However	  by	  making	   some	  assumptions,	   an	  approximate	  value	   for	   the	  T	  →	  R	   activation	  energy	  was	   derived	   for	   the	   unliganded	   T	   and	   R	   states.	   	   Assuming	   that	   the	   respective	  transition	  states	  in	  both	  the	  T	  →	  R	  transition	  and	  R	  →	  T	  transition	  are	  the	  same,	  and	  the	  free	  energy	  difference	  between	  the	  T	  and	  R	  states	  is	  3.3	  kcal/mol,17,31	  then	  the	  activation	  energy	  for	  the	  T	  →	  R	  transition	  should	  be	  in	  the	  range	  of	  15–18	  kcal/mol.	  	  The	   charged-­‐charged	   hydrogen	   bonds	   between	   Glu239	   and	   Lys164	   and	   non-­‐charged	   hydrogen	   bonds	   between	   Glu239	   and	   Tyr165	   are	   critical	   for	   the	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stabilization	   of	   both	   the	   T	   and	   R	   state	   conformations	   of	   the	   enzyme,	   which	   are	  interchain	  in	  the	  T	  state	  and	  intrachain	  in	  the	  R	  state.7	  Sakash	  et	  al.34	  showed	  that	  three	   of	   the	   six	   stabilizing	   interactions	   between	   catalytic	   chains	   on	   opposing	  subunits	   involving	   Glu239	   are	   sufficient	   to	   stabilize	   the	   enzyme	   in	   the	   T	   state	  conformation.	  Thus	  at	  least	  three	  of	  the	  hydrogen	  bonds	  involving	  Glu239	  must	  be	  broken	   during	   the	   allosteric	   transition.	   Considering	   a	   typical	   charged-­‐charged	  hydrogen	   bond	   energy	   is	   approximately	   4	   kcal/mol	   and	   a	   non-­‐charged	   hydrogen	  bond	  energy	   is	  approximately	  0.5	   -­‐	  1.5	  kcal/mol,35,36	   the	  minimal	  energy	   required	  for	   the	   allosteric	   transition	   of	   the	   enzyme	   is	   13.5	   -­‐	   16.5	   kcal/mol.	   The	   results	  reported	  here	  are	  consistent	  with	  these	  calculations.	  The	  rate	  of	  the	  allosteric	  transition	  was	  also	  measured	  when	  ATCase	  is	  mixed	  with	  two	  substrate	  analogs;	  succinate,	  an	  aspartate	  analog	  that	  promotes	  the	  T	  →	  R	  state	  transition	  when	  combined	  with	  CP,	  and	  PALA,	  a	  bisubstrate	  analog	  that	  binds	  at	   nanomolar	   affinity	   and	   also	   causes	   the	   T	  →	   R	   state	   transition.	   	   The	   structural	  transition	  rate	  with	  succinate	  and	  CP	  at	  a	  concentration	  of	  50	  mM	  each	  was	  slightly	  lower	  than	  the	  rate	  with	  the	  natural	  substrates	  at	  equivalent	  concentration	  and	  was	  observed	  to	  be	  a	  single	  exponential	  process.	   	  This	  may	  be	  because	  succinate	  binds	  approximately	   one	   order	   of	   magnitude	   more	   tightly	   than	   aspartate17,37,38	   and	  therefore	   the	   bulk	   of	   the	   T	   state	  molecules	   should	   be	   highly	   liganded	   during	   the	  transition	  to	  the	  R	  state.	  	  However	  the	  structural	  transition	  rate	  with	  PALA	  was	  over	  one	  order	  of	  magnitude	  slower	  than	  with	  the	  natural	  substrates.	  	  The	  kinetics	  of	  the	  interaction	  of	  PALA	  with	  the	  isolated	  catalytic	  subunit	  at	  pH	  7.0	  and	  25°	  C	  has	  been	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studied	  using	  stopped	  flow	  kinetics	  and	  31P	  saturation	  transfer	  NMR	  by	  Cohen	  and	  Schachman.39	   They	   observed	   a	   rapid	   binding	   of	   PALA	   followed	   by	   a	  much	   slower	  isomerization	  of	  the	  complex	  with	  a	  forward	  rate	  constant	  of	  0.18	  s-­‐1,	  similar	  to	  the	  rate	  constant	  of	  the	  slow	  phase	  we	  observed	  by	  TR-­‐SAXS	  of	  0.31	  s-­‐1.	   	  However,	  the	  catalytic	   subunit	   by	   itself	   does	   not	   undergo	   a	   T	  →	   R	   transition	   so	   it	   is	   unclear	  whether	   the	   similarity	   of	   these	   values	   implies	   a	   similar	   mechanism	   between	   the	  change	  in	  the	  tertiary	  structure	  following	  PALA	  binding	  to	  the	  catalytic	  subunit	  and	  change	  in	  quaternary	  structure	  following	  PALA	  binding	  to	  the	  holoenzyme.	  	  The	  rate	  constant	   data	   and	   integrated	   scattering	   intensity	   presented	   here	   were	   obtained	  after	  mixing	  PALA	  with	  enzyme	  premixed	  with	  CP,	   to	  be	  consistent	  with	  the	  other	  experimental	  conditions.	  	  In	  addition	  experiments	  were	  performed	  where	  PALA	  was	  mixed	  with	  only	   the	  enzyme	  and	  the	  rate	  constants	   for	   the	  T	  →	  R	   transition	  were	  essentially	  identical	  (data	  not	  shown),	  which	  suggests	  the	  slow	  allosteric	  transition	  after	   PALA	   binding	   is	   not	   caused	   by	   having	   to	   displace	   CP	   from	   the	   active	   site.	  	  Because	   PALA	   combines	   elements	   of	   both	   substrates	   into	   one	   covalently	   linked	  bisubstrate	  analog,	  when	  the	  CP	  moiety	  of	  PALA	  initially	  binds	  the	  aspartate	  moiety	  may	  not	  be	  able	  to	  bind	  well	  to	  the	  aspartate	  binding	  site	  with	  the	  domains	  open,	  as	  they	   are	   in	   the	   T	   state.	   	   Subsequently	   the	   enzyme	   may	   undergo	   a	   slow	  conformational	   change	   in	   order	   for	   the	   aspartate	  moiety	   to	   bind	   tightly	   and	   then	  complete	  the	  T	  →	  R	  structural	  conversion.	  	  In	  this	  regard	  PALA	  appears	  to	  fit	  in	  the	  category	   of	   a	   slow	   tight-­‐binding	   inhibitor.40	   However	   the	   phenomenon	   of	   PALA	  being	  a	  very	   tight	  binding	  bisubstrate	  analog	   that	  causes	  an	   initial	   conformational	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change	   followed	   by	   a	   much	   slower	   conformational	   change	   needs	   further	  investigation	  to	  be	  better	  understood.	  In	   summary,	   our	  data	   showed	  ethylene	   glycol	   had	   a	  profound	   influence	  on	  the	  kinetics	  and	  behavior	  of	  ATCase,	  so	  therefore	  the	  time-­‐evolution	  of	  the	  allosteric	  transition	  of	  ATCase	  was	   reinvestigated	   in	   the	  absence	  of	  ethylene	  glycol	  by	  SAXS	  revealing	   several	   important	   new	   insights.	   Experimentally,	   these	   studies	  demonstrate	   that	   SAXS	   is	   now	   capable	   of	   monitoring	   relatively	   rapid	   structural	  changes	  at	  temperatures	  approaching	  physiological.	  The	  allosteric	  transition	  is	  not	  the	   rate-­‐limiting	   step	   in	   ATCase	   catalysis,	   and	   the	   rate	   of	   allosteric	   transition	   is	  increased	   with	   increasing	   substrate	   concentration	   up	   to	   50	   mM.	   ATP	   appears	   to	  destabilize	  the	  T	  state	  and	  have	  little	  effect	  on	  the	  R	  state.	  CTP	  and	  the	  combination	  of	  CTP/UTP	  appear	  to	  destabilize	  the	  R	  state	  and	  stabilize	  the	  T	  state.	  PALA	  causes	  a	  very	   slow	   conformational	   change	   as	   compared	   to	   the	   natural	   substrates.	   In	   the	  future,	   novel	   TR-­‐SAXS	   experiments	   could	   be	   performed	   with	   hybrid	   ATCase	  molecules	  that	  bind	  one,	   two,	  three,	   four,	  or	   five	  aspartate	  molecules	  to	  determine	  the	  individual	  rate	  constants	  and	  activation	  energies	  for	  each	  one	  of	  these	  species.	  Such	   studies	   will	   be	   facilitated	   by	   further	   instrumental	   upgrades	   that	   are	   being	  made	   to	   improve	   time-­‐resolution.	  We	   believe	  we	   have	   begun	   to	   arrive	   at	   a	   clear	  understanding	   of	   the	   allosteric	  mechanism	  of	   ATCase,	   and	   further	   studies	   into	   its	  dynamic	  behavior	  utilizing	  such	  time-­‐resolved	  techniques	  as	  employed	  here	  will	  be	  invaluable	  in	  this.	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Trapping	  and	  Structure	  Determination	  of	  an	  Intermediate	  in	  the	  
Allosteric	  Transition	  of	  Aspartate	  Transcarbamoylase	  An	  article	  published	  in	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  by	  Wenyue	  Guo,	  Jay	  M.	  West,	  Andrew	  Dutton,	  Hiro	  Tsuruta	  and	  Evan	  R.	  Kantrowitz	  	  	  	  	  	  	  	  	  	  	  	  *Contribution	  to	  work:	  Conducted	  all	  experiments	  except	  the	  small	  angle	  X-­‐ray	  scattering	  experiments	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Introduction	  Although	  many	  aspects	  of	  allosteric	  regulation	  and	  cooperativity	  have	  been	  established	   for	  Escherichia coli	  aspartate	   transcarbamoylase	   (ATCase),	   the	   enzyme	  that	   catalyzes	   the	   committed	   step	   in	   pyrimidine	   nucleotide	   biosynthesis,	  many	   of	  the	   details	   of	   how	   the	   active	   sites	   change	   from	   low-­‐activity,	   low-­‐affinity	   to	   high-­‐activity,	   high-­‐affinity	   during	   the	   T	   to	   R	   transition	   have	   not	   been	   delineated.1	   The	  major	  limitation	  has	  been	  that	  stabilization	  of	  the	  enzyme	  in	  the	  R	  state	  requires	  the	  presence	   of	   active	   site	   ligands,	   thus	   making	   interpretation	   of	   the	   structural	  rearrangements	   upon	   the	   T	   to	   R	   transition,	   in	   the	   absence	   of	   ligands,	   difficult.	  Newell	  and	  Schachman2	  have	  concluded,	  from	  sedimentation	  velocity	  experiments,	  that	   the	  quaternary	  structures	  of	  ATCase	  with	   the	  catalytic	   chain	  mutation	  K164E	  and	   the	   catalytic	   chain	   double-­‐mutation	   K164E	   and	   E239K	   exist	   in	   the	   R-­‐state,	  irrespective	  of	   the	  presence	  of	  active	  site	   ligands.	  The	  enzymatic	  properties	  of	   the	  double	  mutant	  (K164E/E239K	  ATCase)	   include	  a	   lack	  of	  homotropic	  cooperativity	  and	  an	  inability	  to	  be	  activated	  by	  ATP	  or	  inhibited	  by	  CTP:	  properties	  coincident	  of	  an	  enzyme	  that	  cannot	  transition	  between	  the	  two	  allosteric	  states.2	  More	  recently,	  Velyvis	   et	   al.3	   demonstrated	   that	   the	   partially	   labeled	   K164E/E239K	   ATCase	  exhibited	   certain	   chemical	   shifts	   in	   solution	   NMR	   studies	   that	   they	   conclude	   are	  characteristic	   of	   the	  R	   state	   of	   the	   enzyme.	   These	   same	   chemical	   shifts	  were	   also	  observed	   when	   the	   wild-­‐type	   enzyme	   was	   bound	   with	   the	   bisubstrate	   analog	   N-­‐phosphonacetyl-­‐L-­‐aspartate	  (PALA),3	  which	  is	  known	  to	  stabilize	  fully	  the	  R-­‐state	  of	  the	  enzyme.4	  Thus,	  a	  crystal	  structure	  of	  K164E/E239K	  ATCase	  should	  provide	  us	  a	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means	   to	   obtain	   the	   structural	   details	   of	   an	   R-­‐state	   active	   site	   in	   the	   absence	   of	  ligands.	  However,	  here	  we	  report	  the	  X-­‐ray	  crystal	  structure	  and	  the	  solution	  SAXS	  data	   for	   the	   K164E/E239K	   ATCase,	   which	   clearly	   demonstrates	   that	   this	   double	  mutant	  enzyme	  is	  not	  in	  the	  R-­‐quaternary	  structure.	  Instead	  this	  mutant	  enzyme	  is	  in	  a	  unique	  intermediate	  state	  on	  the	  path	  between	  the	  T	  and	  R	  structural	  states.	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Results	  and	  Discussion	  
Crystal	   Structure	   of	  K164E/E239K	  ATCase	   is	  Different	   from	   the	  Wild-­type	  R	  
State	  Structure	  The	  K164E/E239K	  ATCase	  was	  purified	  and	  subsequently	  crystallized	  in	  the	  absence	   of	   ligands	   as	   described	   in	   Chapter	   7.	   The	   detailed	   statistics	   of	   data	  collection	  and	  refinement	  are	  given	  in	  Table	  3.1.	  The	  crystals	  were	  determined	  to	  be	  in	   the	   P212121	   space	   group	  with	   unit	   cell	   dimensions	   of	  a	   =	   124.1,	  b	   =	   144.8,	   c	   =	  203.4	  with	  α	  =	  β	  =	  γ	  =	  90°.	  A	  previously	  determined	  structure	  of	  R-­‐state	  ATCase	  in	  the	   presence	   of	   the	   PALA	   has	   also	   been	   solved	   in	   the	   P212121	   space	   group.5	  However,	  the	  unit	  cell	  dimensions	  (a	  =	  125.5,	  b	  =	  153.5,	  c	  =	  185.7	  with	  α	  =	  β	  =	  γ	  =	  90°)	  vary	  significantly	  from	  those	  determined	  for	  the	  K164E/E239K	  ATCase.	  In	  the	  crystal	  of	  the	  PALA-­‐ATCase	  complex	  the	  molecular	  three-­‐fold	  axis	  is	  parallel	  to	  the	  crystallographic	  b-­‐axis.5	  The	  almost	  9	  Å	  shorter	  b-­‐axis	  of	  the	  K164E/E239K	  ATCase	  crystals	   was	   the	   first	   indication	   that	   the	   structure	   of	   this	   double	  mutant	   enzyme	  may	  not	  be	  an	  R-­‐state	  structure.	  	  	  In	   order	   to	   quantitatively	   compare	   the	   quaternary	   conformation	   of	   the	  K164E/E239K	   structure	   to	   the	   canonical	   ATCase	   T	   and	   R	   structures,	   the	   vertical	  separation6	  between	  the	  upper	  and	  lower	  catalytic	  subunits,	  planar	  angle	  between	  allosteric	   domains	   of	   the	   regulatory	   dimer,	   and	   the	   rotation	   about	   the	   3-­‐fold	   axis	  (Figure	  3.1)	  of	  the	  K164E/E239K	  structure	  were	  determined	  and	  compared	  to	  the	  corresponding	   values	   for	   the	   published	   T	   and	   R	   structures	   (see	   Figure	   3.2).	   The	  vertical	  separation	  for	  the	  K164E/E239K	  structure	  was	  50.5	  Å	  as	  compared	  to	  47.3	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Table	  3.1.	  Data	  collection	  and	  refinement	  statistics	  for	  the	  K164E/E239K	  ATCase	  structure	  
Data	  collection	  Space	  group	   	  P212121	  Cell	  Dimensions	  	   a,	  b,	  c	  (Å)	   124.1,	  144.8,	  203.4	  	   α,	  β,	  γ	  (°)	   90,	  90,	  90	  Resolution	  (Å)	   50.00-­‐2.80	  (2.90-­‐2.80)	  Rsym(%)	   0.079	  (0.473)	  Average	  (I/σ)	   8.9	  (2.2)	  Completeness	  (%)	   92.4	  (92.4)	  Redundancy	   3.33	  (3.35)	  	  
Refinement	  Resolution	  (Å)	   30.00-­‐2.80	  Reflections	   83,904	  Rwork/Rfree	   0.226	  /	  0.276	  Number	  of	  atoms	  	   Protein	   21258	  	   Waters	   506	  r.m.s.	  deviations	  	   Bond	  lengths	  (Å)	   0.014	  	   Angles	  (°)	   1.51	  Mean	  B	  value	  (Å2)	   81.5	  Values	  in	  parentheses	  are	  for	  the	  highest	  resolution	  shell	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Figure	  3.1.	  	  The	  ATCase	  holoenzyme	  showing	  the	  three-­‐fold	  and	  two-­‐fold	  axes.	  The	  asymmetric	   unit	   (c1-­‐r1-­‐r6-­‐c6),	   corresponding	   to	   one-­‐third	   of	   the	   molecule,	   is	  represented	   as	   a	   ribbon	   diagram.	   The	   other	   two-­‐thirds	   of	   the	  molecule	   is	   shown	  without	  secondary	  structure.	  Planar	  angles	  between	  the	  CP	  and	  ASP	  domains	  of	  the	  catalytic	  chain	  (PA1)	  and	  the	  allosteric	  domains	  of	  the	  r1-­‐r6	  regulatory	  chains	  (PA2)	  are	  also	  shown.	  Insets,	  the	  c1	  and	  r1-­‐r6	  chains	  with	  the	  corresponding	  PA1	  and	  PA2	  are	   shown	   in	   an	   orientation	   to	   better	   visualize	   the	   planar	   angle	   between	   the	  domains	   as	  well	   as	   the	   centers	   of	   gravity	   of	   these	   domains.	   Also	   indicated	   is	   the	  vertical	   separation	  between	   the	  centers	  of	  gravity	  of	  an	  upper	  and	   lower	  catalytic	  chain.	  	  This	  figure	  was	  produced	  using	  MOLSCRIPT7	  	  and	  RASTER3D8.	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Figure	   3.2.	   Comparison	   of	   the	   structures	   of	   (A)	   wild-­‐type	   ATCase	   in	   the	   T	   state	  (PDB	  ID	  code	  1ZA1),	  (B)	  wild-­‐type	  ATCase	  in	  the	  R	  state	  (PDB	  ID	  code	  1D09),	  and	  (C)	  the	  K164E/E239K	  mutant	  ATCase	  (PDB	  ID	  code	  4E2F).	  The	  vertical	  separation	  between	  the	  center	  of	  masses	  of	  the	  upper	  and	  lower	  catalytic	  trimers	  are	  indicated.	  The	  catalytic	  chains	  are	  dark	  and	  the	  regulatory	  chains	  are	  light	  in	  color.	  	  This	  figure	  was	  drawn	  with	  PyMol.9	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Å	  and	  57.9	  Å	  for	  the	  T-­‐state	  (PDB	  ID	  code	  1ZA1	  used	  throughout)	  and	  R-­‐state	  (PDB	  ID	   code	   1D09	   used	   throughout),	   respectively.	   The	   average	   planar	   angle	   between	  allosteric	  domains	  of	  the	  regulatory	  dimer	  in	  the	  K164E/E239K	  structure	  was	  153°,	  which	  compares	  to	  152.0°	  and	  155.8°	  for	  the	  T	  and	  R	  structures,	  respectively,	  of	  the	  wild-­‐type	   enzyme.	   For	   the	   wild-­‐type	   enzyme	   the	   relative	   rotation	   around	   the	  molecular	   three-­‐fold	   axis	   between	   the	   T	   and	   R	   structures	   is	   12°,	   whereas	   the	  rotation	  from	  the	  wild-­‐type	  T	  structure	  to	  the	  K164E/E239K	  structure	  is	  only	  4.8°.	  The	  vertical	  separation,	  the	  angle	  between	  the	  allosteric	  domains	  of	  the	  regulatory	  dimer,	   and	   the	   rotation	   of	   the	   catalytic	   subunits	   about	   the	   3-­‐fold	   axis	   all	   indicate	  that	   the	   K164E/E239K	   structure	   is	   not	   globally	   in	   either	   the	   wild-­‐type	   T	   or	   R	  structure.	  The	   analysis	   of	   the	   global	   conformation	   of	   the	   K164E/E239K	   structure	   by	  means	  of	  X-­‐ray	  crystallography	  does	  not	  agree	  with	  the	  previously	  reported	  data	  as	  determined	   by	   sedimentation	   velocity.2	   Therefore,	   we	   used	   the	   program	  HydroPRO10	  to	  calculate	  the	  hydrodynamic	  properties	  based	  upon	  the	  wild-­‐type	  and	  K164E/E239K	  structures.	  In	  particular,	  the	  radius	  of	  gyration	  (Rg)	  was	  compared	  to	  the	  corresponding	  values	  for	  wild-­‐type	  ATCase	  in	  the	  T	  and	  R	  states.	  The	  Rg	  values	  of	  the	  wild-­‐type	  T	  and	  R-­‐states	  were	  calculated	  to	  be	  46.4	  and	  49.1	  Å,	  respectively,	  which	   compares	   well	   with	   the	   reported	   values	   of	   46.6	   ±	   0.3	   and	   49.3	   ±	   0.2	   Å,	  respectively.11	  The	  calculated	  Rg	  for	  the	  K164E/E239K	  structure	  was	  47.2	  Å,	  a	  value	  closer	  to	  the	  T	  than	  the	  R	  state	  of	  the	  wild-­‐type	  enzyme.	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K164E/E239K	  ATCase	  Exists	  in	  a	  Different	  Structural	  State	  from	  the	  Wild-­type	  
R-­state	  in	  Solution	  For	   the	   wild-­‐type	   enzyme,	   the	   percent	   change	   in	   the	   sedimentation	  coefficient	  between	   the	  T-­‐	   and	  R-­‐state	   structures	  has	  been	   reported	   to	  be	   -­‐3.8%.2	  The	   corresponding	   percent	   difference	   calculated	   between	   the	   K164E/E239K	   and	  wild-­‐type	   R-­‐state	   structures	  was	   -­‐0.4%.2	   These	   data	   suggest	   that	   the	   structure	   of	  K164E/E239K	   enzyme	   may	   be	   different	   in	   solution	   than	   it	   is	   in	   the	   crystal.	  Therefore,	   we	   used	   small-­‐angle	   X-­‐ray	   scattering	   (SAXS)	   to	   obtain	   additional	  structural	  data	  on	  the	  K164E/E239K	  ATCase	  in	  solution.12,13	  SAXS	   data	   were	   recorded	   using	   Beamline	   4-­‐2	   at	   the	   Stanford	   Synchrotron	  Research	   Laboratory	   at	   pH	   values	   8.3,	   7.5	   and	   7.0.	   In	   addition	   to	   recording	   SAXS	  data	   for	   the	   K164E/E239K	   enzyme,	   data	   were	   also	   recorded	   for	   the	   wild-­‐type	  ATCase	  in	  the	  absence	  of	  ligands	  (T-­‐state	  control)	  and	  in	  the	  presence	  of	  PALA	  (R-­‐state	  control).	  The	  SAXS	  patterns	  (Figure	  3.3),	  plotted	  as	  normalized	  Kratky	  Plots,14	  for	  the	  T	  and	  R-­‐states	  of	  the	  wild-­‐type	  enzyme	  are	  dramatically	  different.	  The	  SAXS	  pattern	   for	   the	   K164E/E239K	   enzyme	   at	   pH	   8.3	   (Figure	   3.3	   A)	   is	   intermediate	  between	   the	  T	   and	  R-­‐states	   observed	   for	   the	  wild-­‐type	   enzyme.	  The	   intermediate	  curve	  observed	  for	  the	  K164E/E239K	  enzyme	  can	  be	  explained	  in	  at	  least	  two	  ways.	  First,	   the	   K164E/E239K	   enzyme	   exists	   in	   a	   new	   structural	   state	   that	   is	   different	  from	  the	  wild-­‐type	  T	  or	  R-­‐state;	  or	  second,	  in	  solution	  the	  K164E/E239K	  enzyme	  is	  a	  mixture	  of	  two	  or	  more	  structures.	  The	  second	  explanation	  is	  consistent	  with	  the	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Figure	   3.3.	   	   Small-­‐angle	   X-­‐ray	   scattering	   of	   the	   wild-­‐type	   and	   the	   K164E/E239K	  enzymes	  at	  pH	  8.3	  (A),	  pH	  7.5	  (B)	  and	  pH	  7.0	  (C).	  At	  each	  pH	  the	  wild-­‐type	  enzyme	  in	  the	  absence	  of	  ligands	  is	  shown	  in	  black	  and	  in	  the	  presence	  of	  PALA	  in	  blue.	  The	  K164E/E239K	  enzyme	  in	  the	  absence	  of	  ligands	  is	  shown	  in	  red	  and	  in	  the	  presence	  of	   PALA	   in	   orange.	   The	   data	   are	   plotted	   as	   normalized	   Kratky	   Plots.14	   The	   green	  dash	  line	  indicates	  the	  best	  fit	  of	  a	  combination	  of	  the	  wild-­‐type	  T	  pattern	  and	  the	  K164E/E239K	   PALA	   R	   pattern	   to	   the	   K164E/E239K	   pattern	   in	   the	   absence	   of	  ligands.	  Each	  scattering	  curve	  corresponds	   to	  100	  data	  points	  connected	  by	   linear	  line	  segments.	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K164E/E239K	   enzyme	   having	   a	   T	   to	   R	   equilibrium	   shifted	   from	   the	   T-­‐state	  dominated	  equilibrium	  observed	  for	  the	  wild-­‐type	  enzyme.	  	  If	  the	  SAXS	  pattern	  of	  the	  K164E/E239K	  enzyme	  is	  a	  mixture	  of	  wild-­‐type	  T	  and	  R	  structures,	   it	   should	  be	  possible	   to	  generate	   the	  SAXS	  pattern	  of	   the	  double	  mutant	  enzyme	  by	  a	  linear	  combination	  of	  the	  wild-­‐type	  T	  and	  R-­‐state	  patterns.	  The	  dotted	  line	  in	  Figure	  3.3	  A,	  B	  and	  C	  corresponds	  to	  the	  best	  fit	  of	  the	  SAXS	  pattern	  of	  the	  K164E/E239K	  enzyme	  using	  the	  wild-­‐type	  T	  and	  R	  curves.	  At	  each	  pH,	  the	  best-­‐fit	  curve	  does	  not	  match	  that	  observed	  for	  the	  K164E/E239K	  enzyme.	  In	  particular,	  the	   position	   and	   amplitude	   of	   the	   first	   subsidiary	   minimum	   is	   not	   predicted	  correctly.	  The	  inability	  to	  deconvolute	  the	  curve	  into	  T	  and	  R	  components	  suggests	  that	   in	   solution	   the	   K164E/E239K	   enzyme	   is	   neither	   the	   T	   or	   R-­‐quaternary	  structure	  of	  the	  wild-­‐type	  enzyme	  or	  a	  mixture	  thereof.	  As	  opposed	  to	  the	  wild-­‐type	  enzyme	  in	  the	  absence	  or	  presence	  of	  PALA,	  the	  SAXS	  pattern	  for	  the	  K164E/E239K	  enzyme	  is	  pH	  dependent	  (compare	  Figure	  3.3	  A,	  B,	  C).	  Thus,	  by	  altering	  the	  pH	  either	  the	  quaternary	  structure	  of	  the	  K164E/E239K	  enzyme	  is	  shifting	  or	  the	  population	  of	  molecules	  in	  the	  R-­‐state	  is	  increasing	  relative	  to	  the	  T-­‐state.	  According	  to	  these	  SAXS	  data,	  at	  no	  pH	  between	  7.0	  and	  8.3	  does	  the	  unliganded	  K164E/E239K	  enzyme	  exist	  in	  a	  structure	  that	  would	  be	  considered	  the	  same	  as	  the	  R	  structure	  of	  the	  wild-­‐type	  enzyme.	  As	  the	  pH	  is	  varied	  from	  8.3	  to	  7.0	  the	  SAXS	  pattern	  of	  the	  unliganded	  K164E/E239K	  enzyme	  shifts	  towards	  the	  wild-­‐type	  R	  structure.	  This	  shift	  in	  structure	  could	  be	  modeled	  based	  on	  the	  SAXS	  pattern	  of	   the	   K164E/E239K	   enzyme	   at	   pH	   8.3	   in	   the	   presence	   and	   absence	   of	   PALA,	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suggesting	   that	   this	   shift	   in	   the	   SAXS	   pattern	  was	   due	   to	   a	   change	   in	   the	   relative	  population	  of	  the	  two	  structures	  in	  solution.	  The	  SAXS	  data	  for	  the	  wild-­‐type	  and	  the	  K164E/E239K	   enzymes	   are	   also	   plotted	   as	   scattering	   intensity	   and	   the	   log	   of	   the	  scattering	  intensity	  versus	  the	  momentum	  transfer	  (q)	  (Figure	  3.4	  and	  Figure	  3.5).	  These	   results	   suggest	   that	   the	   previously	   reported	   findings	   that	   the	  K164E/E239K	  ATCase	  is	  in	  the	  R-­‐state	  may	  need	  to	  be	  re-­‐evaluated.2,3	  The	  evidence	  presented	  here	  clearly	  demonstrates	  the	  quaternary	  structure	  of	  the	  K164E/E239K	  ATCase	  is	  not	  identical	  to	  the	  wild-­‐type	  ATCase•PALA	  complex,	  the	  typical	  structure	  used	   to	   define	   the	   R-­‐state.	   The	   sedimentation	   velocity	   experiments	   on	   the	  K164E/E239K	   ATCase,	   which	   indicated	   R-­‐state	   like	   sedimentation	   values	   were	  performed	  at	  20°	  C	  and	  pH	  7.0,2	  a	  temperature	  and	  pH	  that	  may	  perturb	  the	  enzyme	  toward	  a	  more	  R-­‐like	  structure.	  The	  SAXS	  data	  in	  Figure	  3.3	  show	  that	  lowering	  the	  pH	   from	  8.3	   to	  7.0	  causes	  a	  shift	   in	   the	  structure	   toward	   the	  R-­‐state.	  The	  solution	  NMR	  report	  by	  Velyvis	  et	  al.	  3	  also	  asserts	  the	  K164E/E239K	  ATCase	  is	  in	  the	  R-­‐state	  and	  concludes	  the	  Monod,	  Wyman,	  and	  Changeux	  (MWC)	  model15	  can	  fully	  account	  for	  the	  allosteric	  properties	  of	  ATCase.	  The	  experiments	  performed	  by	  Velyvis	  et	  al.3	  were	  carried	  out	  at	  37°	  C	  and	  pH	  7.5.	  	  At	  this	  pH	  value	  and	  25°C,	  the	  K164E/E239K	  ATCase	  is	  not	  in	  the	  canonical	  R-­‐state	  structure	  (Figure	  3.3	  B).	  Although	  the	  higher	  temperature	  of	  the	  NMR	  experiments	  may	  cause	  a	  shift	  in	  the	  structure	  towards	  the	  R-­‐state,	   the	   temperature	   dependence	   of	   SAXS	   data	   has	   been	   determined	   for	   the	  wild-­‐type	   and	   the	   D236A	   enzyme.	   The	   wild-­‐type	   enzyme	   showed	   no	   change	   in	  structure	  by	  SAXS	  through	  the	  temperature	  range	  of	  4°	  C	  to	  55°	  C,	  while	  the	  D236A	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Figure	   3.4.	   Small-­‐angle	   X-­‐ray	   scattering	   of	   the	   wild-­‐type	   and	   the	   K164E/E239K	  enzymes	  at	  pH	  8.3	  (A),	  pH	  7.5	  (B)	  and	  pH	  7.0	  (C).	  The	  data	  are	  plotted	  as	  scattering	  intensity	   versus	   momentum	   transfer	   (Q).	   Scattering	   intensity	   was	   normalized	   to	  take	   into	  account	  the	  small	  differences	   in	  enzyme	  concentration	  between	  samples.	  At	  each	  pH	  the	  wild-­‐type	  enzyme	  in	  the	  absence	  of	  ligands	  is	  shown	  in	  black,	  and	  in	  the	  presence	  of	  PALA	  in	  blue.	  The	  K164E/E239K	  enzyme	  in	  the	  absence	  of	  ligands	  is	  shown	  in	  red	  and	  in	  the	  presence	  of	  PALA	  in	  orange.	  The	  green	  dash	  line	  indicates	  the	  best	  fit	  of	  a	  combination	  of	  the	  wild-­‐type	  T	  pattern	  and	  the	  K164E/E239K	  PALA	  R	   pattern	   to	   the	   K164E/E239K	   pattern	   in	   the	   absence	   of	   ligands.	   Each	   scattering	  curve	  corresponds	  to	  100	  data	  points	  connected	  by	  linear	  line	  segments.	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Figure	   3.5.	   Small-­‐angle	   X-­‐ray	   scattering	   of	   the	   wild-­‐type	   and	   the	   K164E/E239K	  enzymes	  at	  pH	  8.3	  (A),	  pH	  7.5	  (B)	  and	  pH	  7.0	  (C).	  The	  data	  are	  plotted	  as	  scattering	  intensity	   versus	   momentum	   transfer	   (Q).	   Scattering	   intensity	   was	   normalized	   to	  take	   into	  account	  the	  small	  differences	   in	  enzyme	  concentration	  between	  samples.	  At	  each	  pH	  the	  wild-­‐type	  enzyme	  in	  the	  absence	  of	  ligands	  is	  shown	  in	  black,	  and	  in	  the	  presence	  of	  PALA	  in	  blue.	  The	  K164E/E239K	  enzyme	  in	  the	  absence	  of	  ligands	  is	  shown	  in	  red	  and	  in	  the	  presence	  of	  PALA	  in	  orange.	  The	  green	  dash	  line	  indicates	  the	  best	  fit	  of	  a	  combination	  of	  the	  wild-­‐type	  T	  pattern	  and	  the	  K164E/E239K.	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ATCase	  exhibited	  a	   large	   shift	   towards	   the	  T-­‐state	  between	  4°	  C	  and	  30°	  C	  with	  a	  minor	  shift	  back	  towards	  the	  R-­‐state	  between	  30°	  C	  and	  45°	  C.16	  These	  data	  suggest	  that	  under	  the	  NMR	  conditions	  (37°	  C),	  the	  K164E/E239K	  ATCase,	  which	  has	  similar	  properties	  to	  the	  D236A	  ATCase,	  would	  not	  be	  shifted	  toward	  the	  R-­‐state.	  This	  study	  underscores	   the	   need	   for	   extreme	   caution	   when	   making	   inferences	   about	   the	  allosteric	  mechanism	   of	   a	   wild-­‐type	   protein	   when	  working	   with	   a	  model	   system,	  which	  in	  this	  case	  is	  the	  double-­‐mutant	  enzyme.	  
K164E/E239K	   ATCase	   is	   in	   an	   Intermediate	   State	   during	   the	   Allosteric	  
Transition	  from	  the	  T	  to	  the	  R-­state	  Both	  the	  X-­‐ray	  crystallographic	  and	  SAXS	  data	  indicate	  that	  the	  structure	  of	  the	  K164E/E239K	  enzyme	   in	   the	   absence	   of	   ligands	   is	   not	   in	   the	  R	   structure,	   but	  rather	   it	   is	   an	   intermediate	   structure	   between	   the	   canonical	   T	   and	   R	   structures.	  Instead	   of	   providing	   a	  model	   for	   the	   R-­‐state,	   the	   K164E/E239K	   enzyme	   gives	   us	  structural	  information	  on	  the	  pathway	  of	  the	  T	  to	  the	  R-­‐state	  transition	  of	  ATCase.	  When	   wild-­‐type	   ATCase	   undergoes	   the	   allosteric	   transition	   to	   the	   R-­‐state,	   the	  enzyme	   expands	   10.6	  Å	   and	   the	   upper	   catalytic	   trimer	   rotates	   12°	   relative	   to	   the	  lower	  trimer	  along	  the	  3-­‐fold	  axis.	  Compared	  to	  the	  wild-­‐type	  T-­‐state	  structure	  the	  K164E/E239K	   enzyme	   only	   expands	   2.8	   Å	   and	   the	   upper	   catalytic	   trimer	   rotates	  only	  4.4°	  relative	  to	  the	  lower	  trimer	  (Figure	  3.6	  A).	  Previous	  studies	  revealed	  that	  the	   planar	   angle	   between	   the	   allosteric	   domains	   of	   the	   regulatory	   dimer	   changes	  almost	   linearly	   with	   changes	   in	   the	   size	   of	   the	   molecule,6	   which	   increases	   from	  152.0°	  to	  155.8°	  as	  the	  enzyme	  transitions	  from	  the	  T	  to	  the	  R	  state.	  The	  fact	  that	  in	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Figure	   3.6.	   (A)	   The	   percent	   change	   in	   quaternary	   structural	   properties	   of	   the	  K164E/E239K	  ATCase.	  As	  reference,	   the	  wild-­‐type	  enzyme	  characteristics	  go	   from	  0%	  (T	  state)	   to	  100%	  (R	  state).	   (B)	  The	  T	  structure	  of	  one	  catalytic	  chain	  of	  wild-­‐type	  ATCase	  (PDB	  ID	  code	  1ZA1).	  (C)	  The	  R	  structure	  of	  one	  catalytic	  chain	  of	  wild-­‐type	  ATCase	  (PDB	  ID	  code	  1D09).	  In	  B	  and	  C	  the	  diameter	  of	  the	  tube	  corresponds	  to	  the	  (α-­‐carbon)	  RMSD	  between	  the	  wild-­‐type	  and	  the	  K164E/E239K	  structures.	  The	  portions	   of	   the	   tube	   highlighted	   in	   black	   correspond	   to	   those	  with	   RSMD	   greater	  than	  1.5	  Å.	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the	  K164E/E239K	  structure	  this	  planar	  angle	  is	  only	  153°	  suggests	  that	  the	  size	  of	  the	  double	  mutant	   is	  between	   the	  size	  of	   the	  wild-­‐type	  T	  and	  R-­‐state	  enzymes.	  As	  seen	   in	   Figure	   3.6	   A,	   the	   percent	   change	   in	   the	   vertical	   separation,	   the	   angle	  between	   the	   allosteric	   domains	   of	   the	   regulatory	   dimer,	   the	   rotation	   about	   the	   3-­‐fold	  axis	  and	  the	  radius	  of	  gyration	  observed	  in	  the	  K164E/E239K	  structure	  are	  all	  about	  one-­‐third	  of	  the	  difference	  in	  the	  parameters	  observed	  between	  the	  T	  and	  R	  states	   of	   the	   wild-­‐type	   enzyme.	   Therefore	   the	   K164E/E239K	   exists	   in	   an	  intermediate	   structure	   shifted	   about	   one-­‐third	   towards	   the	  wild-­‐type	   R	   structure	  from	  the	  T	  structure.	  	  Not	   only	   is	   the	   quaternary	   conformation	   of	   the	   K164E/E239K	   structure	  intermediate	  between	  the	  canonical	  ATCase	  T	  and	  R	  structures	  but	  also	  the	  tertiary	  structure	  of	  the	  individual	  chains	  is	  intermediate	  as	  well.	  As	  seen	  in	  Figure	  3.6	  B	  and	  3.6	   C,	   the	   root	   mean	   square	   deviation	   (RMSD)	   of	   the	   Cα	   in	   the catalytic	   chain between	  the	  wild-­‐type	  and	  the	  K164E/E239K	  structures	  is	  reflected	  in	  the	  diameter	  of	  the	  tube.	  The	  catalytic	  chain	  of	  the	  K164E/E239K	  structure	  has	  less	  RMSD	  to	  that	  of	  the	  T-­‐state	  structure	  than	  the	  R-­‐state	  structure.	  Thus,	  the	  tertiary	  structure	  of	  the	  double	  mutant	  represents	  an	  intermediate	  state	  closer	  to	  the	  T-­‐state.	  Another	  prominent	  feature	  of	  the	  T	  to	  R	  transition	  is	  the	  closure	  of	  the	  two	  domains	  of	  each	  catalytic	  chain	   to	  rearrange	   the	  active	  site	  residues	  so	  as	   to	  push	  the	  substrates	  toward	  one	  another	  in	  the	  bimolecular	  reaction.	  However,	  the	  active	  site	   of	   the	   K164E/E239K	   ATCase	  more	   closely	   resembles	   the	   T-­‐state	   than	   the	   R-­‐state	  active	  site	  (Figure	  3.7).	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Figure	  3.7.	  	  Stereoview	  of	  the	  K164E/E239K	  ATCase	  2	  Fo	  –	  Fc	  electron	  density	  map	  of	   the	  active	  site	  region	  contoured	  at	  1.3	  σ.	  Overlaid	  onto	   the	  electron	  density	  are	  the	  side	  chains	  known	  to	  be	  involved	  in	  substrate	  binding	  and	  catalysis.	  	  Side	  chains	  are	   shown	   for	   the	   K164E/E239K	   (cyan	   carbons),	   wild-­‐type	   T-­‐state	   (magenta	  carbons)	   and	   wild-­‐type	   T-­‐state	   (orange)	   ATCases.	   The	   three	   structures	   were	  overlaid	  based	  upon	  the	  α-­‐carbon	  positions	  of	  the	  active	  site	  residues.	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A	  comparison	  of	  the	  active	  site	  region	  of	  the	  K164E/E239K	  ATCase	  with	  the	  T	  and	  R-­‐states	  of	  the	  wild-­‐type	  enzyme	  is	  shown	  with	  electron	  density	  in	  Figure	  3.7.	  Key	  differences	  include	  significant	  alterations	  in	  the	  positions	  of	  Arg54	  and	  Arg167	  that	  are	  two	  key	  residues	  involved	  in	  catalysis.	  	  Both	  Arg54	  and	  Arg167	  swing	  out	  of	  the	  active	  site	  in	  the	  K164E/E239K	  ATCase	  structure.	  These	  alterations	  in	  side	  chain	  position	  may	  be	  responsible	  for	  the	  reduced	  catalytic	  activity	  and	  increased	  [Asp]0.5	  of	  the	  K164E/E239K	  compared	  to	  the	  wild-­‐type	  enzyme.2	  In	   addition	   to	   the	  K164E/E239K	   enzyme	   reported	   here,	   SAXS	   experiments	  have	  shown	  that	  the	  E239Q	  and	  D236A	  enzymes	  also	  exhibit	  patterns	  intermediate	  between	  the	  T	  and	  R	  patterns	  of	  the	  wild-­‐type	  enzyme.11,16	  These	  mutants	  break	  the	  T-­‐state	  interchain	  c1-­‐c4	  interactions	  between	  Glu239	  and	  both	  Lys164	  and	  Tyr165	  or	   the	   c1-­‐r4	   interaction	   between	   Asp236c	   and	   Lys143r.	   In	   order	   for	   ATCase	   to	  transition	   from	   the	  T-­‐	   to	   the	  R-­‐quaternary	   structure,	   these	   interchain	   interactions	  must	  break	  (see	  Figure	  3.8	  A,	  C),	  although	  for	  the	  wild-­‐type	  enzyme	  in	  the	  R-­‐state,	  c1	   intrachain	  interactions	  are	  formed	  between	  Glu239	  to	  both	  Lys164	  and	  Tyr165	  (see	  Figure	  3.8	  C).	   In	   the	   case	  of	   the	  K164E/E239K	  enzyme,	   the	  possible	   salt	   link	  between	  Glu164	   and	   Lys239	  does	   not	   form	   (average	   distance	   between	  Glu164	  Oε	  and	  Lys239	  Nζ	  is	  4.78	  ±	  0.7	  Å).	  Furthermore,	  the	  salt-­‐link	  between	  Asp236	  (c1/c4)	  and	  Lys143	  (r4/r1)	  observed	  in	  the	  T-­‐state	  structure	  (Figure	  3.8.	  A)	  is	  broken	  in	  the	  K164E/E239K	   enzyme	  with	   an	   average	   distance	   between	   the	   Asp236	   Oδ	   and	   the	  Lys143	  Nζ	  of	  8.17	  ±	  3.5	  Å	  (Figure	  3.8	  B).	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Figure	  3.8.	  	  The	  c1-­‐c4,	  c1-­‐r4	  and	  c4-­‐r1	  interfaces.	  (A)	  The	  T-­‐state	  residue	  positions	  	  and	   interactions	   of	   the	  wild-­‐type	   enzyme	   (PDB	   code	   1ZA1),	   (B)	   the	   same	   residue	  positions	   in	   the	   K164E/E239K	   ATCase	   reported	   here	   and	   (C)	   the	   R-­‐state	   residue	  positions	  and	  interactions	  of	  the	  wild-­‐type	  enzyme	  (PDB	  code	  1D09).	  Shown	  are	  the	  interactions	  involving	  Glu239	  (wild-­‐type	  T	  state	  (A)	  and	  R	  state	  (C)	  or	  Lys239	  in	  the	  K164E/E239K	  structure	  (B)).	   	  Also	  shown	  are	  the	   interactions	  between	  Asp236	  of	  the	  catalytic	   chains	  and	  Lys143	  of	   the	   regulatory	  chains.	  For	   clarity	  Tyr165	   is	  not	  labeled.	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   Most	   interestingly,	   the	   scattering	   curve	  of	   the	  K164E/E239K	  ATCase	   at	   pH	  8.3	  is	  comparable	  to	  the	  intermediate	  curve	  of	  the	  structure	  at	  the	  end	  of	  the	  early	  fast-­‐rising	   phase	   of	   the	   time-­‐resolved	   stop-­‐flow	   X-­‐ray	   scattering	   of	   ATCase	   upon	  mixing	  with	   substrates	   carbamoyl	   phosphate	   and	   L-­‐aspartate.17	   The	   elongation	   of	  the	   enzyme	   is	   a	   necessary	   part	   of	   the	   allosteric	   transition,	   which	   requires	   the	  breaking	  of	  the	  T-­‐state	  intersubunit	  interactions	  involving	  both	  Glu239	  and	  Asp236;	  thus	   the	  K164E/E239K	   structure,	   lacking	   these	   interactions,	   is	   a	   unique	   structure	  along	  the	  path	  of	  the	  quaternary	  structural	  transition	  from	  the	  T	  to	  the	  R-­‐state.	  As	  such,	   these	   findings	   suggest	   that	   there	   are	   transiently	   stable	   intermediate	  structures,	   such	   as	   the	  K164E/E239K,	   that	   the	   protein	   passes	   through	   and	  which	  lower	  the	  overall	  activation	  energy	  of	  the	  allosteric	  transition.	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   for	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Introduction	  	   Escherichia coli	  aspartate	  transcarbamoylase	  (ATCase,	  EC	  2.1.3.2),	  which	  has	  been	   established	   as	   a	   classic	   model	   for	   allosteric	   regulation,1	   catalyzes	   the	   first	  committed	  step	  in	  the	  de	  novo	  pyrimidine	  biosynthetic	  pathway,	  the	  carbamoylation	  of	   the	   amino	   group	   of	   L-­‐aspartate	   (Asp)	   by	   carbamoyl	   phosphate	   (CP)	   to	   form	  N-­‐carbamoyl-­‐L-­‐aspartate	   (CA).	   This	   enzyme	   is	   highly	   regulated	   by	   the	   nucleotide	  effectors,	  which	  bind	  at	  the	  allosteric	  sites	  about	  60	  Å	  away	  from	  the	  catalytic	  sites.2	  The	   end-­‐product	   of	   the	   pyrimidine	   pathway,	   CTP,	   feedback	   inhibits	   the	   enzyme,	  whereas	  ATP,	   the	  end-­‐product	  of	   the	  parallel	  purine	  pathway,	   exerts	   the	  opposite	  effect,	   activating	   the	   enzyme.	   However,	   both	   nucleotides	   have	   been	   shown	   to	  competitively	   bind	   at	   the	   same	   allosteric	   sites.3	   Other	   purine	   nucleotides,	   such	   as	  GTP	  and	  ITP,	  inhibit	  the	  enzyme	  (25-­‐30%)	  but	  less	  than	  that	  by	  CTP	  (50-­‐70%).4	  UTP,	  another	  end-­‐product	  of	  the	  pyrimidine	  pathway,	  is	  a	  synergistic	  inhibitor	  of	  ATCase	  in	   the	   presence	   of	   CTP,	   however	   UTP	   has	   no	   independent	   effect	   at	   pH	   7.0.5	   The	  inhibition	   (90-­‐95%)	  by	  CTP	  and	  UTP	   is	  much	  more	   than	   that	  by	  either	  nucleotide	  alone.	   However,	   this	   synergistic	   inhibitory	   effect	   is	   not	   as	   pronounced	   at	   pH	   8.3	  when	  UTP	  alone	  slightly	  inhibits	  the	  enzyme.5 	   Extensive	  work,	  including	  but	  not	  limited	  to	  enzyme	  kinetics4,6-­‐8	  and	  binding	  studies	   9-­‐13	   of	   both	   the	   wild-­‐type	   and	   mutant	   ATCases,	   have	   been	   performed	   to	  understand	  the	  allosteric	  regulation	  of	  the	  enzyme	  by	  nucleotide	  effectors.	  Most	  of	  these	  studies	  simply	  used	  the	  sodium	  salts	  of	  the	  nucleotides	  for	  their	  experiments,	  though	  it	  was	  reported	  as	  early	  as	  1966	  by	  Kleppe	  and	  Spaeren14	  	  that	  the	  Mg2+ATP	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and	  Mg2+CTP	  complexes	  had	  modified	  regulatory	  effects	  on	  the	  enzyme	  relative	  to	  the	  sodium	  nucleotides.	  More	  than	  10	  years	  later,	  both	  the	  work	  of	  Christopherson	  
et	   al.15	   and	   Honzatko	   et	   al.16	   indicated	   an	   enhanced	   enzymatic	   activity	   by	   the	  complexes	  of	  nucleotides	  (ATP,	  CTP	  and	  GTP)	  and	  several	  metals	  (Mg2+,	  Mn2+,	  Ca2+,	  Al3+	   and	   Gd3+)	   relative	   to	   that	   produced	   by	   the	   nucleotides	   free	   of	   these	   metals.	  Later	   Fetler	   et	  al.17	   investigated	   solution	  X-­‐ray	   small-­‐angle	   scattering	   curves	   of	  E. 
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Results	  
Comparison	  of	  Effect	  of	  Nucleotides	  on	  the	  Activity	  of	  ATCase	   in	  the	  Absence	  
and	  Presence	  of	  Mg2+	  Colorimetric	   assays	   were	   performed	   with	   various	   purine	   and	   pyrimidine	  nucleotide	   triphosphates	   independently	   and	   in	   combination	   in	   the	   absence	   and	  presence	  of	  Mg2+.	  The	  contamination	  of	  metal	  ions	  in	  some	  commercial	  nucleotides	  was	  reported	  to	  reverse	  the	  effect	  of	  the	  nucleotides	  reported	  in	  previous	  studies.4	  In	  our	  studies	  all	  the	  commercial	  nucleotides	  were	  pretreated	  with	  Chelex	  100	  resin	  (Bio-­‐Rad)	   to	   remove	  metals	   prior	   to	   assays.	   In	   order	   to	   compare	  our	   results	  with	  those	   reported	   by	   Wild	   et	   al.,5	   ATCase	   activity	   was	   measured	   under	   the	   same	  conditions	   at	   saturating	   carbamoyl	   phosphate	   (2	   mM)	   and	   5	   mM	   aspartate,	   the	  concentration	  required	  for	  half-­‐maximal	  activity	  [S]0.5	  at	  pH	  7.0,	  28°	  C.	  Interestingly,	  as	  shown	  in	  Table	  4.1	  the	  relative	  activities	  reported	  by	  Wild	  et	  
al.5	  were	  in	  agreement	  with	  our	  results	  for	  the	  nucleotides	  and	  their	  combinations,	  except	  for	  CTP,	  ATP/CTP	  and	  CTP/GTP,	  in	  the	  presence	  of	  Mg2+	  rather	  than	  those	  in	  the	  absence	  of	  Mg2+.	  The	  effect	  of	  CTP	  to	  reverse	  the	  activation	  by	  ATP,	  as	  previously	  reported,5,20	   is	   possible	   only	   in	   the	   absence	   of	   Mg2+.	   In	   the	   presence	   of	   Mg2+,	  CTP/ATP	   increases	   enzyme	   activity 125%,	  which	   is	   lower	   than	   the	   activation	   by	  ATP	  alone	  (129%).	  GTP	  alone	  inhibits	  the	  enzyme	  about	  5%	  and	  UTP	  alone	  has	  no	  effect	  on	  the	  enzyme.	  However,	  in	  the	  absence	  of	  Mg2+	  GTP/UTP	  together	  inhibit	  the	  enzyme	  about	  30,	  much	  more	   than	  either	   alone.	  Addition	  of	  Mg2+	   slightly	   reduces	  this	  inhibition	  to	  25%.	  Either	  GTP	  or	  UTP	  when	  paired	  with	  ATP	  enhances	  the	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Table	  4.1.	  Relative	  activitiesa	  of	  ATCase	  for	  nucleotide	  effectors	  in	  the	  absence	  and	  presence	  of	  Mg2+	  at	  pH	  7.0	  
	   	   	   	   Mg2+	  (mM)d	  	  	  	   	   	   ________________________________________	   	  	   NTPb	   Reported	  Valuec	   0	  	   1.0	   2	  .0	  
	   ATP	   	   1.35	   1.29	  ±	  0.071	   1.33	  ±	  0.067	   1.52	  ±	  0.13	  	   CTP	   0.43	   0.49	  ±	  0.011	   0.80	  ±	  0.051	   0.97	  ±	  0.050	  	   UTP	   0.95	   0.99	  ±	  0.0068	   0.97	  ±	  0.014	   0.89	  ±	  0.036	  	   GTP	   0.71	   0.95	  ±	  0.051	   0.61	  ±	  0.060	   0.84	  ±	  0.042	  	   ATP/CTP	   0.85	   0.87	  ±	  0.023	   	   	   	   1.25	  ±	  0.034	  	   ATP/UTP	   1.52	   1.40	  ±	  0.055	   	   	   1.43	  ±	  0.056	  	   ATP/GTP	   1.58	   1.38	  ±	  0.041	   	   	   1.57	  ±	  0.054	  	   CTP/UTP	   0.06	   0.47	  ±	  0.098	   	   	   0.12	  ±	  0.041	  	   CTP/GTP	   0.58	   0.61	  ±	  0.080	   	   	   0.81	  ±	  0.15	  	   UTP/GTP	   0.84	   0.68	  ±	  0.011	   	   	   0.75	  ±	  0.024	   	  	   	   	  	  	   	   	   	   	   	   	   	   	  a	  Relative	   activities	   are	   determined	   by	   dividing	   the	   values	   of	   specific	   activities	   of	  ATCase	  in	  the	  presence	  of	  nucleotide(s)	  by	  that	  in	  the	  absence	  of	  nucleotide(s)	  b	  Concentration	  is	  2	  mM	  for	  each	  nucleotide.	  c	  The	  relative	  activities	  reported	  by	  Wild	  et	  al.5	  d	  All	  experiments	  were	  performed	  at	  28	  °C	   in	  20	  mM	  bis-­‐Tris,	  20	  mM	  Tris,	  and	  20	  mM	   Caps	   buffer,	   pH	   7.0.	   Saturating	   carbamoyl	   phosphate	   (2	   mM)	   and	   5	   mM	  aspartate	  were	  used	  throughout	  the	  assays.	  The	  values	  reported	  are	  the	  average	  of	  four	  determinations.	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activation	   by	   ATP	   alone,	   which	   is	   even	  more	   enhanced	  with	  Mg2+.	   Among	   all	   the	  effect	  of	  nucleotides	  with	  and	  without	  Mg2+,	  the	  maximal	  increase	  in	  activity	  	  (157%)	  is	   from	   the	   combination	   of	   ATP,	   GTP	   and	   Mg2+,	   despite	   the	   fact	   that	   2	   mM	   GTP	  inhibits	   the	  enzyme	  about	  40%	  with	  1	  mM	  Mg2+	  and	  15%	  with	  2	  mM	  Mg2+.	   In	   the	  absence	   of	   Mg2+,	   GTP	   reduces	   the	   CTP	   inhibition	   from	   50%	   to	   40%.	   2	   mM	  Mg2+	  further	  reduces	  the	  inhibition	  by	  CTP/GTP	  to	  only	  20%.	  Though	  UTP	  alone	  has	  no	  effect	  on	  the	  enzyme,	  2	  mM	  UTPMg2+	  (ratio	  1:1)	  inhibits	  the	  enzyme	  about	  10%.	  	  Mg2+	  reduces	  the	  CTP	  inhibition.	  At	  2	  mM	  CTPMg2+	  (ratio	  1:1)	  there	  is	  only	  3%	   inhibition,	   however	   the	   addition	   of	   Mg2+	   to	   CTP/UTP	   increases	   the	   CTP	  inhibition	  from	  50%	  to	  88%,	  which	  is	  very	  similar	  to	  the	  94%	  synergistic	  inhibition	  of	   the	   enzyme	  by	  CTP	  and	  UTP	   reported	   first	  by	  Wild	  et	  al.5 On	   the	   contrary,	   the	  combination	  of	  CTP	  and	  UTP	  in	  the	  absence	  of	  Mg2+	  only	  inhibits	  the	  enzyme	  53%,	  which	   is	   closer	   to	   the	   inhibition	   by	   CTP	   alone	   (50%)	   rather	   than	   the	   previous	  reported	  synergistic	  inhibition	  by	  CTP	  and	  UTP.	  	  
Mg2+	  is	  Required	  for	  the	  Synergistic	  Inhibition	  by	  CTP	  and	  UTP	  	  
	   To	   understand	   the	   role	   of	   Mg2+	   on	   the	   synergistic	   inhibition	   of	   ATCase,	  saturation	   studies	   with	   CTP,	   UTP	   and	   their	   Mg2+-­‐complexes	  were	   performed.	   As	  shown	  in	  Figure	  4.1	  A,	  de-­‐metaled	  CTP	  is	  able	  to	  reduce	  the	  activity	  of	  ATCase	  about	  50%	  but	  de-­‐metaled	  UTP	  is	  not	  able	  to	  enhance	  this	  inhibition.	  	  However,	  as	  shown	  in	  Figure	  4.1	  B,	  UTPMg2+	  (1:1	  ratio)	  has	  the	  ability	  to	  synergistically	  inhibit	  ATCase	  in	   the	  presence	  of	  CTP.	  There	   is	  no	   inhibitory	  effect	  on	  ATCase	  observed	   from	  de-­‐metaled	  UTP	  alone	  whereas	  UTPMg2+	  exhibits	  slight	  inhibition	  (see	  Figure	  4.2).	  In	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Figure	   4.1.	   Influence	   of	   CTP	   and	   UTP	   in	   the	   presence	   of	   CTP	   on	   the	   activity	   of	  ATCase	  (A)	  in	  the	  absence	  of	  Mg2+	  and	  (B)	  in	  the	  presence	  of	  Mg2+.	  Each	  data	  point	  is	  the	  average	  of	  three	  determinations	  with	  a	  deviation	  of	  ±8.1%.	  Measurements	  were	  made	   at	   pH	   7.0	   in	   the	   same	   conditions	   as	   described	   in	   Table	   4.1.	   (A)	   The	  independent	  effect	  of	  CTP	  ()	  was	  determined	  up	  to	  4	  mM.	  The	  effect	  of	  UTP	  plus	  CTP	  ()	  was	  determined	  by	  adding	   increasing	  concentrations	  of	  UTP	  (0-­‐2	  mM)	  to	  the	   enzyme	   while	   the	   CTP	   concentration	   was	   held	   constant	   at	   2	   mM.	   (B)	   The	  independent	  effect	  of	  CTP	  ()	  was	  determined	  up	  to	  4	  mM.	  The	  effect	  of	  UTPMg2+	  plus	  CTP	  ()	  was	  determined	  by	  adding	  increasing	  concentrations	  of	  UTPMg2+	  (0-­‐2	  mM)	  to	  the	  enzyme	  while	  the	  CTP	  concentration	  was	  held	  constant	  at	  2	  mM.	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Figure	   4.2.	   Influence	   of	   UTP	   and	   CTP	   in	   the	   presence	   of	   UTP	   on	   the	   activity	   of	  ATCase	  (A)	  in	  the	  absence	  of	  Mg2+	  and	  (B)	  in	  the	  presence	  of	  Mg2+.	  Each	  data	  point	  is	  the	  average	  of	  three	  determinations	  with	  a	  deviation	  of	  ±6.5%.	  Measurements	  were	  made	   at	   pH	   7.0	   under	   the	   same	   conditions	   as	   described	   in	   Table	   4.1.	   (A)	   The	  independent	  effect	  of	  UTP	  ()	  was	  determined	  up	  to	  4	  mM.	  The	  effect	  of	  CTP	  plus	  UTP	  ()	  was	  determined	  by	  adding	   increasing	  concentrations	  of	  CTP	  (0-­‐2	  mM)	  to	  the	   enzyme	   while	   UTP	   concentration	   was	   held	   constant	   at	   2	   mM.	   (B)	   The	  independent	  effect	  of	  UTPMg2+	  ()	  was	  determined	  up	  to	  4	  mM.	  The	  effect	  of	  CTP	  plus	  UTPMg2+	  ()	  was	  determined	  by	  adding	  increasing	  concentrations	  of	  CTP	  (0-­‐2	  mM)	  to	  the	  enzyme	  while	  the	  UTPMg2+	  concentration	  was	  held	  constant	  at	  2	  mM.	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the	  presence	  of	  2	  mM	  de-­‐metaled	  UTP,	  the	  inhibition	  curve	  of	  CTP	  (Figure	  4.2	  A)	  is	  similar	   to	   that	  of	  CTP	  alone	   (Figure	  4.1	  A).	  The	  maximal	   inhibition	  percentages	  of	  both	  curves	  fall	   in	  the	  range	  of	  50-­‐60%.	  The	  CTP	  concentrations	  required	  to	  reach	  half	  of	  the	  maximal	  inhibition	  were	  0.136	  ±	  0.042	  mM	  in	  the	  absence	  of	  UTP,	  which	  agrees	  with	  the	  reported	  value	  (0.14	  mM)	  by	  Wild	  et	  al.,	  and	  0.099	  ±	  0.034	  mM	  in	  the	  presence	  of	  UTP.	  The	  inhibition	  curve	  of	  CTP	  changes	  drastically	  in	  the	  presence	  of	  2	  mM	  UTPMg2+	  (see	  Figure	  4.2	  B).	  The	  maximal	   inhibition	  of	  CTP	  in	  this	  curve	  increases	  to	  90%,	  which	  reaches	  the	  same	  maximum	  level	  of	  inhibition	  by	  UTPMg2+	  in	   the	   presence	   of	   2	   mM	   CTP.	   Moreover	   the	   CTP	   concentration	   required	   for	   half	  maximal	   inhibition	  is	  reduced	  to	  0.029	  ±	  0.0041	  mM	  in	  the	  presence	  of	  UTPMg2+.	  Compared	   to	   that in	   the	   presence	   of	   de-­‐metaled	   UTP,	   the	   CTP	   concentration	  required	   for	   half	  maximal	   inhibition	   in	   the	  presence	   of	  UTPMg2+	  is	   closer	   to	   that	  reported	  by	  Wild	  et	  al.	  for	  the	  synergistic	  inhibition	  by	  CTP	  and	  UTP.	  	  The	  synergistic	  inhibition	  is	  not	  observed	  when	  de-­‐metaled	  CTP	  and	  UTP	  are	  used.	  But	   in	   the	  presence	  of	  Mg2+,	  CTP	  and	  UTP	  exhibited	  the	  synergistic	  effect	  on	  ATCase	  activity,	  as	  previously	  reported.	  It	  is	  possible	  that	  in	  previous	  studies	  there	  was	   sufficient	   metal	   ion	   contamination	   in	   the	   nucleotide	   solutions	   to	   allow	   this	  effect.	  These	   results	   suggest	   that	  a	  metal	   ion	  such	  as	  Mg2+	  is	   indispensable	   for	   the	  synergism	   inhibition	  by	  CTP	  and	  UTP.	  Furthermore,	   it	   appears	   that	  Mg2+	  not	  only	  serves	  to	  improve	  the	  inhibitory	  effects	  by	  CTP/UTP,	  but	  also	  promotes	  the	  binding	  of	  CTP	  as	  the	  affinity	  of	  the	  enzyme	  for	  CTP	  in	  the	  presence	  of	  UTPMg2+	  is	  about	  5-­‐fold	  higher	  to	  that	  for	  CTP	  alone.	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At	  pH	  8.3,	  UTP	  and	  CTP	  Can	  Synergistically	  Inhibit	  ATCase	  in	  the	  Presence	  of	  
Mg2+ 	   Wild	   et	   al.	   stated	   that	   the	   synergistic	   effect	   observed	   at	   pH	   7.0	   was	  unnoticeable	  at	  pH	  8.3.	  However,	  UTP	  alone	  can	   inhibit	   the	  enzyme	  by	  15-­‐20%	  at	  pH	  8.3.5	  We	   found	   that	   at	  pH	  8.3	  UTP	  and	  CTP	  can	  also	   synergistically	   inhibit	   the	  enzyme	  when	  Mg2+	  was	  present.	  Figure	  4.3	  shows	  that	  UTPMg2+	  can	  further	  reduce	  the	  activity	  of	  the	  enzyme	  saturated	  with	  CTP	  to	  only	  10%	  residual	  activity,	  which	  is	  significantly	  lower	  than	  that	  by	  UTP	  alone.	  It	   is	  worthwhile	  to	  note	  the	  differences	  between	  the	  synergistic	  effect	  at	  pH	  8.3	  and	  pH	  7.0.	  A	  2-­‐fold	  higher	  concentration	  of	  UTPMg2+	   was	   needed	   at	   pH	   8.3	   than	   at	   pH	   7	   to	   reach	   the	   maximal	   synergistic	  inhibition	   in	   combination	   with	   2	   mM	   CTP.	   UTPMg2+	   inhibits	   the	   enzyme	   in	   the	  presence	  of	  CTP	  significantly	  more	  at	  pH	  7	  than	  at	  pH	  8.3	  when	  the	  concentration	  of	  UTPMg2+	   is	   less	   than	  0.5	  mM.	  At	  0.5	  mM	  UTPMg2+,	   the	  enzyme	  activity	  at	  2	  mM	  CTP	  is	  further	  decreased	  by	  about	  60%	  at	  pH	  7	  compared	  to	  only	  about	  12%	  at	  pH	  8.3.	  This	  difference	  of	  the	  influence	  of	  Mg2+	  at	  different	  pH	  values	  is	  most	  likely	  due	  to	  the	  differences	  in	  the	  strength	  of	  the	  interactions	  between	  Mg2+	  and	  nucleotides,	  as	  the	  ionization	  of	  the	  nucleotides	  vary	  according	  to	  pH.	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Figure	   4.3.	   Influence	   of	   CTP	   and	   UTP	   in	   the	   presence	   of	   CTP	   on	   the	   activity	   of	  ATCase	  (A)	   in	  the	  absence	  of	  Mg2+	  and	  (B)	   in	  the	  presence	  of	  Mg2+	  at	  pH	  8.3.	  Each	  data	   point	   is	   the	   average	   of	   three	   determinations	   with	   a	   deviation	   of	   ±4.4%.	  Measurements	  were	  made	   in	   the	   same	   condition	   as	  described	   in	  Table	  4.1	   except	  pH.	   (A)	   Independent	   effect	   of	   CTP	   ()	  was	  determined	  up	   to	  4	  mM.	  The	   effect	   of	  UTP	  plus	  CTP	  ()	  was	  determined	  by	  adding	  increasing	  concentrations	  of	  UTP	  (0-­‐2	  mM)	   to	   the	   enzyme	   while	   CTP	   concentration	   was	   held	   constant	   at	   2	   mM.	   (B)	  Independent	  effect	  of	  CTP	  ()	  was	  determined	  up	  to	  6	  mM.	  The	  effect	  of	  UTPMg2+	  plus	  CTP	  ()	  was	  determined	  by	  adding	  increasing	  concentrations	  of	  UTPMg2+	  (0-­‐4	  mM)	  to	  the	  enzyme	  while	  CTP	  concentration	  was	  held	  constant	  at	  2	  mM.	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Discussion	  
	   The	   influence	   of	   metal	   ions	   on	   the	   activity	   of	   E. coli	   ATCase	   was	   first	  examined	   by	   Kleppe	   and	   Spaeren.14	   They	   reported	   that	   the	   divalent	   metal	   ions	  inhibited	  the	  holoenzyme	  while	  the	  alkali	  metals	  had	  no	  effect.	  They	  also	  reported	  that	  the	  activation	  of	  ATCase	  by	  ATP	  and	  inhibition	  by	  CTP	  were	  greatly	  dependent	  on	   the	   concentration	   of	   Mg2+.	   Additional	   kinetic	   studies	   were	   carried	   out	   to	  understand	   the	   regulatory	   properties	   of	   ATCase	   with metal-­‐NTP	   complexes.15,16	  The	  results	  of	  these	  studies	  showed	  an	  enhanced	  enzyme	  activity	  by	  ATP,	  CTP	  and	  GTP	   in	   the	  presence	   of	  Mg2+	   relative	   to	   that	   produced	  by	   the	  nucleotides	  without	  addition	   of	  Mg2+.	   It	   was	   noted	   that	   the	   contamination	   of	   heavy	  metal	   ions	   in	   the	  commercial	  supply	  of	  nucleotides	  may	  alter	  the	  nucleotide	  effects	  opposite	  to	  what	  was	  previously	  reported.4	  However,	  the	  above	  studies14-­‐16	  of	  the	  influence	  of	  metal	  ions	  on	  the	  nucleotide	  regulation	  of	  ATCase	  overlooked	  the	  metal	  contamination	  of	  the	   nucleotides.	   Thus	   the	   reported	   enzyme	   activity	   measured	   with	   sodium-­‐salt	  nucleotide	   solutions,	   which	   were	   used	   without	   the	   removal	   of	   trace	   metals,	   may	  include	  the	  effect	  of	  their	  complexes	  with	  non-­‐sodium	  metal	  ions,	  such	  as	  Mg2+.	  Our	  results	   should	   provide	   a	   more	   accurate	   comparison	   between	   the	   effect	   of	  nucleotides	   on	   the	   enzyme	   in	   the	   absence	   and	   presence	   of	   Mg2+	   since	   all	   the	  nucleotide	  solutions	  used	  in	  the	  present	  experiments	  have	  been	  de-­‐metaled	  before	  use.	   Since	   its	   discovery	   by	  Wild	  et	  al.	   in	   1989,5	   there	   has	   been	   no	   data	   published	  regarding	   the	   influence	   of	  Mg2+	   on	   the	   synergistic	   inhibitory	   effect	   of	   UTP	   in	   the	  presence	   of	   CTP.	   Thus	  we	   have	  made	   here	   a	   systematic	   study	   of	   the	   influence	   of	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Mg2+	  with	  ATP,	  CTP,	  GTP	  and	  UTP	  to	  fill	  this	  gap,	  providing	  a	  more	  complete	  picture	  of	  regulation	  of	  ATCase	  by	  the	  Mg2+•nucleotide	  complexes.	  	  	  
A	  Model	  for	  Nucleotide	  Regulation	  of	  ATCase	  Including	  Mg2+ 	   An	  early	  model	  of	  nucleotide	   regulation	  of	  ATCase	  without	   considering	   the	  influence	   of	   metal	   ions	   was	   proposed	   by	   London	   and	   Schmidt4	   based	   on	   the	  assumption	  that	  each	  regulatory	  chain	  contained	  one	  nucleotide	  binding	  site,	  which	  was	  equivalent	  to	  the	  other	  sites	  and	  existed	  at	  least	  in	  two	  different	  conformations.	  Different	  nucleotides	  have	  different	  affinities	  for	  the	  different	  conformations	  of	  the	  binding	  site,	  which	  is	  related	  to	  the	  quaternary	  conformation	  of	  the	  enzyme.	  When	  the	   quaternary	   conformation	   is	   more	   open	   and	   the	   enzyme	   is	   more	   active,	   the	  binding	  site	  favors	  a	  less	  contracted	  conformation,	  and	  vice	  versa.	  According	  to	  this	  model	   ATP	   activation	   is	   the	   consequence	   of	   ATP	   only	   binding	   to	   the	   expanded	  conformation	  of	   the	  binding	  site,	  which	   leads	   to	  a	  more	  open	  conformation	  of	   the	  enzyme	  having	  more	  activity.	  Recently	  Peterson	  et	  al.21	  discovered	  a	  novel	  allosteric	  site	  for	  UTP	  binding	  on	  each	  regulatory	  chain	  by	  determining	  the	  X-­‐ray	  structure	  of	  the	  ATCase•UTP	  complex.	  The	  UTP	  was	  bound	   to	  a	  site	   (referred	   to	  as	   the	  B	  site) adjacent	  to	  the	  known	  allosteric	  site	  (referred	  to	  as	  the	  A	  site)	  where	  ATP	  and	  CTP	  bind.22	   Thus	   each	   regulatory	   chain	   contains	   two	   distinct	   nucleotide-­‐binding	   sites,	  which	  naturally	  requires	  the	  need	  to	  modify	  the	  previous	  model	  in	  which	  only	  one	  nucleotide-­‐binding	  site	  per	  regulatory	  chain	  is	  considered.	  	  Though	  the	  synergistic	  inhibition	  of	  CTP	  and	  UTP	  is	  suggested	  by	  Peterson	  et	  
al.21	  as	  a	  result	  of	  the	  concurrent	  binding	  of	  CTP	  at	  the	  A	  site	  and	  UTP	  at	  the	  B	  site,	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the	  kinetic	  studies	  reported	  here	  clearly	  demonstrate	  that	  this	  synergistic	  inhibition	  can	  be	  observed	  only	  upon	  addition	  of	  Mg2+	  to	  the	  combination	  of	  CTP	  and	  UTP.	  This	  indicates	   that	   Mg2+	   is	   essential	   for	   the	   synergic	   inhibition	   to	   occur.	   Mg2+ATP	   is	  observed	   in	  many	   crystal	   structures	   that	  have	  been	  deposited	   in	   the	  Protein	  Data	  Bank.23-­‐25	  Mg2+	  is	  found	  mostly	  forming	  bidentate	  complexes	  with	  Mg2+	  interacting	  with	   the	   β	   and	   γ	   phosphate	   groups.17	   In	   the	   presence	   of	   CTP,	   replacing	  UTP	  with	  UDP	  results	  in	  the	  loss	  of	  synergistic	  inhibition.26	  These	  observations	  may	  indicate	  that	  Mg2+	   coordinates	  with	   the	   oxygen	   atoms	   of	   the	   β	   and	   γ	   phosphate	   groups	   of	  CTP	  and	  UTP，aligning	  both	  nucleotides	  in	  the	  proper	  orientation	  for	  binding	  to	  the	  enzyme	   at	   the	   combined	   AB	   site.	   Without	   Mg2+,	   CTP	   and	   UTP	   are	   probably	   not	  favored	  to	  bind	  simultaneously	  to	  the	  AB	  site	  due	  to	  the	  repulsion	  of	  their	  negative	  charge	   phosphates.	   Therefore,	   the	   combined	   synergistic	   inhibitory	   effect	   is	   only	  possible	   when	   CTP	   binds	   to	   the	   A	   site	   and	   UTP	   binds	   to	   the	   B	   site	   through	   the	  connection	   of	   Mg2+.	   Since	   UTP	   by	   itself	   binds	   exclusively	   to	   the	   B	   site21	   without	  having	  any	  effect	  on	  the	  enzyme	  while	  the	  A	  site	  is	  left	  empty,	  these	  results	  suggest	  that	   for	   the	   synergistic	   inhibition	   UTP	   in	   the	   B	   site	   only	   acts	   to	   magnify	   the	  inhibition	  by	  CTP	  bound	  in	  the	  A	  site	  when	  CTPMg2+UTP	  is	  bound	  together	  in	  the	  combined	  AB	  site.	  	  	   From	   this	   understanding	   of	   the	  CTP/UTP	   synergism,	  we	  propose	   a	   revised	  model	  for	  nucleotide	  regulation	  of	  ATCase	  that	  can	  provide	  a	  probable	  explanation	  for	  the	  observed	  nucleotide	  effects	  in	  the	  absence	  and	  presence	  of	  Mg2+	  reported	  in	  this	  study.	  In	  this	  model	  each	  of	  the	  six	  regulatory	  chains	  contains	  two	  neighboring	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nucleotide	  binding	  sites,	  the	  A	  site	  which	  has	  been	  identified	  as	  the	  only	  nucleotide	  binding	  site	  in	  the	  past,	  and	  the	  B	  site	  where	  UTP	  was	  discovered	  to	  bind	  (see	  Figure	  4.5).21	  The	  nucleotides	  have	  different	  favoritism	  of	  binding	  to	  the	  A	  site	  or	  the	  B	  site	  as	   the	   residues	   involved	   in	   binding	   interactions	   are	   different	   between	   the	   two	  sites.21	   Not	   only	   that,	   binding	   of	   the	   same	   nucleotide	   acts	   differently	   in	   allosteric	  control	  of	  the	  enzyme	  at	  the	  A	  site	  from	  that	  at	  the	  B	  site:	  the	  nucleotide	  bound	  at	  the	  A	  site	  directly	  affects	  enzyme	  activity,	  either	  activating	  (ATP)	  or	  inhibiting	  (CTP),	  whereas	  binding	  of	  the	  nucleotide	  in	  the	  B	  site	  only	  serves	  to	  magnify	  or	  modify	  the	  effect	  of	  the	  nucleotide	  at	  the	  A	  site,	  but	  has	  no	  direct	  effect	  on	  the	  enzyme.	  In	  the	  crystal	  structure	  of	   the	  ATCaseCTPUTPMg2+	  complex,27	  CTP	  binds	   to	   the	  A	  site,	  UTP	  binds	   in	   the	  B	   site	  and	  Mg2+	  acts	  as	  a	  bridge	  between	   the	  β	  and	  γ	  phosphate	  groups	   of	   the	   two	   nucleotides.	   In	   the	   absence	   of	  metal	   ions,	   the	   repulsion	   of	   the	  negatively	   charged	   phosphate	   oxygens	   would	   prevent	   the	   binding	   of	   any	   two	  nucleotide	  molecules	  to	  the	  A	  and	  B	  sites	  at	  the	  same	  time.	  Therefore,	  the	  apparent	  effect	  of	  nucleotide(s)	   is	  determined	  by	   the	   total	  effect	  of	  nucleotide(s)	  binding	  at	  the	  A	   site,	   the	  B	   site	  or	   the	  AB	   site,	  which	  depends	  on	   the	  presence	  of	  metal	   ions and	  the	  relative	  affinities	  of	  the	  nucleotide(s)	  for	  the	  A	  and	  B	  sites.	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Figure	  4.4.	  The	  A	  and	  B	  nucleotide-­‐binding	  sites	  of	  one	  regulatory	  chain.	  (A)	  The	  A	  site	  was	  shown	  with	  CTP	  bound	  (PDB	  ID	  8AT1)	  and	  (B)	  the	  B	  site	  was	  shown	  with	  UTP	  bound	  (PDB	  ID	  4F04)	  from	  the	  same	  viewpoint.	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Reevaluation	  of	  Nucleotide	  Effects	  on	  ATCase	  Based	  on	  the	  Proposed	  Model	  	  Unfortunately	  many	  of	  the	  previous	  studies	  providing	  the	  binding	  and	  kinetic	  data	   for	   the	   nucleotide	   effectors	   on	   ATCase	   are	   questionable	   since	   the	   extent	   of	  metal	  ion	  contamination	  in	  these	  experiments	  is	  unknown.	  Here	  we	  reevaluate	  the	  functional	  effects	  of	  the	  nucleotides	  and	  their	  combinations	  on	  ATCase	  based	  on	  the	  proposed	  model	  using	  our	  kinetic	  results	  in	  the	  absence	  and	  presence	  of	  Mg2+.	  
CTP	  and	  UTP	  UTP	  alone	  greatly	  favors	  binding	  to	  the	  B	  site	  over	  the	  A	  site,	  which	  is	  due	  to	  a	  more	   favorable	   electrostatic	   interaction	  between	   the	  4-­‐keto	   group	  of	  uracil	   ring	  and	   Lys60	   revealed	   in	   the	   structure	   of	   ATCaseUTP	   complex.21	   According	   to	   our	  model,	  a	  nucleotide	  bound	  at	  the	  B	  site	  has	  little	  or	  no	  effect	  on	  the	  enzyme	  activity.	  As	   a	   result,	  UTP	   in	   the	   absence	   of	  metals	   has	   no	   effect	   on	   enzyme	   activity,	  which	  agrees	  with	  our	  kinetic	  data	  for	  UTP	  without	  Mg2+.	  	  However	  in	  the	  presence	  of	  Mg2+,	  up	  to	  10%	  inhibition	  is	  observed	  for	  2	  mM	  UTP.	  Similar	  to	  the	  synergistic	  inhibition	  induced	  by	  the	  combined	  binding	  of	  CTP	  and	  UTP	  with	  Mg2+	  in	  the	  AB	  allosteric	  site,	  this	   altered	   effect	   could	   be	   explained	   by	   the	   simultaneous	   binding	   of	   two	   UTP	  molecules	  linked	  by	  a	  Mg2+	  ion,	  one	  at	  the	  A	  site	  and	  the	  other	  at	  the	  B	  site.	  The	  UTP	  bound	  to	  the	  A	  site	  would	  inhibit	  the	  enzyme	  and	  this	  inhibition	  would	  be	  amplified	  by	   the	   UTP	   bound	   in	   the	   B	   site.	   This	   also	   explains	   the	   increasing	   trend	   of	   the	  inhibition	  when	  more	  Mg2+	   is	  added	  to	  the	  same	  amount	  of	  UTP.	  In	  the	  mixture	  of	  UTP	  and	  Mg2+	  solution,	  more	  UTP	  would	  complex	  with	  Mg2+	  with	  less	  free	  UTP	  left	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as	   the	   amount	   of	   Mg2+	   increases,	   resulting	   in	   a	   larger	   apparent	   inhibitory	   effect	  observed	  for	  2	  mM	  UTP	  with	  2	  mM	  Mg2+	  than	  with	  1	  mM	  Mg2+.	  Previous	  binding	  studies	  suggested	  six	  binding	  sites	  on	  the	  enzyme	  for	  CTP,	  three	  high-­‐affinity	  and	  three	  low-­‐affinity	  sites.28	  With	  the	  discovery	  of	  the	  B	  site	  on	  each	   regulatory	   chain,	   there	   are	   a	   total	   of	   twelve	   possible	   binding	   sites	   for	  nucleotides.	   These	   two	   results	   are	   not	   comparable	   as	   all	   of	   the	   previous	   binding	  experiments	  performed	  with	  CTP	  did	  not	  control	  for	  the	  metal	  contamination.	  New	  binding	  experiments	  with	  consideration	  of	  the	  influence	  of	  metal	  ions	  are	  required	  to	   better	   understand	   the	  binding	  of	   CTP.	  Despite	   this	   difference	   in	   the	  number	   of	  binding	  sites	  for	  CTP,	  it	  is	  well	  known	  from	  kinetic	  and	  structural	  studies	  that	  CTP	  binds	   to	   the	   A	   site	   and	   inhibits	   the	   enzyme	   about	   50%.3,22,29,30	   This	   reported	  inhibition	  is	  about	  the	  same	  as	  our	  data	  for	  CTP	  inhibition	  in	  the	  absence	  of	  Mg2+.	  As	  seen	  in	  Table	  4.1,	  the	  addition	  of	  Mg2+	  diminishes	  instead	  of	  increases	  the	  inhibition	  by	  2	  mM	  CTP,	  which	  is	  almost	  completely	  relieved	  when	  Mg2+	  concentration	  reaches	  to	  the	  same	  level	  as	  CTP.	  Additionally,	  the	  electrostatic	  attraction	  observed	  between	  UTP	  and	  Lys60	  at	  the	  B	  site	  would	  become	  a	  positive	  charge-­‐charge	  repulsion	  when	  the	   4-­‐keto	   group	   of	   UTP	   is	   replaced	   by	   the	   4-­‐amino	   group	   of	   CTP,	   which	   may	  prevent	  CTP	  from	  binding	  to	  the	  B	  site.21	  Since	  even	  as	  little	  as	  0.1	  mM	  (5%	  of	  2	  mM)	  free	  CTP	   can	   inhibit	   the	   enzyme	  about	  15%	  as	   seen	   in	  Figure	  4.1	  B,	   the	   less	   than	  10%	  inhibition	  by	  2	  mM	  CTP	  in	  the	  presence	  of	  2	  mM	  Mg2+	  may	  be	  explained	  by	  the	  exclusion	  of	  CTPMg2+CTP	  binding	  in	  the	  AB	  site	  due	  to	  the	  inability	  of	  CTP	  to	  bind	  to	  the	  B	  site	  and	  the	  preference	  of	  free	  CTP	  binding	  to	  the	  Mg2+	  than	  to	  the	  enzyme.	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Not	  surprisingly	  the	  synergistic	  inhibition	  by	  CTP	  and	  UTP	  is	  achieved	  when	  both	  nucleotides	  are	  allowed	  to	  bind	  to	  the	  enzyme	  with	  their	  favorable	  interactions,	  CTP	  to	  the	  A	  site	  and	  UTP	  to	  the	  B	  site,	  through	  the	  coordination	  of	  Mg2+	  as	  seen	  in	  the	   structure	   of	   the	   ATCaseCTPUTPMg2+	   complex.27	   The	   combined	   binding	   of	  CTPMg2+UTP	   to	   the	  AB	  allosteric	   site	  could	  stabilize	   the	  T	  state	  even	  more	   than	  CTP	  alone,	  shifting	  the	  T	  to	  R	  equilibrium	  further	  towards	  the	  T	  state. 	  
ATP	  and	  its	  combination	  with	  other	  nucleotides	  In	   the	   same	   fashion,	   ATP-­‐induced	   activation	   could	   be	   enhanced	   by	   Mg2+	  through	  the	  combined	  binding	  of	  ATP•Mg2+•ATP	  in	  the	  allosteric	  site.	  The	  response	  of	   the	   ATP	   in	   the	   A	   site	   would	   be	   amplified	   by	   the	   binding	   of	   ATP	   in	   the	   B	   site.	  Though	   ATP	   was	   only	   observed	   in	   the	   A	   site	   from	   previous	   X-­‐ray	  crystallography,22,30	  the	  possibility	  of	  ATP	  binding	  to	  the	  B	  site	  can	  not	  be	  ruled	  out	  since	  Mg2+	  was	  not	  present	  in	  these	  studies.	  Binding	  of	  UTP	  or	  GTP	  to	  the	  B	  site	  can	  also	  amplify	  the	  activating	  effect	  of	  ATP	  in	  the	  A	  site	  despite	  the	  presence	  of	  Mg2+,	  though	  to	  a	  larger	  extend	  in	  the	  presence	  of	  Mg2+.	  This	  supports	  the	  role	  of	  Mg2+	  in	  assisting	  or	  stabilizing	  the	  simultaneous	  binding	  of	  two	  nucleotides	  in	  the	  AB	  site	  by	  eliminating	   the	   repulsion	   between	   the	   phosphate	   oxygens	   of	   the	   two	   nucleotides.	  When	  ATP	  in	  the	  A	  site	  binds	  to	  the	  enzyme	  with	  another	  nucleotide	  (ATP,	  GTP	  or	  UTP)	  binding	   to	   the	  B	   site	   in	   the	  presence	  of	  Mg2+,	   the	  R	   state	   could	  be	   stabilized	  more	   than	   that	  by	  ATP	  alone	  and	   thereby	   the	  T	   to	  R	  equilibrium	  could	  be	   further	  shifted	   to	   the	  R	  state	   than	   in	   the	  presence	  of	  ATP	  alone.	  Among	  all	   the	  nucleotide	  combinations,	   ATP/GTP	   with	   Mg2+	   induces	   the	   largest	   allosteric	   activation.	   The	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combined	   binding	   of	   ATPMg2+GTP	   appears	   to	   act	   in	   a	   similar	   way	   as	  CTP•Mg2+•UTP	  but	  has	   the	  opposite	  effect	  on	   the	  enzyme.	  Different	   from	  GTP	  and	  UTP,	  CTP	  can	  reverse	  or	  reduce	  the	  activation	  by	  ATP	  in	  the	  absence	  and	  presence	  of	  Mg2+,	   respectively.	  CTP	   is	  known	  to	  compete	  with	  ATP	   for	  binding	   to	   the	  A	  site	  with	   a	   higher	   affinity,	   which	   explains	   the	   inhibitory	   effect	   on	   the	   enzyme	   by	   the	  metal-­‐free	  combination	  of	  ATP/CTP.	  As	  discussed	  above,	  addition	  of	  Mg2+	  can	  allow	  the	   combined	   binding	   of	   ATP•Mg2+•ATP	   in	   the	   allosteric	   site,	   promoting	   the	  stimulation	  of	   the	  enzyme,	  whereas	   the	  ability	  of	  Mg2+	   to	  complex	  with	  CTP	  could	  prevent	   CTP	   from	   binding	   to	   the	   A	   site,	   relieving	   the	   inhibition	   of	   the	   enzyme.	  Therefore	  the	  total	  effect	  of	  the	  ATP/CTP	  with	  Mg2+	  retains	  the	  activating	  effect	  of	  ATP	  with	  a	  slight	  decrease,	  which	  is	  most	  likely	  due	  to	  a	  small	  portion	  of	  the	  CTP	  in	  the	  nucleotide	  mixture	  bound	  to	  the	  enzyme	  not	  to	  the	  Mg2+.	  
GTP	  and	  its	  combinations	  with	  other	  nucleotides	  Though	  GTP	  interacts	  with	  ATP	  and	  Mg2+	  to	  activate	  the	  enzyme,	  GTP	  on	  its	  own	  is	  a	  weak	  inhibitor.	  Similar	  to	  UTP,	  Mg2+	  enhances	  the	  inhibition	  by	  GTP	  but	  in	  a	  different	   fashion.	   When	   more	   Mg2+	   is	   added	   to	   a	   fixed	   concentration	   of	   UTP,	   an	  increase	   in	   inhibition	   is	   observed	   which	   can	   only	   be	   explained	   by	   more	  UTP•Mg2+•UTP	  binding	  to	  the	  AB	  site	  according	  to	  our	  model,	  since	  UTP	  alone	  only	  binds	   to	   the	  B	   site	   and	   has	   no	   inhibitory	   effect.	   This	  may	   lead	   us	   to	   one	   possible	  explanation	  for	  the	  different	  trend	  in	  the	  GTP	  inhibition	  when	  Mg2+	  is	  added:	  Unlike	  UTP,	  GTP	  alone	  can	  bind	  to	  both	   the	  A	  site	  and	  the	  B	  site.	  The	  slight	   inhibition	  by	  GTP	  results	  from	  the	  ability	  of	  GTP	  to	  bind	  to	  the	  A	  site.	  This	  is	  also	  supported	  by	  the	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fact	  that	  GTP	  can	  enhance	  ATP	  activation	  and	  diminish	  CTP	  inhibition	  in	  the	  absence	  of	  Mg2+.	  These	  results	  indicate	  that	  GTP	  can	  bind	  to	  the	  B	  site	  in	  the	  presence	  of	  ATP	  and	  compete	  with	  CTP	   for	   the	  A	   site.	  Due	   to	   the	  difference	   in	   the	   relative	  binding	  affinities	  of	  Mg2+	  and	  ATCase	  for	  GTP	  in	  the	  A	  or	  B	  site,	  2	  mM	  GTP	  could	  produce	  a	  larger	  inhibitory	  effect	  with	  1	  mM	  Mg2+	  than	  with	  2	  mM	  Mg2+.	  The	  mechanism	  of	  the	  de-­‐metaled	  GTP/UTP	   inhibiting	   the	   enzyme	  better	   than	   either	   nucleotide	   alone	   is	  not	  clearly	  explained	  by	  our	  current	  model.	  Binding	  and	  structural	  studies	  for	  GTP	  with	   ATCase	   are	   needed	   in	   the	   absence	   and	   presence	   of	   the	  metal	   ions	   to	   better	  understand	  how	  GTP	  functions	  to	  regulate	  ATCase	  activity.	  	  
The	  Role	  of	  Mg2+	  in	  the	  Allosteric	  Site	  	  	  From	  our	  model,	  UTP	  alone	  in	  the	  B	  site	  has	  no	  effect	  on	  enzyme	  activity,	  but	  when	  Mg2+	  is	  present	  UTP	  in	  the	  B	  site	  can	  magnify	  the	  inhibition	  by	  the	  CTP	  in	  the	  A	  site.	  The	  kinetics	  of	  CTP	  saturation	  curves	  (see	  Figure	  4.1	  and	  4.2)	  shows	  that	  the	  binding	  affinity	  of	  the	  enzyme	  for	  CTP	  in	  the	  presence	  of	  UTPMg2+	  is	  about	  5-­‐fold	  and	   4-­‐fold	   higher	   than	   that	   for	   CTP	   alone	   and	   for	   CTP	   in	   the	   presence	   of	   UTP,	  respectively.	  These	  results	  suggest	  that	  this	  reinforcement	  by	  the	  B	  site	  nucleotide	  on	  the	  effect	  of	  the	  nucleotide	  in	  the	  A	  site	  is	  accomplished	  by	  enhancing	  the	  binding	  of	   the	  nucleotide	   in	  the	  A	  site,	  which	  depends	  on	  the	  presence	  of	   the	  metal	   ion.	   In	  addition	  to	  relieving	  the	  repulsion	  of	  the	  phosphate	  oxygens	  of	  the	  two	  nucleotides	  which	  would	  prevent	  both	  binding	  simultaneously	  at	  the	  AB	  site,	  Mg2+	  may	  help	  to	  create	   more	   interactions	   between	   the	   nucleotide	   in	   the	   A	   site	   and	   the	   enzyme.	  	  	  	  	  Asp19	  of	  the	  regulatory	  chain,	  which	  interacts	  with	  CTP	  in	  the	  A	  site22	  but	  not	  with	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UTP	  in	  the	  B	  site,21	  may	  be	  involved	  in	  the	  binding	  of	  the	  metal	  ions	  in	  the	  allosteric	  site.	   The	  kinetic	   and	  binding	   experiments	   of	   the	  D19A	  mutant	  were	  performed	   in	  parallel	   with	   the	   wild-­‐type	   enzyme.13	   In	   these	   studies	   the	   wild-­‐type	   enzyme	  exhibited	   synergistic	   inhibition	  by	  UTP	   in	   the	  presence	  of	  CTP	  and	  UTP	  enhanced	  the	  binding	  of	  CTP	  for	  the	  wild-­‐type	  enzyme.	  These	  findings	  agree	  with	  our	  results	  in	  the	  presence	  of	  Mg2+,	  indicating	  that	  the	  UTP	  used	  in	  these	  studies	  must	  contain	  contamination	   of	   the	   metal	   ions.	   Not	   only	   the	   synergistic	   inhibition	   but	   also	   the	  enhanced	  binding	  of	  CTP	  by	  UTP	  was	  not	  observed	  for	  the	  D19A	  mutant.	  This	  was	  explained	   by	   the	   binding	   of	   UTP	   to	   the	  mutant	   enzyme	   not	   being	   detected	   in	   the	  presence	   of	   CTP.	   However	   UTP	   alone	  was	   still	   able	   to	   bind	   to	   the	   enzyme.	   If	   the	  same	  UTP	  was	  used	  for	  the	  wild-­‐type	  enzyme	  as	  was	  used	  for	  the	  D19A	  mutant,	  one	  explanation	  to	  account	  for	  all	  these	  data	  based	  on	  our	  model	  is	  that	  Asp19	  is	  critical	  for	  the	  binding	  of	  the	  metal	  ion.	  Without	  the	  metal	  ion,	  the	  binding	  of	  UTP	  to	  the	  B	  site	  is	  not	  favored	  in	  the	  presence	  of	  CTP	  thus	  the	  synergistic	  effect	  is	  lost.	  Therefore	  the	  metal	   ion,	  Mg2+	   in	  our	  study,	   is	  not	  only	   required	   for	   the	  enhanced	  nucleotide	  effect	  but	  also	  the	  nucleotide	  binding	  at	  the	  AB	  allosteric	  site.	  	  	   In	   conclusion	   metal	   ions,	   such	   as	   Mg2+	   studied	   here,	   have	   a	   significant	  influence	  on	  the	  allosteric	  regulation	  of	  ATCase,	  which	  was	  not	  previously	  realized.	  In	  our	  experiments	  all	  nucleotide	  solutions	  were	  de-­‐metaled	  before	  use	  to	  ensure	  an	  accurate	  comparison	  between	  the	  nucleotide	  effects	  in	  the	  absence	  and	  presence	  of	  Mg2+.	  Interestingly,	  most	  of	  the	  previous	  reported	  nucleotide	  effects	  agree	  with	  the	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nucleotide	   effects	   determined	   with	   Mg2+	   in	   our	   study	   rather	   than	   those	   without	  Mg2+.5	   Along	   with	   the	   recent	   discovery	   of	   a	   novel	   UTP	   binding	   site	   on	   each	  regulatory	  chain,21	  we	  propose	  a	  modified	  model	  for	  nucleotide	  regulation	  involving	  metal	  ions	  in	  which	  there	  are	  two	  adjacent	  but	  not	  overlapping	  nucleotide	  binding	  sites	   on	   each	   regulatory	   chain.	   In	   this	   model,	   the	   nucleotides	   either	   inhibit	   or	  activate	   the	   enzyme	   when	   binding	   to	   the	   A	   site	   but	   have	   no	   direct	   effect	   when	  binding	  to	  the	  B	  site.	  In	  the	  presence	  of	  the	  metal	  ions,	  two	  nucleotides	  can	  bind	  in	  the	   combined	   AB	   site,	   the	   nucleotide	   in	   the	   B	   site	   amplifying	   the	   effect	   of	   the	  nucleotide	   in	   the	   A	   site.	   Since	   nucleotides	   are	   most	   likely	   present	   as	   nucleotide-­‐metal	   complexes	   in	   cells,	  our	  model	  would	  provide	  a	  more	   relevant	  picture	  of	   the	  allosteric	   control	   of	   ATCase	   under	   physiological	   conditions.	   Based	   on	   this	   model,	  CTP	  alone	  binds	  to	  the	  A	  site	  and	  inhibits	  the	  enzyme	  but	  with	  Mg2+	  this	  inhibition	  is	  greatly	  weakened	  as	  the	  binding	  of	  CTP	  to	  the	  B	  site	  is	  not	  favored.	  UTP	  alone	  binds	  to	  the	  B	  site	  and	  thus	  has	  no	  effect	  on	  the	  enzyme.	  Mg2+	  enhances	  the	  binding	  of	  UTP	  to	   the	   A	   site	   and	   allows	   another	   UTP	   to	   bind	   in	   the	   B	   site	   at	   the	   same	   time,	  producing	  a	  slight	  inhibitory	  effect	  on	  ATCase.	  In	  the	  presence	  of	  Mg2+,	  CTP	  binds	  to	  the	  A	  site	  and	  UTP	  synergistically	  inhibits	  the	  enzyme	  by	  binding	  to	  the	  B	  site	  which	  enhances	  the	  CTP	  inhibition.	  The	  inhibition	  by	  CTPUTPMg2+	  may	  be	  of	  biologically	  importance	  as	  it	  compensates	  for	  the	  weak	  inhibition	  by	  CTPMg2+,	  which	  would	  be	  the	  dominant	  form	  of	  CTP	  under	  physiological	  conditions.	  Therefore,	  the	  synergism	  of	   CTP	   and	   UTP	   is	   necessary	   to	  maintain	   the	   feedback	   inhibition	   of	   ATCase.	   ATP	  alone	   favors	   binding	   to	   the	   A	   site	   and	   activates	   the	   enzyme.	   This	   activation	   is	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enhanced	   when	   ATP,	   UTP	   or	   GTP	   binds	   to	   the	   B	   site	   with	   addition	   of	   Mg2+.	   The	  combined	  binding	  of	  ATPMg2+GTP	  activates	  the	  enzyme	  the	  most.	  Therefore,	  the	  combination	   of	   ATP	   and	   GTP,	   end	   products	   of	   the	   purine	   biosynthetic	   pathway,	  provides	   a	   synergistic	   control	   that	   activates	  ATCase	   to	  produce	  CTP	  and	  UTP,	   the	  end	  products	  of	  the	  parallel	  pathway	  for	  pyrimidine	  biosynthesis,	  when	  the	  level	  of	  the	   purine	   nucleotides	   is	   elevated	   in	   E. coli.	   In	   this	   way,	   the	   pool	   of	   purine	   and	  pyrimidine	  nucleotides	   can	  be	  balanced	   for	   the	  biosynthesis	   of	   nucleic	   acids	   in	  E. 
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Drug	  Discovery	  of	  Dihydroorotase	  using	  a	  Virtual	  	  
High	  Throughput	  Screening	  System	  A	  poster	  presented	  at	  the	  236th	  ACS	  national	  meeting	  	  by	  	  Wenyue	  Guo	  and	  Evan	  R.	  Kantrowitz	  	  	  	  	  	  	  	  
	  	  *Contribution	  to	  work:	  Conducted	  all	  experiments	  including	  the	  virtual	  screening	  of	  the	  compounds,	  analysis	  of	  the	  docking	  results	  and	  biochemical	  validation	  of	  the	  candidates	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Introduction 	   Pyrimidine	  nucleotide	  metabolism	  is	  critical	   for	  the	  survival	  of	   the	  cell	  as	   it	  provides	  the	  pyrimidine	  nucleotides	  which	  are	  not	  only	  used	  for	  the	  biosynthesis	  of	  the	   nucleic	   acids,	   but	   are	   also	   involved	   in	   assembly	   of	   cell	   membranes,	   protein	  glycosylation	   and	   glycogen	   synthesis1,2	   in	  which	   sugar	   nucleotides	   act	   as	   glycosyl	  donors.	   There	   are	   two	   ways	   that	   cells	   obtain	   pyrimidines	   and	   pyrimidine	  nucleotides,	   one	   is	   from	   the	   de	   novo	   biosynthesis,	   and	   the	   other	   is	   from	   the	  catabolism	  of	  foodstuffs	  via	  a	  salvage	  pathway.	  Since	  the	  pyrimidine	  nucleotides	  are	  necessary	  for	  nucleic	  acid	  synthesis,	  the	  enzymes	  of	  pyrimidine	  production,	  both	  in	  the	  de	  novo	  and	  salvage	  pathways,	  have	  become	  targets	  for	  anti-­‐proliferation	  drugs.	  The	   inhibitors	   used	   clinically	   as	   salvage	   pathway	   inhibitors	   are	   methotrexate,	   5-­‐fluorouracil,	   and	   6-­‐azauridine.3	   However,	   all	   these	   compounds	   have	   clinical	   side	  effects.	   Therefore,	   there	   is	   a	   need	   to	   develop	   a	   new	   class	   of	   lead	   compounds	   for	  blocking	   the	   de	   novo	   pathway.	   Dihydroorotase	   (DHOase)	   becomes	   an	   attractive	  target	   for	   drug	   design	   as	   it	   catalyzes	   the	   reversible	   cyclization	   of	   N-­‐carbamoyl-­‐L-­‐aspartate	   (CA)	   to	   L-­‐dihydroorotate	   (DHO)	   in	   the	   pyrimidine	   biosynthesis	   (see	  Figure	   1.9).4 The	   inhibitors	   of	   DHOase	   may	   also	   become	   potential	   anti-­‐malarial	  drugs	   since	   the	   malarial	   parasite	  Plasmodium falciparum	   does	   not	   have	   a	   salvage	  pathway	  for	  pyrimidines.	  There	   are	   two	   general	   classes	   of	   DHOase:	   the	   class	   I	   enzymes	   are	   found	   in	  higher	   organisms	   as	   multifunctional	   proteins	   such	   as	   mammalian	   CAD	   or	  monofunctional	   proteins	   in	   gram	   positive	   bacteria;	   the	   class	   II	   enzymes	   are	   all	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monofunctional	  proteins	  from	  gram	  negative	  bacteria	  and	  yeast.	  There	  are	  no	  high-­‐resolution	  structures	  available	  for	  the	  DHOase	  component	  of	  CAD	  and	  P. falciparum	  DHOase.5	  However,	  sequence	  alignments	  of	  E. coli	  DHOases	  with	  these	  two	  DHOases	  show	  highly	  conserved	  regions	  corresponding	  to	  the	  residues	   involved	  in	  catalysis	  and	  metal	   binding.	   Therefore,	   the	   1.9	  Å	   X-­‐ray	   crystal	   structure	   of	  E. coli	   DHOase6 can	   serve	   as	   the	   target	   structure	   for	   drug	   discovery	   for	   both	   the	   human	   and	   P. 
falciparum	  enzymes. Conventional	   drug	   discovery	   often	   involves	   experimental	   high-­‐throughput	  screening	   of	   millions	   of	   compounds.	   However,	   as	   this	   screening	   is	   both	   cost-­‐inefficient	  and	  time-­‐consuming,	  virtual	  high-­‐throughput	  screening	  (vHTS),	  which	  is	  a	  computational	  screening	  method	  applied	  to	  evaluate	  the	  ability	  of	  a	  large	  number	  of	  compounds	  to	  form	  complexes	  with	  the	  target	  receptor	  in	  silico,	  has	  emerged	  as	  an	   alternative	   and	   complementary	  method	   over	   the	   past	   decade.7	  With	   the	   rapid	  increase	   in	   the	  number	  of	  available	  macromolecular	   three-­‐dimensional	   structures,	  vHTS	  has	  been	  successfully	  used	  to	  identify	  inhibitors	  against	  targets	  such	  as	  HIV-­‐1	  protease,8	  protein	  kinase,9	  and	  aldose	  reductase.10  Though	   it	   is	   relatively	   straightforward	   to	  perform	  a	   small	  virtual	   screening	  (<100	   compounds)	   using	   a	   single	   docking	   program,	   it	   remains	   a	   challenge	   to	  perform	   vHTS	   (>1,000,000	   compounds)	   with	   different	   docking	   programs.	   Dr.	  Kantrowitz	  has	  developed	  an	  easy	  to	  use	  vHTS	  system,	  which	  is	  able	  to	  screen	  large	  virtual	   libraries	   of	   compounds.	  Based	  on	   the	   crystal	   structure	   of	  E. coli	  DHOase,	   I	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utilized	   this	   vHTS	   system	   to	   identify	   new	   lead	   inhibitors	   for	   further	   drug	  development	  as	  anti-­‐proliferation	  and	  anti-­‐malarial	  drugs.	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Results	  	  
Identification	  of	  DHOase	  Inhibitors	  through	  the	  vHTS	  System	  	   During	  this	  project,	  I	  used	  the	  vHTS	  system	  (set	  up	  of	  the	  system	  is	  described	  in	  details	  in	  Chapter	  7)	  to	  find	  inhibitors	  against	  the	  DHO-­‐bound	  subunit	  of	  DHOase	  by	   screening	   about	   1,500,000	   compounds	   obtained	   from	   the	   ZINC	   database	  (http://blaster.docking.org/zinc/).	   Before	   screening	   these	   ligands	   I	   first	   validated	  four	   docking	   programs	   (AutoDock3.011,	   DOCK5.012,	   Surflex13	   and	   GOLD14)	   to	  determine	  the	  parameters	  used	  to	  predict	   the	  docking	  pose	  of	  DHO	  closest	   to	   that	  from	  the	  available	  X-­‐ray	  structure.	  The	  quality	  of	  the	  results	  from	  virtual	  screening	  was	  directly	  related	  to	  the	  ability	  of	  the	  docking	  program	  to	  position	  the	  ligands	  into	  the	  receptor	  target	  with	  accuracy.	  For	  each	  docking	  program,	  the	  X-­‐ray	  structure	  of	  subunit	  with	  DHO	  bound6	  (PDB	  ID	  1XGE)	  was	  used	  as	  receptor	   target.	  DHO	  in	   the	  active	  site	  was	  first	  removed,	  and	  its	  coordinates	  were	  altered	  so	  that	  DHO	  was	  in	  a	  different	   spatial	   position,	   unrelated	   to	   actual	   binding	   site.	   Then	   the	   docking	   of	  product	  DHO	  was	  performed	  with	   the	   four	  programs.	  The	   four	  docking	  programs	  gave	   acceptable	   DHO	   conformations	   compared	   to	   that	   determined	   by	   the	   X-­‐ray	  crystallography	   (See	   Table	   5.1).	   In	   order	   to	   screen	   a	   large	   scale	   of	   compounds	  against	  DHO	  efficiently	  within	  a	  reasonable	  time,	  we	  initially	  used	  Surflex13	  because	  it	  utilized	  the	  shortest	  time,	  compared	  to	  the	  other	  three	  docking	  programs,	  about	  5	  seconds	   to	   dock	   and	   evaluate	   one	   ligand.	   	   After	   completion	   of	   docking	   1,500,000	  compounds,	  the	  top	  500	  hits	  that	  were	  generated	  from	  the	  energy	  scoring	  function	  of	  Surflex	  were	  docked	  using	  three	  other	  docking	  programs	  that	  employed	  different	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Table	   5.1.	   RMSD	   (non	   hydrogen	   atoms,	   in	   Å)	   between	   docked	   conformations	   of	  substrate	   CA	   and	   product	   DHO	   (top	   solution	   of	   each	   docking	   program)	   of	   E.coli	  DHOase	  and	  their	  conformations	  in	  the	  X-­‐ray	  crystal	  structure	  (PDB	  ID	  1XGE)	  	   Docking	  Program	  	  	  	  	  Ligand	   AutoDock3.0	   DOCK5.0	   GOLD	   Surflex	  DHO	   0.03	   0.67	   0.38	   1.57	  CA	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   0.54	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scoring	  functions.	  Lastly	  the	  Xscore15 program	  was	  used	  to	  reevaluate	  the	  docking	  results	  of	  the	  top	  500	  compounds	  with	  the	  four	  docking	  programs	  by	  calculating	  the	  binding	  score	  for	  the	  protein-­‐ligand	  complex	  structures.	  The	  top	  50	  poses	  ranked	  by	  Xscore15	  were	  selected	  and	  analyzed.	  Among	  the	  top	  50	  poses,	  certain	  compounds	  were	  selected	  more	  than	  once	  by	  different	  programs	  as	  the	  Xscore15	  evaluated	  the	  docking	   pose	   independently.	   For	   example,	   the	   docking	   pose	   of	   zinc902674	   from	  Surflex	  was	  ranked	  first	  by	  Xscore	  and	  the	  docking	  pose	  of	  the	  same	  compound	  from	  GOLD	   was	   ranked	   second	   by	   Xscore.	   Among	   the	   top	   10	   compounds	   ranked	   by	  Xscore	   from	   the	   results	   using	  different	   docking	  programs,	   three	   compounds	  were	  available	   to	   be	   purchased	   immediately	   at	   a	   reasonable	   cost:	   zinc902674,	  zinc903866	   and	   zinc391516.	   These	   compounds	   were	   obtained	   for	   experimental	  validation.	  Shown	  in	  Figure	  5.1	  A	  are	  the	  structures	  of	  zinc902674,	  zinc903866	  and	  zinc391516. The	  active	  site	  of	  CA-­‐bound	  subunit	  was	  much	  less	  open	  compared	  to	  that	  of	  the	  DHO-­‐bound	  subunit	  due	  to	  the	  closure	  of	  the	  100s	  loop.6	  Therefore,	  I	  performed	  a	  separate	  test	  screening	  to	  find	  inhibitors	  against	  the	  CA-­‐bound	  subunit.	  Validation	  of	  Surflex13	  program	  was	  performed	  for	  CA	  in	  the	  similar	  manner	  as	  that	  for	  DHO.	  The	   RMS	   deviations	   between	   the	   coordinates	   from	   docking	   and	   crystal	   structure	  were	  less	  than	  2	  Å	  (see	  Table	  5.1).	  For	  inhibitors	  targeting	  the	  CA	  binding	  site,	  we	  finished	   screening	   about	   750,000	   compounds	   using	   Surflex.	   Surflex13	   ranked	   the	  docking	  results	  by	  pKi	   score.	  The	  higher	   the	  pKi	  value	  was,	   the	  higher	   the	  binding	  affinity	  of	  the	  docked	  ligand	  was	  to	  the	  protein	  target.	  The	  pKi	  score	  of	  the	  top	  five	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Figure	  5.1.	  The	  chemical	  structure	  of	  the	  hits	   identified	  through	  the	  vHTS	  system.	  (A)	   Three	   hits	   targeting	   DHO	   binding	   site	   of	   DHOase;	   (B)	   Two	   hits	   targeting	   CA	  binding	  site	  of	  DHOase.	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docking	  poses	  varied	  from	  10.37	  to	  11.31,	  which	  were	  higher	  than	  the	  pKi	  of	  docked	  CA	   (pKi	   =	   10.10).	   Two	   out	   of	   the	   five	   compounds	  were	   available	   to	   be	   purchased	  immediately	   at	   a	   reasonable	   cost:	   zinc394318	   and	   zinc402968.	  These	   compounds	  were	  obtained	  for	  experimental	  validation.	  Shown	  in	  Figure	  5.1	  B	  are	  the	  structures	  of	  zinc394318	  and	  zinc402968.	  
Biochemical	   Validation	   of	   DHOase	   Inhibitors	   Identified	   through	   the	   vHTS	  
System	  The	   three	   hits	   (zinc902674,	   zinc903866	   and	   zinc391516)	   identified	   through	   the	  vHTS	   system	   targeting	   the	   DHO-­‐bound	   active	   site	   were	   further	   characterized	   for	  their	  ability	   to	   inhibit	  DHOase.	  For	  simplicity	   the	  enzymatic	  activity	   in	   the	  reverse	  direction	   was	   measured	   using	   the	   colorimetric	   assay	   described	   in	   Chapter	   7.	  Zinc902674	   and	   zinc903866	   showed	   no	   significant	   inhibition	   while	   zinc391516	  decreased	   the	  enzyme	  activity	  by	  80%	  at	  2	  mM	  (See	  Figure	  5.2).	  The	   fact	   that	   the	  activity	  of	  DHOase	  was	  not	  brought	  down	  to	  zero	  at	  the	  saturating	  concentration	  of	  	  zinc391516	  indicated	  that	  zinc391516	  was	  not	  a	  competitive	  inhibitor.	  In	  order	  to	  understand	   the	   inhibition	   of	   zinc391516	   against	   DHOase,	   DHO	   saturation	   curves	  were	  performed	  at	  0,	  200,	  600	  and	  1400	  uM	  of	  zinc391516.	  Both	  the	  overlay	  of	  DHO	  saturation	  curves	  and	  the	  corresponding	  double	  reciprocal	  curves	  showed	  that	  the	  Km	   remained	   constant	   but	   the	   Vmax	  decreased	   as	   the	   concentration	   of	   zinc391516	  increased	   (see	  Figure	  5.3).	  Therefore,	   zinc391516	   is	  a	  noncompetitive	   inhibitor	  of	  DHOase	  with	  a	  Ki	  of	  1.41	  mM.	  




























Figure	  5.2.	  Inhibition	  effect	  of	  (A)	  zinc902674,	  (B)	  zinc903866	  and	  (C)	  zinc391516	  on	  the	  activity	  of	  DHOase.	  Each	  data	  point	  was	  determined	  in	  duplicate,	  and	  the	  data	  points	  shown	  are	  the	  average.	  All	  measurements	  were	  made	  at	  25°	  C	  in	  the	  presence	  of	  50	  mM	  Tris-­‐phosphate,	  pH	  8.0	  with	  0.08	  mM	  DHO	  and	  0.25	  μg	  E. coli	  DHOase.	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Figure	  5.3.	  Specific	  activity	  of	  DHOase	  in	  the	  presence	  of	  0.2	  mM	  (),	  0.6	  mM	  (),	  1.4	   mM	   ()	   and	   in	   the	   absence	   ()	   of	   inhibitor	   zinc391516	   (A)	   plotted	   versus	  concentration	   of	   DHO	   and	   (B)	   its	   corresponding	   Lineweaver-­‐Burk	   plot.	   All	  measurements	  were	  made	  at	  25°	  C	  in	  the	  presence	  of	  50	  mM	  Tris-­‐phosphate,	  pH	  8.0	  with	   0.08	   mM	   DHO	   and	   0.25	   μg	   E. coli	   DHOase.	   Specific	   activity	   is	   reported	   in	  mmoles	  of	  carbamoyl	  aspartate	  formed	  per	  hour	  per	  mg	  of	  DHOase.	  The	  data	  points	  shown	  are	  the	  average	  of	  four	  determinations	  with	  a	  deviation	  of	  ±	  6.5%.	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The	   two	   hits	   (zinc394318	   and	   zinc402968)	   identified	   through	   the	   vHTS	  system	   targeting	   the	   CA-­‐bound	   active	   site	   were	   further	   characterized	   for	   their	  inhibition	  of	  DHOase	  in	  the	  biosynthetic	  direction	  using	  the	  direct	  assay	  described	  in	   Chapter	   7.	   	   Zinc394318	   fully	   inhibited	   the	   enzyme	   at	   2	  mM	  while	   zinc402968	  inhibited	  about	  50%	  at	  2	  mM	  (see	  Figure	  5.4).	  Zinc394318	  is	  an	  inhibitor	  versus	  the	  enzyme	   substrate	   CA	   with	   an	   IC50	   of	   16.2	   μM.	   Though	   zinc402968	   doesn’t	   fully	  inhibit	  the	  enzyme,	  the	  compound	  has	  a	  lower	  IC50	  of	  14.1	  μM.	  
	   154	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	  5.4.	  Inhibition	  effect	  of	  (A)	  zinc394318	  and	  (B)	  zinc402968	  on	  the	  activity	  of	  DHOase.	  Each	  data	  point	  was	  determined	   in	  duplicate,	   and	   the	  data	  points	   shown	  are	   the	  average.	  All	  measurements	  were	  made	  at	  37°	  C	   in	   the	  presence	  of	  75	  mM	  Na2HPO4	  buffer,	  pH	  5.5	  with	  1	  mM	  DL-­‐CA	  and	  50	  μg	  E. coli	  DHOase.	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Discussion	  and	  Future	  Prospects	  
	   We	  have	  applied	  the	  vHTS	  system	  developed	  in	  our	  lab	  to	  screen	  more	  than	  a	  million	  compounds	  but	  unfortunately	  no	  compounds	  tested	  can	  be	  considered	  as	  an	  acceptable	   lead	   for	   drugs	   as	   the	   IC50	   of	   all	   candidates	   are	   larger	   than	   10	   μM.16	  Several	   explanations	   could	   account	   for	   this	   result	   as	   I	   examine	   our	   docking	  experiments	   as	   a	   comparison	   to	   those	   giving	   successful	   results.8-­‐10	   Firstly,	   the	  number	   of	   compounds	   tested	   is	   too	   small. Vangrevelinghe	   et	   al	   tested	   12	  candidates	  out	  of	  400,000	  compounds	  screened,	  four	  of	  which	  turned	  out	  to	  inhibit	  protein	  kinase	  CK2.9	  In	  another	  docking	  study	  to	  find	  inhibitors	  of	  aldose	  reductase,	  36	   candidates	   were	   tested	   out	   of	   120,000	   compounds	   screened.	   10	   out	   of	   36	  compounds	   showed	  more	   than	   40%	   inhibition.10	   For	   inhibitions	   against	   DHO,	  we	  only	   tested	   three	   candidates	   out	   of	   1,500,000	   compounds	   screened	   and	   only	   one	  inhibited	   in	   the	   millimolar	   range.	   Better	   results	   may	   appear	   if	   we	   increase	   the	  number	   of	   compounds	   tested.	   Secondly,	   the	   virtual	   screening	   procedure	  we	   used	  may	  not	   be	   a	   powerful	  method	   to	   identify	   potential	   candidate	   inhibitors.	  Docking	  methods	   and	   the	   scoring	   function	  have	   shown	  dependence	  on	   the	   target	   selected,	  for	   example	   GOLD	   and	   Surflex	   ranks	   better	   with	   more	   reliable	   scores	   for	   highly	  polar	   active	   sites,	   whereas	   the	   scoring	   function	   of	   DOCK	   was	   found	   to	   perform	  better	   for	   hydrophobic	   active	   sites.17	   Since	   DHO	   binding	   site	   is	   highly	   polar,	   the	  scoring	   function	   of	   GOLD	   and	   Surflex	   may	   rank	   candidates	   more	   accurate	   than	  DOCK.	  Moreover	  no	  clear	  relationships	  could	  be	  found	  between	  rank	  of	  compounds	  by	  docking	  and	  scoring.17	  For	  example,	  one	  compound	  docks	  better	  with	  a	  smaller	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RMS	  deviation	  than	  another	  compound	  by	  GOLD	  may	  have	  a	  worse	  score.	  To	  have	  a	  more	  efficient	  procedure	  for	  virtual	  screening	  of	  DHOase	  inhibitors,	  a	  test	  screening	  of	  a	  smaller	  set	  of	  compounds	  containing	  a	  few	  known	  ligands	  can	  first	  be	  used	  to	  select	   the	  optimal	  docking	  and	  scoring	  combinations	   from	  the	  available	  programs.	  Then	  the	  scheme	  giving	  the	  highest	  hit	  rate	  can	  be	  applied	  to	  screen	  the	  entire	  set	  of	  compounds.	  Lastly,	  DHOase	  may	  not	  be	  an	  ideal	  target	  for	  docking	  in	  the	  discovery	  of	   inhibitors.	   Compared	   to	   the	   enzymes	   used	   as	   targets	   in	   the	   successful	   docking	  examples,8-­‐10	  DHOase	   has	  much	   less	   binding	   interactions	  with	   the	   substrate	  DHO.	  This	  may	  restrict	  the	  possible	  orientations	  of	  ligand	  at	  the	  binding	  site.  Though	   we	   were	   only	   able	   to	   identify	   one	   moderate	   noncompetitive	  inhibitor,	   zinc391516,	  against	   the	  DHO-­‐bound	  subunit,	   the	   chemical	   structure	  and	  binding	  mode	  of	  zinc391516	  to	  the	  active	  site	  of	  DHO	  revealed	  to	  us	  a	  novel	  class	  of	  inhibitors	  against	  DHOase.	  First,	  the	  chemical	  structure	  of	  zinc391516	  is	  distinctive	  from	  the	  existing	  inhibitors	  targeting	  DHO	  binding	  site	  of	  E. coli	  DHOase	  (see	  Figure	  5.5).18	   The	   size	   of	   the	   molecule	   is	   much	   larger	   and	   it	   is	   not	   a	   substrate/product	  analog	   or	   a	   transition-­‐state	   analog,	   which	   are	   the	   two	   categories	   for	   the	   existing	  inhibitors.	   The	   best	   pose	   of	   zinc391516	   shown	   in	   Figure	   5.6	   shows	   that	   the	  molecule	  actually	  binds	  at	  the	  area	  above	  the	  pocket	  where	  DHO	  binds.	  The	  binding	  mode	   of	   zinc391516	   agrees	   with	   the	   kinetic	   results	   that	   this	   compound	   is	   a	  noncompetitive	   inhibitor,	   binding	   at	   a	   different	   location	   from	   where	   DHO	   binds.	  Through	  this	  we	  discovered	  that	  the	  active	  site	  for	  DHO	  is	  unusual,	  as	  it	  is	  actually	  a	  pocket	  within	  a	  pocket.	  The	  product	  DHO	  binds	  at	  the	  bottom	  of	  the	  big	  pocket	  with	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Figure	  5.5.	  Structure	  comparison	  of	  inhibitor	  zinc391516	  to	  the	  existing	  inhibitors	  designed	  to	  target	  the	  DHO	  bound	  active	  site	  of	  E. coli	  DHOase.14	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Figure	   5.6.	   The	   best	   docked	   pose	   of	   zinc391516	   (thick	   lines)	   in	   the	   active	   site	  where	  DHO	  bound	  with	  protein	  surface	  shown	  in	  yellow	  and	  DHO	  (thin	  lines).	  Both	  zinc391516	  and	  DHO	  are	  colored	  according	  to	  atom	  types	  (carbon	  atoms	  in	  white,	  nitrogen	  atoms	  in	  blue	  and	  oxygen	  atoms	  in	  red)	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the	  upper	  pocket	  empty,	  which	  makes	  a	  way	  for	  the	  release	  of	  the	  product	  after	  the	  reaction.	  The	  upper	  pocket	  provides	  a	  novel	  binding	  site	  for	  the	  potential	  inhibitors	  to	  DHOase.	  A	  new	  class	  of	  inhibitor	  can	  be	  either	  a	  molecule	  filling	  up	  the	  space	  of	  the	  upper	  pocket	  or	  a	   fragment	  binding	  at	   the	  upper	  pocket	  while	  connecting	  to	  a	  DHO	  like	  portion.	  On	  the	  other	  hand,	  the	  active	  site	  for	  CA	  is	  rather	  small	  and	  closed.	  There	  is	  no	  open	  area	  above	  the	  site	  where	  CA	  binds.	  As	  seen	  in	  Figure	  5.2	  B	  the	  two	  	  inhibitors	   found	   through	   our	   vHTS	   system	   resembles	   similar	   structure	   to	   the	  substrate	  CA.	  	  	   For	  future	  work	  there	  are	  two	  ways	  to	  improve	  the	  inhibition	  of	  zinc391516:	  (i)	  zinc391516	  doesn’t	   fill	  up	  the	  entire	  upper	  pocket	  above	  DHO	  and	  there	   is	  still	  empty	   space	   left.	   The	   inhibition	   may	   be	   improved	   by	   extending	   the	   molecule	   to	  cover	   the	  whole	   pocket.	   An	   approached	   for	   this	   is	   to	   perform	   the	   docking	   to	   the	  binding	  pocket	  with	  DHO	  bound.	  It	  also	  might	  be	  possible	  to	  divide	  the	  upper	  pocket	  to	  sub-­‐binding	  sites	  and	  use	  these	  binding	  sites	  separately	  as	  the	  target	  to	  search	  for	  the	  best	   fragment	   that	   can	  bind	  at	  a	   specific	  part	  of	   the	   large	  pocket.	  After	  all	   the	  fragments	  are	  found,	  they	  can	  be	  combined	  together	  and	  tested	  as	  one	  inhibitor.	  (ii)	  The	  part	  of	  zinc391516	  trying	  to	  reach	   into	  the	  bottom	  of	   the	  pocket	   is	  a	  benzene	  ring	  at	  one	  end	  of	  the	  molecule.	  However,	  the	  DHO	  ring	  is	  a	  non-­‐planar	  six-­‐member	  ring,	  which	  has	  a	  different	  conformation	  from	  the	  benzene	  ring.	  The	  inhibition	  might	  be	   improved	   by	   modifying	   the	   benzene	   ring	   to	   a	   ring	   similar	   to	   DHO.	   When	   we	  modified	  the	  ring	  in	  silico	  and	  docked	  the	  modified	  zinc391516	  (see	  Figure	  5.7)	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Figure	  5.7.	  Modification	  of	  the	  benzene	  ring	  at	  one	  end	  of	  zinc391516	  to	  a	  DHO-­‐like	  ring	  improves	  the	  binding	  energy	  to	  DHOase	  calculated	  by	  AutoDock3.0.	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Introduction	  	   	  Dihydroorotase	   (DHOase),	   which	   catalyzes	   the	   reversible	   cyclization	   of	   N-­‐carbarmyl-­‐L-­‐aspartate	   (CA)	   to	   L-­‐dihydroorotate	   (DHO),	   belongs	   to	   the	  amidohydrolase	  superfamily,	  which	  comprises	  of	  a	  variety	  of	  hydrolytic	  enzymes	  of	  the	  (β/α)8-­‐barrel	  (or	  TIM-­‐barrel)	  fold.	  The	  first	  structure	  of	  DHOase	  from	  E. coli	  was	  reported	  to	  a	  resolution	  of	  1.7	  Å	  by	  Thoden	  et	  al.1	  (PDB	  ID	  1J79)	  Although	  the	  E. coli	  DHOase	   has	   been	   reported	   to	   contain	   one	   zinc	   at	   the	   active	   site,2-­‐4	   this	   high	  resolution	   structure	   clearly	   showed	   a	   binuclear	   zinc	   center	   with	   a	   carboxylated	  lysine	  residue	  bridging	  the	  two	  metals.	  The	  crystals	  were	  grown	  in	  the	  presence	  of	  the	   racemic	   substrate,	   DL-­‐CA,	   however	   surprisingly,	   the	   structure,	   which	   had	   a	  dimer	   in	   the	   asymmetric	   unit,	   revealed	   that	   one	   subunit	   (subunit	   B)	   had	   the	  substrate	  CA	  bound	   in	   its	   active	   site,	  while	   the	   other	   subunit	   (subunit	  A)	   had	   the	  product	   DHO	   bound	   in	   its	   active	   site.	   No	   explanation	   was	   given	   for	   this	   unusual	  structure.	   Subsequently,	   Lee	   et	   al.5	   reported	   the	   structure	   of	   E. coli	   DHOase	  crystallized	   in	   the	  presence	   of	   the	   optically	   pure	  product,	   L-­‐DHO,	   refined	   at	   1.9	  Å	  resolution	   (PDB	   ID	  1XGE).	  Though	   the	  enzyme	  was	  crystallized	   in	   the	  presence	  of	  product	   DHO	   instead	   of	   the	   substrate	   CA,	   the	   structure	   confirmed	   the	   previous	  results.	   Importantly,	   this	   structure	  provided	  an	  explanation	   for	   the	  observation	  of	  CA	  bound	  to	  the	  active	  site	  of	  subunit	  B	  and	  DHO	  bound	  to	  the	  active	  site	  of	  subunit	  A.	   Comparison	   between	   the	   two	   subunits	   revealed	   that	   except	   for	   one	   loop,	   the	  100’s	  loop	  comprised	  of	  residues	  105-­‐115,	  the	  rest	  of	  the	  two	  subunits	  were	  nearly	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identical,	  with	  an	  RMS	  deviation	  of	  α-­‐carbon	  atoms	  of	  only	  0.26	  Å.	  The	  100’s	   loop	  had	   significantly	   different	   conformation	   in	   each	   subunit.	   In	   subunit	   B,	   this	   loop	  reached	  in	  toward	  the	  active	  site	  (Figure	  6.1),	  with	  two	  residues	  Thr109	  and	  Thr110	  directly	  making	  hydrogen-­‐bonding	  contact	  with	  the	  bound	  substrate,	  CA	  (“loop-­‐in”	  conformation).	  In	  subunit	  A,	  the	  100’s	  loop	  flipped	  out	  of	  the	  active	  site	  (Figure	  6.1),	  not	  interacting	  with	  the	  bound	  product	  DHO,	  and	  instead	  forming	  part	  of	  the	  protein	  surface	  (“loop-­‐out”	  conformation).	  	  Gerstein	  et	  al.6	  proposed	  a	  mechanism	  of	  the	  movement	  of	  the	  loops	  during	  enzymatic	  reaction.	  They	  stated	  that	  the	  states	  of	  enzyme	  in	  the	  loop-­‐in	  or	  loop-­‐out	  conformations	   were	   only	   slightly	   different	   in	   energy	   and	   were	   in	   dynamic	  equilibrium	  at	  room	  temperature.	  The	   loops	   that	  constitute	  active	  site	   lids	  usually	  had	  different	  conformations	  depending	  on	  the	  catalytic	  state	  of	  the	  enzyme	  and	  the	  relative	   stabilities	   of	   the	   closed	   and	   open	   states	   of	   the	   loops	   depended	   upon	   the	  substrate	  bound	  in	  the	  active	  site.	  When	  substrate	  bound,	  the	  loop	  formed	  contacts	  with	  the	  substrate	  or	  the	  enzyme	  that	  stabilized	  the	  closed	  state	  of	  the	  loop.	  When	  product	  was	  formed,	  these	  interactions	  may	  be	  lessened	  thus	  making	  the	  open	  state	  of	  the	  loop	  more	  stable,	  which	  caused	  the	  release	  of	  the	  product	  favorable.	  Such	  loop	  movements	   involved	   in	   the	   reaction	   of	   enzyme	  were	   critical	   to	   the	  mechanism	  of	  catalysis.	  	  The	  crystallography	  method	  has	  the	  limitation	  to	  probe	  the	  dynamics	  of	  the	  loop	  motion	  as	  the	  crystal	  structure	  can	  only	  capture	  a	  static	  state	  of	  the	  enzyme.	  In	  the	  crystal	  structure	  of	  subunit	  A	  with	  loop-­‐out	  (PDB	  ID	  1XGE),	  residues	  of	  the	  loop	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Figure	   6.1.	   The	   100’s	   loop	   conformations.	   The	   “loop-­‐in”	   (shown	   in	   cyan)	  conformation	  in	  subunit	  B	  is	  observed	  when	  CA	  is	  bound	  at	  the	  active	  site	  and	  faces	  away	   from	   the	   active	   site	   as	   the	   “loop-­‐out”	   (shown	   in	   green)	   conformation	   in	  subunit	   A	   when	   DHO	   is	   bound	   at	   the	   active	   site	   (not	   shown	   here).	   Thr109	   and	  Thr110	  form	  direct	  contact	  with	  CA	  when	  the	  100’s	  loop	  reaches	  into	  the	  active	  site.	  Subunit	  A	  and	  B	  are	  compared	  after	  superposition.	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were	   found	   to	   make	   hydrogen-­‐bonding	   interactions	   with	   symmetry	   related	  molecules	   in	   the	   crystal.	   These	   interactions,	   involving	   only	   this	   subunit,	  would	  be	  sufficient	   to	   align	   the	   dimer	   in	   the	   crystal	   and	   made	   the	   two	   subunits	  distinguishable.	   Therefore	   there	   is	   a	   possibility	   that	   the	   observed	   “loop-­‐in”	   and	  “loop-­‐out”	  conformations	  were	  due	  to	  crystal	  packing	  forces.	  In	  order	  to	  determine	  if	  the	  loop	  positions	  observed	  in	  the	  structure	  occur	  in	  solution	  and	  the	  role	  of	  100’s	  loop	  motion	   for	   catalysis,	   we	   employed	   the	   system	   developed	   by	   Schultz	   and	   co-­‐workers,	  specifically	  the	  methodology	  of	  Wang	  et	  al,7	  to	  genetically	  incorporate	  the	  fluorescent	  amino	  acid	  L-­‐(7-­‐hydroxycoumarin-­‐4-­‐yl)ethylglycine	  (HCE-­‐Gly),	  which	  is	  sensitive	   to	   solvent	  polarity	  and	  pH,	   site-­‐specifically	  on	   the	  100’s	   loop	  of	  DHOase.	  These	  experiments	  validate	  the	  usefulness	  of	  the	  methods	  developed	  by	  Schultz	  and	  co-­‐workers	  to	  incorporate	  unnatural	  amino	  acids	  into	  the	  structure	  of	  proteins	  as	  a	  useful	  probe	  for	  many	  biological	  studies.	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Results	  and	  Discussion	  
Selection	  of	  HCE-­Gly	  Incorporation	  Site	  	  	   One	   of	   the	   challenges	   is	   the	   selection	   of	   the	   appropriate	   location	   to	   place	  HCE-­‐Gly,	  where	  it	  does	  not	  influence	  the	  function	  of	  the	  enzyme	  but	  the	  movement	  of	   the	   loop	  should	  perturb	   the	   local	  environment	  of	   the	  HCE-­‐Gly	   in	  such	  a	   fashion	  that	   its	   fluorescence	   would	   be	   altered.	   After	   visual	   examination	   of	   the	   DHOase	  structure	  with	   in	   silico	  mutation	   of	   the	   protein	   residue	   to	  HCE-­‐Gly	   in	   Pymol8	   and	  	  sequence	  alignment	  of	  the	  amino	  acid	  sequence	  of	  DHOases,	  four	  sites	  were	  selected	  for	   incorporation	   of	   HCE-­‐Gly:	   Asn107,	   Ser113,	   His114	   and	   Ala46.	   The	   first	   three	  positions	   are	   within	   the	   100’s	   loop.	   Alignment	   of	   ~500	   DHOase	   sequences	   was	  carried	   out	   using	   ClustalW.9	   Shown	   in	   Figure	   6.2	   is	   a	   representation	   of	   the	  conserved	   residues	   in	   the	  100’s	   loop	   region	  of	  DHOase	   from	   the	  alignment	   result.	  Asn107,	  Ser113	  and	  His114	  were	  least	  conserved	  and	  would	  be	  the	  first	  candidates	  for	   a	   site	   to	   introduce	   the	   fluorescent	   probe.	   	   Ala46,	   a	   residue	   that	   was	   not	  conserved	   located	   on	   the	   edge	   of	   the	   active	   site	   pocket	   and	   so	   predicted	   to	   be	  sensitive	   to	   the	   movement	   of	   the	   loop,	   was	   another	   possible	   location	   for	   the	  fluorescent	  probe.	  
Expression	  and	  Purification	  of	  HCE-­Gly	  DHOase	  
	   Our	   initial	   attempt	   to	   express	   the	   HCE-­‐Gly	   DHOase	   using	   plasmid,	   pSup-­‐CouRS-­‐D8,	   which	   had	   been	   constructed	   by	   the	   Schultz	   Lab	   for	   a	   more	   efficient	  incorporation	  of	  the	  unnatural	  amino	  acid,	  was	  not	  successful.	  Instead	  two	  plasmids	  were	  utilized	  to	  successfully	  incorporate	  HCE-­‐Gly	  into	  DHOase.	  The	  first	  plasmid	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Figure	  6.2.	  Alignment	  of	  the	  100’s	  loop	  (residues	  105-­‐115)	  region	  from	  about	  500	  DHOase	   sequences.	   The	   larger	   the	   letter	   the	  more	   conserved	   the	   residue	   is.	   This	  figure	  was	  created	  with	  WebLogo.10	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pBK-­‐CouRS-­‐D87	   contained	   the	   gene	   for	   a	   special	  Methanococcus jannaschii	   tyrosyl-­‐tRNA	   synthetase,	   which	   was	   paired	   with	   a	   mutant	   M. jannaschii	   tyrosyl	   amber	  suppressor	   tRNA7	   to	   uniquely	   insert	   HCE-­‐Gly	   in	   response	   to	   a	   TAG	   amber	   stop	  codon.	   The	   tRNA	   was	   supplied	   by	   the	   second	   plasmid,	   pEK701,	   a	   derivative	   of	  pBAD/JYAMB-­‐4TAG-­‐Myo,7	  in	  which	  the	  myoglobin	  gene	  was	  replaced	  by	  the	  E. coli	  
pyrC	   gene,	   encoding	  DHOase.	   The	   codons	   at	   position	   107	   or	   114	   of	  DHOase	  were	  altered	  to	  the	  amber	  codon	  TAG	  by	  site-­‐directed	  mutagenesis	  but	  attempts	  to	  alter	  the	   other	   two	   selected	   sites	   46	   and	   113	  were	   not	   successful.	   The	   expression	  was	  performed	   by	   growth	   of	   Top10	   cells	   (Invitrogen)	   containing	   both	   of	   the	   above	  plasmids	   in	  glycerol	  minimal	  media	  supplemented	  by	  1.0	  mM	  HCE-­‐Gly,	  which	  was	  synthesized	   as	   described	   previously.7	   Protein	   was	   purified	   by	   the	   Ni2+	   affinity	  chromatography	   as	   a	   His6	   tag	   was	   introduced	   at	   the	   C-­‐terminal	   of	   the	   DHOase	  sequence.	   The	   success	   of	   incorporation	   was	   confirmed	   directly	   by	   gel	  electrophoresis,	  since	  the	  modified	  protein	  is	  fluorescent	  (see	  Figure	  6.3).	  The	  level	  of	  suppression	  of	  the	  TAG	  codon	  was	  significantly	  better	  at	  position	  114	  than	  107.	  We	  were	  unable	  to	  obtain	  sufficient	  HCE-­‐Gly107	  DHOase	  for	  further	  investigations.	  	  
Kinetic	  and	  Fluorescence	  Analysis	  of	  HCE-­Gly114	  DHOase 	   From	  the	  results	  of	   the	  colorimetric	  assay	  of	  DHOase	  carried	   in	  the	  reverse	  reaction	   from	   DHO	   to	   CA,	   the	   HCE-­‐Gly114	   DHOase	   exhibited	   about	   10-­‐fold	   less	  activity	   than	   the	   His-­‐tag	   DHOase	   into	   which	   the	   HCE-­‐Gly	   was	   incorporated	   (See	  Table	  6.1).	  From	  the	  sequence	  alignment	  of	  the	  100’s	  loop	  from	  ~500	  DHOases	  (See	  Figure	  6.2)	  8	  out	  of	  11	  residues	  comprising	  the	  100’s	  loop	  were	  highly	  conserved,	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Figure	   6.3.	  HCE-­‐Gly114	  and	  His-­‐tag	  DHOases	   are	   visualized	  on	   the	   SDS-­‐PAGE	  gel	  stained	  by	  Coomassie	  blue	  (right).	  The	  fluorescence	  of	  HCE-­‐Gly114	  DHOase	  on	  the	  same	  SDS-­‐PAGE	  gel	  can	  be	  visualized	  under	  UV	  light	  (left).	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Table	  6.1.	  Kinetic	  parameters	  of	  the	  His-­‐tag	  and	  HCE-­‐Gly114	  DHOases	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Vmax	  a	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  [S]0.5b	  His-­‐tag	  DHOase	   7.79	  ±	  1.11	   0.27	  ±	  0.075	  HCE-­‐Gly114	  DHOase	   0.73	  ±	  0.022	   0.15	  ±	  0.019	  	  All	  experiments	  were	  performed	  at	  25	  °C	  in	  50	  mM	  Tris-­‐phosphate	  buffer	  at	  pH	  8.0	  The	  values	  reported	  are	  the	  average	  deviation	  of	  three	  determinations.	  
aThe	  maximal	  observed	  velocity	  of	  CA	  formation	  (mmol	  hr-­‐1	  mg-­‐1)	  
bSubstrate	  concentration	  [DHO]	  at	  half	  of	  the	  maximal	  observed	  velocity	  (mM)	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which	  indicate	  the	  importance	  of	  the	  100’s	  loop	  for	  the	  function	  of	  DHOase.	  Though	  His114	  was	  not	  conserved	  and	  didn’t	  form	  direct	  contacts	  with	  either	  Zn	  atoms	  or	  substrate	  CA	   at	   the	   active	   site,	   the	   hydrogen-­‐bonding	   interaction	  between	  His114	  and	  Tyr79	  was	  critical	  for	  anchoring	  the	  100’s	  loop	  to	  the	  remainder	  of	  the	  chain.5	  Replacement	  of	  His114	  with	  HCE-­‐Gly	  might	  eliminate	  this	   interaction	  destabilizing	  the	  100’s	   loop,	  which	  could	  possibly	  cause	   the	  Thr109	  and	  Thr110	  not	  positioned	  correctly	   to	  CA	   and	   influence	   the	   catalysis.	   Interestingly,	  DHO	  appeared	   to	  have	   a	  higher	  binding	  affinity	  to	  HCE-­‐Gly114	  DHOase	  than	  His-­‐tag	  DHOase	  based	  on	  kinetic	  data.	   As	   seen	   in	   Table	   6.1,	   the	   half-­‐saturating	   concentration	   of	   DHO	   for	   the	  fluorescent	  DHOase	  was	  about	  half	  of	  that	  for	  the	  His-­‐tag	  DHOase.	  Despite	  the	  fact	  that	   the	   incorporation	   of	   the	   HCE-­‐Gly	   at	   position	   114	   was	   not	   as	   expected	   to	  produce	   a	   functional	   DHOase	   with	   kinetic	   properties	   very	   similar	   to	   the	   His-­‐tag	  DHOase,	   the	   fluorescence	  measurements	   of	   HCE-­‐Gly114	   DHOase	  were	   performed	  since	   HCE-­‐Gly114	   DHOase	   was	   the	   only	   successful	   incorporation	   at	   the	   desired	  location	  in	  DHOase	  among	  the	  four	  selected	  sites.	  	  The	  structure	  of	  E. coli	  DHOase	  crystallized	  in	  the	  presence	  of	  DHO5	  (PDB	  ID	  1XGE)	  revealed	   that	   the	  100’s	   loop	  adopted	   the	   loop-­‐out	  conformation	  when	  DHO	  bound	  at	  the	  active	  site	  and	  the	  loop-­‐in	  conformation	  when	  CA	  bound	  at	  the	  active	  site.	  However,	  for	  the	  DHOase	  dimers	  in	  solution	  there	  can	  be	  many	  combinations	  of	  loop	   conformations	   that	   were	   possible	   since	   the	   reaction	   of	   CA	   to	   DHO	   was	  reversible.	  Therefore	  it	  would	  be	  hard	  to	  depict	  the	  loop	  motion	  if	  we	  measure	  the	  fluorescence	  changes	  of	  HCE-­‐Gly114	  DHOase	   in	   the	  presence	  of	  either	  DHO	  or	  CA.	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The	   structure	   of	   E. coli	   DHOase	   complexed	   with	   5-­‐fluoorotate	   (FOA),	   a	   product	  DHO-­‐like	  inhibitor	  of	  DHOase,	  showed	  that	  in	  subunit	  A	  the	  loop	  was	  out	  when	  the	  active	   site	   was	   fully	   occupied	   by	   FOA	  while	   in	   subunit	   B	   parts	   of	   the	   100’s	   loop	  (residues	  108-­‐114)	  were	  disordered	  when	  the	  active	  site	  was	  partially	  occupied	  by	  FOA.11	  When	  FOA	  bound	   to	   the	  enzyme	  the	   loop-­‐in	  conformation	  was	  not	   feasible	  because	   FOA	   cannot	  make	   hydrogen	   bonding	   to	   Thr109	   and	   Thr110	   of	   the	   100’s	  loop,	   which	   was	   required	   for	   the	   loop-­‐in	   conformation.11	   Therefore	   fluorescence	  changes	   caused	   by	   the	   movement	   of	   the	   100’s	   loop	   with	   addition	   of	   FOA	   were	  monitored.	  (Methods	  described	  in	  Chapter	  7)	  As	  the	  concentration	  of	  FOA	  increased	  up	   to	   30	   mM,	   the	   fluorescence	   intensity	   at	   455	   nm	   decreased	   significantly	   with	  almost	   no	   shift	   in	   the	   emission	   maximum	   (see	   Figure	   6.4	   A)	   The	   relative	  fluorescence	  was	  plotted	  as	  a	  function	  of	  FOA	  concentration,	  and	  the	  concentration	  of	   FOA	   required	   for	   half-­‐maximal	   reduction	   in	   the	   relative	   fluorescence	   is	   8.84	   ±	  1.63	  mM	  (see	  Figure	  6.4	  B).	  As	  a	  comparison,	   the	   inhibition	  of	  FOA	  was	  measured	  for	   the	   HCE-­‐Gly114	   DHOase	   at	   the	   same	   pH	   and	   buffer	   (see	   Figure	   6.5).	   The	  concentration	  of	  FOA	  required	  for	  half-­‐maximal	  inhibition	  (IC50)	  is	  4.04	  ±	  0.27	  mM.	  If	  the	  alteration	  of	  fluorescence	  intensity	  reflects	  the	  binding	  of	  FOA	  to	  the	  enzyme,	  the	   concentration	   of	   FOA	   required	   for	   half-­‐maximal	   reduction	   in	   relative	  fluorescence	  should	  agree	  with	  the	  IC50	  value	   from	  the	  kinetic	  data.	  However	   from	  our	  experiments,	   the	  concentration	  of	  FOA	  when	  the	  relative	   fluorescence	  reaches	  half-­‐maximum	   is	   about	   two-­‐fold	   greater	   than	   the	   IC50	   obtained	   from	   the	   protein	  assay	  of	  HCE-­‐Gly114	  DHOase	  in	  the	  presence	  of	  FOA.	  The	  fluorescence	  response	  to	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Figure	   6.4.	   Monitoring	   inhibitor	   FOA	   binding	   to	   HCE-­‐Gly114	   DHOase	   by	  fluorescence.	  (A)	  Fluorescence	  spectrum	  of	  HCE-­‐Gly114	  DHOase	  as	  a	  function	  of	  the	  FOA	  concentrations.	  HCE-­‐Gly114	  DHOase	  (32	  μg/ml)	  in	  50	  mM	  Tris-­‐phosphate,	  pH	  8.0	  at	  25°	  C	  was	  excited	  at	  355	  nm,	  and	  the	  emission	  spectrum	  was	  measured	  from	  400	  –	  550	  nm.	  As	  the	  FOA	  concentration	  was	  increased	  from	  0	  mM	  (open	  circle)	  to	  30	  mM	  (solid	  circle),	   the	  emission	   intensity	  at	  455	  nm	  decreased	  significantly.	   (B)	  Corresponding	   plot	   of	   the	   fluorescence	   intensity	   at	   455	   nm	   normalized	   to	   the	  highest	  value	  (0	  mM	  FOA)	  versus	  the	  FOA	  concentration.	  The	  data	  points	  shown	  are	  the	  average	  of	  five	  determinations.	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Materials	  and	  General	  Methods	  	   Ampicillin,	   kanamycin,	   tetracycline,	   magnesium	   chloride	   hexahydrate,	   zinc	  chloride,	   ATP,	   UTP,	   glycine,	   glucose,	   PEG4000,	   EDTA,	   agar,	   L-­‐aspartate,	   N-­‐carbamoyl-­‐L-­‐aspartate,	  2-­‐mercaptoethanol,	  uracil,	  ethidium	  bromide,	  arabinose	  and	  bis-­‐Tris	  were	  obtained	  from	  Sigma-­‐Aldrich.	  Compounds	  tested	  for	  virtual	  screening	  (zinc391516,	   zinc902674,	   zinc903866,	   zinc402968,	   zinc394318)	   were	   also	  purchased	   from	   Sigma-­‐Aldrich.	   CTP	  was	   from	   Santa	   Cruz	   Biotechnology	   Inc.	   Tris,	  imidazole,	   CAPS,	   electrophoresis-­‐grade	   acrylamide	   and	   enzyme-­‐grade	   ammonium	  sulfate	  and	  GTP	  were	  from	  MP	  Biomedicals.	  Antipyrine,	  diacetylmonoxime,	  sodium	  molybdate	   dihydrate,	   tryptone	   and	   yeast	   extract	   were	   obtained	   from	   Fisher.	  Casamino	   acid	   was	   from	   Becton,	   Dickinson	   and	   Company.	   Agarose,	   ammonium	  persulfate	  (APS),	  sodium	  dodecyl	  sulfate,	  coomassie	  brilliant	  blue,	  Chelex	  100	  resin,	  the	   protein	   assay	   dye	   and	   the	   Bio-­‐Prep	   SE-­‐1000/17	   column	   for	   size	   exclusion	  chromatography	  were	  purchased	  from	  Bio-­‐Rad.	  L-­‐dihydroorotic	  acid	  was	  obtained	  from	   Chem-­‐Impex	   International.	   5-­‐fluoroorotic	   acid	   (5-­‐FOA)	   was	   from	   Research	  Products	   International	   Corp.	   The	   oligonucleotides	   required	   for	   site-­‐specific	  mutagenesis	   and	   sequencing	   were	   obtained	   from	   Operon	   Technologies.	  Crystallization	  VDXTM	  plates,	  siliconized	  glass	  circle	  cover	  slides	  and	  cryo-­‐mounting	  loops	  were	  purchased	  from	  Hampton	  Research.	  Carbamoyl	  phosphate	  dilithium	  salt	  obtained	   from	   Sigma	   was	   purified	   before	   use	   by	   precipitation	   from	   50%	   (v/v)	  ethanol	  and	  was	  stored	  desiccated	  at	  -­‐20°	  C.1	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Protein	  Expression	  and	  Purification	  
Wild-­type	  ATCase	  	   Wild-­‐type	   ATCase	   holoenzyme	   was	   overexpressed	   utilizing	   E. coli	   strain	  EK1104	  [F-­‐	  ara,	  thi,	  ∆(pro-­lac),	  ∆pyrB,	  pyrF±,	  rpsL]2	  containing	  plasmid	  pEK152.3	  The	  enzyme	  was	  isolated	  based	  on	  the	  procedure	  described	  previously2	  and	  purified	  by	  isoelectric	   precipitation	   at	   pH	   5.8,	   ion-­‐exchange	   and	   hydrophobic	   interaction	  chromatography	   following	   ammonium	   sulfate	   precipitation.	   For	   the	   ion-­‐exchange	  purification,	  a	  Q-­‐Sepharose	  Fast	  Flow	  (GE	  Healthcare)	  column	  (11	  cm	  x	  2.5	  cm)	  was	  employed.	   The	   column	   was	   first	   equilibrated	   with	   0.05	   M	   Tris-­‐acetate,	   2	   mM	   2-­‐mercaptoethanol,	   pH	   8.3	   (Low	   Q	   buffer)	   at	   a	   flow	   rate	   of	   1.0	   mL/min.	   Protein	  sample	  was	   loaded	  onto	   the	  column	  after	  being	  dialyzed	  against	   two	  changes	  of	  4	  liters	  of	  Low	  Q	  buffer	   for	  12	  hrs	  per	  change.	  The	  column	  was	  washed	  with	  60	  mL	  Low	  Q	   buffer,	   and	   the	   protein	  was	   eluted	   using	   a	   linear	   gradient	   developed	   from	  100-­‐mL	  volume	  of	  Low	  Q	  buffer	  and	  Low	  Q	  buffer	  plus	  0.5	  M	  sodium	  chloride	   for	  every	  1	   liter	  of	  culture	  harvested.	  5.0	  mL	  fractions	  were	  collected	  at	  a	   flow	  rate	  of	  1.0	  mL/min.	  For	  the	  hydrophobic	  interaction	  chromatography,	  a	  Phenyl	  Sepharose	  High	  Performance	  (GE	  Healthcare)	  column	  (8.5	  cm	  x	  2	  cm)	  was	  employed.	  After	  the	  ion-­‐exchange	  chromatography,	  ATCase	  containing	  fractions	  were	  dialyzed	  into	  Low	  Q	   and	   brought	   to	   20%	   saturation	   with	   ammonium	   sulfate	   and	   loaded	   onto	   the	  Phenyl	  Sepharose	  column	  pre-­‐equilibrated	  with	  Low	  Q	  buffer	  plus	  20%	  saturating	  ammonium	  sulfate.	  The	  column	  was	  washed	  with	  60	  mL	  of	  Low	  Q	  buffer	  plus	  20%	  saturating	   ammonium	   sulfate	   at	   a	   flow	   rate	   of	   1.0	  mL/min.	  After	   that	   the	   protein	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was	   eluted	   using	   a	   linear	   gradient	   from	   Low	   Q	   buffer	   plus	   20%	   saturating	  ammonium	  sulfate	  to	  Low	  Q	  buffer	  with	  a	  total	  volume	  of	  300	  mL	  at	  the	  same	  flow.	  The	  purity	  of	   the	  enzyme	  was	  checked	  by	  SDS-­‐PAGE4	  and	  non-­‐denaturing	  PAGE.5,6	  The	  concentration	  of	  the	  purified	  wild-­‐type	  ATCase	  was	  determined	  by	  absorption	  at	  280	  nm	  with	  an	  extinction	  coefficient	  of	  0.59	  cm2mg-­‐1.	  	  
K164E/E239K	  ATCase	  	   The	   mutations	   K164E/E239K	   were	   introduced	   to	   the	   catalytic	   chains	   of	  ATCase	   on	   plasmid	   pEK1523	   by	   site-­‐specific	   mutagenesis	   employing	   the	   Quick-­‐Change	  Site-­‐Directed	  Mutagenesis	  Kit	  (Stratagene)	  to	  produce	  plasmid	  pEK695.	  The	  double	   mutant	   was	   isolated	   based	   on	   the	   procedure	   described	   previously2,	   from	  over-­‐producing	  E. coli	  strain	  EK1104,	  containing	  the	  plasmid	  pEK695.	  The	  enzyme	  was	  purified	  by	  isoelectric	  precipitation,	  ion-­‐exchange	  and	  hydrophobic	  interaction	  chromatography	  as	  indicated	  above	  for	  the	  wild-­‐type	  enzyme.	  The	  homogeneity	  of	  the	   protein	   was	   checked	   by	   SDS-­‐PAGE.4	   The	   concentration	   of	   purified	   double-­‐mutant	  enzyme	  was	  determined	  by	   the	  Bio-­‐Rad	  version	  of	  Bradford’s	  dye-­‐binding	  assay	  using	  wild-­‐type	  ATCase	  as	  the	  standard.7  
Wild-­type	  DHOase 	   Wild-­‐type	   DHOase	   was	   overexpressed	   from	   utilizing	   E. coli	   strain	   EK2110	  (also	   named	   as	   X7014a	   which	   lacks	   a	   functional	   gene	   for	   DHOase)8	   containing	  plasmid	   pEK6629	   which	   is	   a	   gift	   from	   Prof.	   Frank	   M.	   Raushel	   of	   Texas	   A&M	  University.	  Cells	  in	  YT	  media	  containing	  150ug/mL	  ampicillin	  were	  incubated	  at	  37°	  C	   until	   they	   reached	   mid-­‐log	   phase,	   at	   which	   point	   IPTG	   was	   added	   to	   a	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concentration	   of	   0.4	  mM.	   After	   overnight	   incubation,	   the	   cells	   were	   harvested	   by	  centrifugation,	   sonication,	   and	   purified	   as	   described	   previously9	   with	   the	  modification	  of	  employing	   the	  Q-­‐Sepharose	  Fast	  Flow	  (GE	  Healthcare)	  column	  (11	  cm	   x	   2.5	   cm)	   	   followed	   by	   Phenyl	   Sepharose	   High	   Performance	   	   (GE	   Healthcare)	  column	   (8.5	   cm	   x	   2	   cm)	   after	   the	   ammonium	   sulfate	   precipitation	   step.	   The	  procedure	   of	   chromatography	   is	   similar	   to	   that	   for	   ATCase	   purification	   described	  above.	  For	  the	  ion-­‐exchange	  purification,	  the	  column	  was	  first	  equilibrated	  with	  50	  mM	   Tris-­‐phosphate,	   100	   μM	   ZnCl2,	   pH	   7.0,	   (Low	   D	   buffer)	   at	   a	   flow	   rate	   of	   1.0	  mL/min.	  After	   the	  protein	  was	   loaded	  the	  column	  was	  washed	  with	  60	  mL	  Low	  D	  buffer.	  The	  protein	  was	  eluted	  from	  the	  column	  at	  the	  same	  flow	  rate	  using	  a	  linear	  gradient	   from	  Low	  D	  buffer	   to	  Low	  D	  buffer	  plus	  1.0	  M	  sodium	  chloride	   in	  a	   total	  volume	   of	   100	   mL	   for	   every	   1	   liter	   of	   culture	   harvested.	   After	   the	   ion-­‐exchange	  chromatography,	   DHOase	   containing	   fractions	   were	   dialyzed	   into	   Low	   D	   and	  brought	   to	   30%	   saturation	   with	   ammonium	   sulfate	   and	   loaded	   onto	   the	   Phenyl	  Sepharose	   column	   pre-­‐equilibrated	   with	   Low	   D	   buffer	   plus	   30%	   saturating	  ammonium	   sulfate.	   The	   protein	   was	   eluted	   using	   a	   linear	   gradient	   from	   Low	   D	  buffer	  plus	  30%	  saturating	  ammonium	  sulfate	  to	  Low	  D	  buffer	  in	  a	  total	  volume	  of	  300	  mL	  at	  flow	  rate	  of	  1.0	  mL/min.	  The	  purity	  of	  the	  enzyme	  was	  checked	  by	  SDS-­‐PAGE4	   and	   non-­‐denaturing	   PAGE.5,6	   The	   concentration	   of	   the	   purified	   wild-­‐type	  DHOase	  was	  determined	  by	  absorption	  at	  278	  nm	  with	  an	  extinction	  coefficient	  of	  0.638	  cm2mg-­‐1.10 
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HCE-­Gly114	  DHOase	  The	   DHOase	   gene	   of	   the	   plasmid	   pEK755,	   which	   was	   used	   to	   express	   the	  fluorescent	   DHOase,	   was	   originated	   from	   that	   of	   plasmid	   pEK668.	   This	   plasmid	  contains	  the	  E. coli	  pyrC	  gene	  with	  a	  C-­‐terminal	  His6	  tag,	  which	  was	  inserted	  by	  site-­‐specific	  mutagenesis	  (Quick-­‐Change	  Site-­‐Directed	  Mutagenesis	  Kit	  from	  Stratagene)	  using	  pEK6629	  as	   template.	  A	  Kpn	   I	   site,	  which	  was	  downstream	   to	   the	  6	  His-­‐tail,	  and	   a	   Nco	   I	   site	   overlapping	   the	   ATG	   initiation	   codon	   of	   the	   pyrC	   gene	   were	  introduced	   on	   plasmid	   pEK668	   by	   site-­‐specific	   mutagenesis	   employing	   the	   same	  method	   as	   described	   above	   to	   produce	   plasmid	   pEK700.	   Then	   both	   pEK700	   and	  pBAD/JYAMB-­‐4TAG-­‐Myo11 were	  digested	  with	  Kpn	  I	  and	  Nco	  I	  for	  2.5	  hrs	  at	  37°	  C.	  The	   fragment	   from	   pEK700	   carrying	   the	   pyrC	   gene	   and	   the	   backbone	   of	  pBAD/JYAMB-­‐4TAG-­‐Myo11 were	   extracted	   and	   purified	   after	   DNA	   agarose	   gel	  electrophoresis	  using	   the	  QIAquick	  Gel	  Extraction	  Kit	   	   (Qiagen).	  The	   fragment	  and	  backbone	  were	   then	  mixed	   and	   treated	  with	  T4	  DNA	  Ligase	   in	  1	   x	  T4	  DNA	   ligase	  reaction	  buffer	   (New	  England	  Biolabs)	  at	  16°	  C	   for	  16	  hrs.	  Competent	  Top10	  cells	  (Invitrogen)	   were	   transformed	   with	   the	   ligation	   reaction.	   Cells	   containing	   the	  ligation	   products	   were	   selected	   on	   YT	   plates	   containing	   tetracycline.	   Individual	  colonies	   were	   used	   to	   inoculate	   5	   mL	   YT	   cultures,	   which	   were	   grown	   at	   37°	   C	  overnight.	   The	   plasmids	   were	   isolated	   from	   the	   overnight	   cultures	   using	   the	  QIAprep	   Spin	   Miniprep	   Kit	   (Qiagen).	   After	   digested	   with	   Kpn	   I	   and	   Nco	   I,	   the	  plasmids	  showing	  both	  bands	  for	  the	  pyrC	  gene	  and	  the	  backbone	  of	  pBAD/JYAMB-­‐4TAG-­‐Myo	  on	  the	  DNA	  agarose	  gel	  were	  sent	  for	  sequencing.	  The	  successful	  ligation	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products	   were	   verified	   by	   the	   sequencing	   results	   and stored	   as	   pEK701.	   Finally,	  site-­‐directed	  mutagenesis	  was	  performed	  on	  plasmid	  pEK701	  to	  substitute	  His114	  in	  DHOase	  for	  an	  amber	  stop	  codon	  TAG	  to	  create	  pEK755.	  This	  expression	  plasmid	  pEK755	   contains	   the	  pyrC	   gene	   under	   the	   control	   of	   the	   arabinose	   promoter,	   the	  gene	  for	  the	  Methanococcus janaschii	  tyrosyl	  amber	  suppressor	  tRNA	  that	  specifically	  inserts	   unnatural	   amino	   acid	   HCE-­‐Gly	   in	   response	   to	   the	   TAG	   codon	   and	   the	  tetracycline-­‐resistant	  gene.	  Plasmid	   pEK755	   was	   cotransformed	   with	   pBK-­‐CouRS-­‐D8	   into	   competent	  Top10	  cells	  (Invitrogen)	  and	  plated	  on	  2	  LB	  plates	  with	  12.5	  µg/ml	  tetracycline	  and	  50	   µg/ml	   kanamycin.	   Cells	   were	   amplified	   in	   2	   LB	   media	   (5	   ml)	   with	   the	   same	  antibiotics.	  Starter	  culture	  (1	  ml)	  was	  used	  to	  inoculate	  500	  ml	  of	  liquid	  M9	  glycerol	  minimal	   media	   supplemented	   with	   0.5%	   casamino	   acids	   (Bacto),	   12.5	   µg/ml	  tetracycline,	  50	  µg/ml	  kanamycin,	   and	  1.0	  mM	  HCE-­‐Gly.	  Cells	  were	   then	  grown	  at	  37°	  C	  to	  an	  OD600	  of	  0.5	  and	  protein	  expression	  was	  induced	  by	  the	  addition	  of	  0.2%	  (g/ml)	  arabinose.	  After	  further	  incubation	  at	  37°	  C	  for	  12	  hrs,	  cells	  were	  harvested	  by	   centrifugation	   and	   lysed	   by	   sonication.	   The	   HCE-­‐Gly114	   DHOase	   was	   then	  purified	   by	   immobilized	   metal	   ion	   affinity	   chromatography	   (IMAC)	   employing	  Chelating	  SepharoseTM	  Fast	  Flow	  (GE	  Healthcare)	  column	  (2	  cm	  x	  1.5	  cm)	  charged	  with	  Ni2+.	   The	   column	  was	  pre-­‐equilibrated	  with	  50	  mM	  Tris-­‐phosphate,	   200	  mM	  NaCl,	   pH	   7.0	   at	   1.5	   mL/min.	   After	   protein	   sample	   was	   loaded,	   the	   column	   was	  sequentially	  washed	  with	  40	  mM	  (6	  mL),	  100	  mM	  (6	  mL),	  200	  mM	  (12	  mL)	  and	  400	  mM	   (8	   mL)	   imidazole	   in	   50	   mM	   Tris-­‐phosphate,	   200	   mM	   NaCl,	   pH	   7.0	   at	   1.0	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mL/min.	   The	  pure	  HCE-­‐Gly114	  DHOase	   enzyme	  was	   found	   to	   elute	  with	  200	  mM	  imidazole.	  Purity	  was	  verified	  by	  SDS	  PAGE.4 
Aspartate	  Transcarbamoylase	  Assay 
Kinetic	  characterization	  at	  25°	  C	  and	  5°	  C	  The	  activity	  of	  ATCase	  was	  measured	  by	  the	  colorimetric	  method12	  in	  the	  50	  mM	  Tris	  acetate	  buffer,	  pH	  8.3,	  and	  in	  the	  presence	  of	  4.8	  mM	  CP.	  L-­‐Asp	  saturation	  curves	  in	  the	  absence	  and	  presence	  of	  nucleotide	  effectors	  (ATP,	  CTP	  and	  UTP)	  were	  performed	   at	   both	   25°	   C	   and	   5°	   C.	   Influence	   of	   ATP	   and	   CTP	   on	   the	   activity	   of	  ATCase	  in	  the	  absence	  and	  presence	  of	  20%	  ethylene	  glycol	  were	  observed	  at	  5°	  C.	  All	  data	  were	  collected	  in	  duplicate	  and	  averaged.	  The	  data	  analysis	  was	  carried	  out	  as	  described	  previously.13	  	  
Nucleotide	  Saturation	  Curves	  Saturation	   curves	   of	   nucleotide	   effectors	   ATP,	   CTP,	   GTP	   and	   UTP	   were	  performed	   in	   the	   absence	   and	   presence	   of	   Mg2+	   at	   28°	   C.	   Pretreatment	   of	  nucleotides	  with	  Chelex	  100	  resin	  (Bio-­‐Rad)	  were	  carried	  out	  to	  remove	  any	  metal	  contaminations	  in	  the	  commercial	  supply.	  0.05	  g	  of	  Chelex	  100	  resin	  was	  added	  to	  every	   1.0	  mL	   nucleotide	   solution.	   The	  mixture	  was	   stirred	   gently	   on	   ice	   for	   1	   hr.	  Resin	   was	   removed	   by	   centrifugation	   and	   the	   nucleotide	   solution	   with	   metal	  removed	  was	  obtained	  as	   supernatant.	   Spectrophotometry	  was	  used	   to	  determine	  the	   concentrations	   of	   NTP	   (ATP,	   CTP,	   GTP	   and	   UTP)	   solutions:	   at	   pH	   7.0,	   εATP	   =	  15400	  at	  259	  nm,	  εCTP	  =	  9000	  at	  271	  nm,	  εGTP	  =	  13700	  at	  253	  nm,	  and	  εUTP	  =10000	  at	  262	   nm.14	  Mg-­‐NTP	   solutions	  were	  made	  with	   addition	   of	  MgCl26H2O.	  Due	   to	   the	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critical	  dependence	  of	  enzyme	  activity	  on	  pH,15	  all	  NTP	  and	  Mg-­‐NTP	  solutions	  were	  carefully	  adjusted	  to	  pH	  7.0	  ±	  0.05	  before	  use.	  Colorimetric	  assays12	  were	  performed	  in	  a	  tri-­‐part	  buffer	  at	  either	  pH	  7.0	  or	  pH	  8.3,	  containing	  20	  mM	  Bis-­‐Tris,	  20	  mM	  Tris,	  and	   20	   mM	   CAPS,	   in	   the	   presence	   of	   a	   saturating	   concentration	   of	   carbamoyl	  phosphate	   (2.0	   mM).	   In	   all	   assays	   the	   aspartate	   concentration	   was	   5.0	   mM	   (the	  value	  of	  [S]0.5	  at	  pH	  7.0)16	  and	  the	  concentration	  of	  wild-­‐type	  ATCase	  varied	  from	  6	  x	  10-­‐5	  to	  30	  x	  10-­‐5	  mg/ml.	  Data	  analysis	  of	  the	  steady-­‐state	  kinetics	  was	  carried	  out	  as	  described	  previously.13 
Dihydroorotase	  Assay	  
Kinetic	  Characterization	  	   The	   degradative	   activity	   of	   DHOase	   and	   inhibition	   of	   FOA	   against	   DHOase	  were	   measured	   by	   the	   rate	   of	   CA	   formation	   using	   modified	   colorimetric	   assay	  procedures,12	  which	   had	   been	   used	  many	   years	   for	   the	   kinetic	   studies	   of	   ATCase.	  Each	  reaction	  was	  initiated	  with	  addition	  of	  buffer	  containing	  DHOase	  instead	  of	  CP	  in	  the	  assay	  for	  ATCase.	  All	  colorimetric	  assays	  were	  performed	  at	  25°	  C	  in	  50	  mM	  Tris-­‐phosphate	  buffer	  at	  pH	  8.0.	  	  	   The	  direct	  assay	  used	  to	  measure	  the	  biosynthetic	  conversion	  of	  CA	  to	  DHO	  was	  performed	  as	  described	  by	  Sander	  et	  al..17	  The	  reaction	  mixture	  contained	  75	  mM	   Na2HPO4	   buffer	   (pH	   5.5)	   and	   1	   mM	   DL-­‐CA	   in	   a	   total	   volume	   of	   1.0	   ml.	   The	  reaction	  was	   initiated	   by	   the	   addition	   of	   enzyme	   at	   37°	   C.	   The	   linear	   increase	   in	  absorbance	   at	   230	   nm	   due	   the	   formation	   of	   DHO	   (ε230nm	   =	   1.17	   mM-­‐1	   cm-­‐1)	   was	  followed.	  The	  concentration	  of	  inhibitors	  ranged	  from	  0	  to	  2	  mM	  in	  the	  assays.	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Fluorescence	  Measurements	  For	   the	   HCE-­‐Gly114	   DHOase	   (Chapter	   6),	   all	   steady-­‐state	   measurements	  were	  performed	  using	  a	   JASCO	  spectrofluorometer	  FP-­‐6300	   in	  a	  quartz	  SUPRASIL	  fluorescence	   cell	   (Hellma)	   with	   a	   slit	   width	   of	   5	   nm	   at	   25°	   C	   in	   50	   mM	   Tris-­‐phosphate	   buffer	   at	   pH	   8.0	   and	   32	   µg/ml	   HCE-­‐Gly114	   DHOase.	   An	   excitation	  spectrum	   from	   250-­‐420	   nm	   was	   obtained	   to	   determine	   the	   maximum	   excitation	  wavelength.	   Using	   an	   excitation	   wavelength	   of	   355	   nm	   at	   pH	   8.0,	   a	   fluorescence	  spectrum	  from	  400-­‐600	  nm	  was	  obtained	  in	  the	  absence	  of	  the	  inhibitor	  FOA	  with	  maximum	  emission	  at	  455	  nm.	  Microliter	  amounts	  of	  the	  inhibitor	  FOA	  was	  added	  to	   the	   fluorescence	   cell	   up	   to	   a	   concentration	  of	   30	  mM.	  At	   each	   concentration	  of	  FOA,	   a	   fluorescence	   spectrum	   was	   recorded	   and	   the	   maximum	   fluorescence	  intensity	  was	   determined.	   Data	  was	   adjusted	   by	   dilution	   factor	   as	  more	   inhibitor	  FOA	  was	  added	  to	  the	  fluorescence	  cell.	  
Crystallography	  
Crystallization	  and	  Data	  Collection	  A	   sample	   of	   10	   mg/ml	   purified	   K164E/E239K	   ATCase	   was	   sent	   to	   the	  Hauptman-­‐Woodward	   Institute	   for	   high-­‐throughput	   screening	   of	   crystallization	  conditions.18	   The	   final	   crystallization	   condition	  was	   developed	   based	   upon	   one	   of	  the	   screening	   results.	   The	   mutant	   enzyme	   was	   crystallized	   by	   the	   hanging-­‐drop	  vapor	  diffusion	  method.	  2	  µl	  of	  enzyme	  (10	  mg/ml)	   in	  50	  mM	  Tris-­‐acetate,	  pH	  8.3	  was	   mixed	   with	   2	   µl	   of	   crystallization	   buffer	   (16%	   (w/v)	   PEG	   4000,	   0.04	   M	  Na2MoO4•2H2O,	  0.04	  M	  CAPS	  and	  0.03	  M	  Tris-­‐acetate	  at	  pH	  8.75)	  and	  equilibrated	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over	  a	  reservoir	  of	  1.0	  ml	  of	  crystallization	  buffer	  at	  20°	  C.	  Bar-­‐shaped	  crystals	  grew	  to	  average	  dimensions	  of	  0.3	  x	  0.3	  x	  0.4	  mm	  in	  about	  two	  weeks.	  Crystals	   were	   transferred	   into	   a	   freezing	   solution	   containing	   20%	   (v/v)	  ethylene	  glycol	  in	  crystallization	  buffer	  for	  1	  min	  prior	  to	  freezing	  in	  liquid	  N2.	  Data	  were	  collected	  in	  the	  Boston	  College	  Crystallography	  Facility.	  X-­‐rays	  were	  generated	  using	  a	  Rigaku	  MicroMax-­‐007HF	  rotating-­‐anode	  generator	  operating	  at	  40	  kV	  and	  30	  mA.	  The	  diffraction	  data	  were	  integrated,	  scaled	  and	  averaged	  using	  d*TREK.19 
Structure	  Determination	  Attempts	   to	   solve	   the	   structure	   of	   the	   K164E/E239K	  ATCase	   by	  molecular	  replacement	   were	   successful	   using	   the	   T-­‐state	   ATCase	   structure	   (PDB	   ID	   1ZA1)	  rather	   than	   the	   R-­‐state	   PALA-­‐ATCase	   structure	   in	   the	   same	   space	   group	   (PDB	   ID	  1Q95).	  	  First,	  one	  catalytic	  trimer	  (c3)	  of	  the	  double	  mutant	  was	  found	  by	  using	  the	  c3	  of	   the	  T-­‐state	  structure	  (PDB	  ID	  1ZA1)	   in	  MOLREP20	  as	   implemented	   in	  CCP4.21	  MOLREP	  was	  also	  able	  to	  locate	  the	  second	  c3.	  MOLREP	  was	  then	  used	  to	  locate	  the	  three	   regulatory	   dimers	   (r2)	   by	   fixing	   the	   coordinates	   of	   the	   two	   c3	   subunits.	  Combining	  the	  two	  c3	  and	  three	  r2	  subunits	  positioned	  by	  MOLREP	  the	  initial	  model	  of	  the	  holoenzyme	  (c6r6)	  in	  the	  asymmetric	  unit	  was	  established.	  Refinement	  of	  the	  structure	  was	   performed	  using	   PHENIX.22	   The	   80’s	   loops	   (residues	   77	   to	   84)	   and	  240’s	   loops	   (residues	   231	   to	   245)	   of	   all	   the	   catalytic	   chains	  were	   rebuilt	   into	   the	  refined	  structure	  using	  the	  Autobuild	  protocol	  in	  PHENIX.22	  The	  loop	  positions	  were	  further	   checked	   using	   composite	   omit	   maps,	   calculated	   using	   RESOLVE23	   within	  PHENIX,	  and	  displayed	   in	  COOT24,25	  averaging	  over	   the	  6-­‐fold	  non-­‐crystallography	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symmetry.	  The	  80’s	  and	  240’s	   loops	  of	   the	  catalytic	   chains	  had	  elevated	  B-­‐factors,	  which	  were	  higher	  than	  in	  the	  T-­‐	  or	  R-­‐state	  structure	  of	  the	  wild-­‐type	  enzyme.	  	  The	  higher	   B-­‐factors	   are	   most	   likely	   due	   to	   loss	   of	   a	   number	   of	   loop-­‐stabilizing	  interactions.	   Even	   though	   the	   density	   of	   these	   loops	   was	   weak	   and	   the	   B-­‐factors	  high,	  the	  atomic	  coordinates	  have	  been	  included	  for	  completeness.	  Water	  molecules	  were	   added	   to	   the	   structure	   using	   PHENIX22	   on	   the	   basis	   of	   the	   Fo–Fc	  map	   at	   or	  above	   the	   3.0	   σ	   level.	   After	   completion	   of	   the	   refinement,	   the	   final	   Rwork	  and	   Rfree	  were	   0.214	   and	   0.274,	   respectively.	   The	   model	   was	   checked	   for	   errors	   using	  PROCHECK.26	   Residues	   1-­‐9	   in	   the	   regulatory	   chains	   were	   omitted	   from	   the	  deposited	  structure	  due	  to	  weak	  electron	  density.	  	  
Virtual	  High	  Throughput	  Screening	  
Setup	  of	  the	  Virtual	  High	  Throughput	  Screening	  System	  (vHTS)	  In	   order	   to	  perform	   the	   virtual	   screening	  with	   a	   large	   scale	   of	   compounds, MySQL	  software	  (http://www.mysql.com)	  was	  selected	  both	  as	  the	  database	  for	  the	  storage	  of	  the	  information	  of	  compounds	  for	  screening,	  as	  well	  as	  the	  database	  for	  the	  storage	  of	  docking	  results.	  As	  seen	  in	  Figure	  7.1,	  three	  databases	  had	  been	  set	  up	  on	  the	  MySQL	  server.	  (1)	  The	  Compounds	  database	  was	  the	  storage	  location	  for	  the	  information	  on	  each	  of	  the	  compounds	  in	  their	  appropriate	  formats	  (mol2	  or	  pdbq	  format)	  required	  for	  the	  screening	  programs.	  All	  the	  data	  for	  the	  compounds	  were	  obtained	  from	  the	  non-­‐commercial	  public	  ZINC	  database	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Figure	   7.1.	  Organization	  of	   the	  MySQL	  databases	  and	   tables	   for	   the	  vHTS	  system.	  Databases	  are	  indicated	  in	  yellow	  and	  the	  tables	  in	  green.	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(http://blaster.docking.org/zinc/),	   which	   contained	   a	   large	   number	   of	   small	  molecule	   compounds	   that	   were	   purchasable.	   About	   3,000,000	   compounds	   were	  downloaded	   and	   rearranged	   to	   four	   tables	   named	   all_buy1	   to	   all_buy4,	   each	   of	  which	  contained	  about	  750,000	  compounds.	  (2)	  The	  Setup	  database	  was	  the	  storage	  location	  for	  the	  files	  required	  for	  docking，	  which	  were	  program	  dependent.	  There	  was	   also	   a	   table	   containing	   pointers	   to	   program	   executable	   (exe)	   tar	   files,	   which	  included	   the	   specific	   information	   the	   vHTS	   system	  needed	   to	   execute	   a	   particular	  docking	  program. (3)	  The	  Results	  database	  was	  the	  storage	  location	  for	  the	  output	  of	  the	  docking	  runs.	  The	  tables	  within	  Results	  database	  were	  set	  up	  according	  to	  the	  particular	  docking	  program	  used	  and	  the	  target	  for	  docking.	  The	  entire	  virtual	  high	  throughput	  screening	  (vHTS)	  system	  was	  controlled	  by	   a	   shell	   script	  written	   by	  Dr.	  Kantrowitz.	   Shown	   in	   Figure	  7.2	   is	   a	   schematic	   of	  how	  the	  vHTS	  system	  works.	  Execution	  of	   the	  vHTS	  was	  performed	  on	  the	  Boston	  College	  Linux	  Cluster.	  The	  shell	   script	  would	   first	  determine	   the	   type	  of	   computer	  and	  operating	  system.	  Based	  upon	  this	  information,	  the User	  Input	  file	  would	  then	  direct	   the	   script	   to	   download	   the	   files	   from	   the	   Setup	   database	   required	   for	   the	  docking	  to	  the	  particular	  receptor	  with	  the	  program	  selected	  by	  the	  user.	  The	  User	  
Input	   file	   would	   also	   provide	   the	   parameters	   to	   select	   the	   particular	   set	   of	  compounds	   from	   the	  Compounds	   database.	   After	   the	   docking	  was	   performed,	   the	  results	  was	  extracted	  from	  the	  log	  files	  and	  then	  input	  to	  the	  designated	  table	  in	  the	  
Results	  database	  specified	  in	  the	  User	  Input	  file.	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Figure	   7.2.	   Schematic	   of	   the	   vHTS	   system	   showing	   the	   program	   flow	  of	   the	   shell	  script	   based	   upon	   the	  User	   Input	   file.	   The	  MySQL	   databases	   are	   shown	   in	   yellow	  connected	  with	  the	  tables.	  In	  this	  example,	  the	  docking	  of	  compounds	  in	  the	  all_buy1	  table	   is	   performed	   on	   the	   active	   site	   of	   DHO-­‐bound	   subunit	   of	   DHOase	   using	   the	  Surflex	  program.	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Preparation	  of	  Protein	  Coordinates	  Target	  protein	  coordinates	  used	  for	  docking	  were	  taken	  from	  the	  1.9	  Å	  X-­‐ray	  structure	   of	  E. coli	   DHOase	   (PDB	   ID	   1XGE)	   in	   complex	   with	   substrate	   CA	   in	   one	  subunit	  and	  product	  DHO	  in	  the	  other	  subunit.27	  Since	  the	  surface	  of	  the	  active	  site	  was	   different	   between	   the	   two	   subunits	   due	   to	   the	   position	   of	   the	   100s	   loop	  (residue	  105-­‐115),	  the	  CA-­‐bound	  subunit	  was	  target	  for	  the	  screening	  of	  inhibitors	  against	  CA	  while	  the	  DHO-­‐bound	  subunit	  was	  target	  for	  the	  screening	  of	  inhibitors	  against	   DHO.	   	   Prior	   to	   the	   virtual	   screening	   the	   bound	   substrate	   CA	   and	   product	  DHO	  were	  removed	  from	  the	  active	  site. 
Docking	  and	  Scoring	  of	  Ligands	  Molecular	   docking	   has	   been	   widely	   used	   to	   computationally	   predict	   the	  binding	  mode	  of	  a	  small	  molecule	  (ligand)	  to	  a	  receptor	  (often	  protein).	  During	  the	  docking	  process	  a	  number	  of	  binding	  modes	  for	  each	   ligand	  are	  generated	  and	  for	  each	  binding	  mode	  a	   score	   is	   given	  based	  on	   the	   evaluation	  of	   the	   intermolecular	  interactions	  between	  the	  ligand	  and	  the	  protein	  receptor.	  	  The	  aim	  of	  the	  docking	  is	  to	  find	  the	  optimized	  docking	  conformation	  for	  each	  ligand	  to	  the	  receptor	  with	  the	  minimum	   free	   energy	   of	   binding.	   The	   differences	   among	   docking	   programs	   thus	  mainly	  reside	  in	  these	  two	  parts:	  the	  methods	  employed	  to	  search	  for	  the	  optimized	  binding	   mode	   and	   the	   scoring	   functions.	   Here	   in	   our	   study	   the	   four	   docking	  programs	  used	   for	   the	  virtual	   screening	  were	  AutoDock3.0,28	  DOCK5.0,29	   Surflex30	  and	  GOLD.31	  Xscore32	  was	  used	  as	  a	  score	  function	  for	  the	  docking	  results	  from	  the	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four	   docking	   programs	   with	   default	   parameters.	   The	   details	   about	   docking	   are	  described	  below.	  
AutoDock3.0	  	  AutoDock3.0	  uses	  a	  new	  hybrid	  genetic	  algorithm	  search	  method,	  referred	  as	  the	   Lamarckian	   genetic	   algorithm,	   in	   combination	  with	   an	   empirical	   binding	   free	  energy	   function	   to	   predict	   the	   binding	   mode	   of	   flexible	   ligands	   to	   non-­‐flexible	  macromolecular	   receptors.28	   Unlike	   most	   genetic	   algorithms	   that	   mimic	   the	  Darwinian	   evolution,	   the	   hybrid	   genetic	   algorithm	   employs	   a	   traditional	   genetic	  algorithm	  as	   global	   optimization	  with	   local	   search	   technique,	   and	   resembles	   Jean-­‐Baptiste	   Lamarck’s	   idea	   of	   evolution:	   phenotypic	   characteristics	   of	   an	   individual	  acquired	   during	   its	   lifetime	   that	   can	   be	   inherited	   by	   its	   offspring.	   The	   traditional	  genetic	  algorithm	  will	  be	  described	  in	  more	  detail	   in	  the	  section	  for	  GOLD.	  Here	  in	  AutoDock,	   the	   ligand’s	   state,	  which	   is	  used	   to	  describe	   the	   translation,	  orientation	  and	   conformation	   of	   the	   ligand	   to	   the	   protein,	   corresponds	   to	   the	   genotype.	   The	  ligand’s	   atomic	   coordinates	   and	   energy	   calculated	   from	   that	   represent	   the	  phenotype.	  In	  Lamarckian	  genetic	  algorithm,	  new	  genotype	  can	  be	  obtained	  from	  a	  phenotype	   found	  by	   local	  search	  whereas	   in	   the	   traditional	  genetic	  algorithm	  new	  genotype	  can	  only	  be	  obtained	  from	  another	  genotype.	  The	  scoring	  function	  used	  to	  evaluate	   the	   docking	   conformations	   in	   AutoDock3.0	   is	   improved	   from	   previous	  versions.	   Besides	   the	   typical	   molecular	   mechanics	   terms	   for	   Van	   der	   Waals	  potential,	  hydrogen	  bonding,	  and	  electrostatics,	  two	  new	  terms	  have	  been	  included:	  desolvation	   free	   energy	  of	   the	   ligand	   and	   restriction	  of	   conformational	   degrees	  of	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freedom	   of	   the	   ligand	   upon	   binding.	   The	   coefficients	   of	   all	   the	   terms	   in	   the	   free	  energy	  function	  are	  empirically	  derived	  using	  linear	  regression	  analysis	  from	  a	  set	  of	   30	   protein-­‐ligand	   complexes	  with	   known	   structures	   and	   binding	   constants.	   To	  calculate	   the	   free	   energy	   of	   binding,	   AutoDock	   requires	   potential	   grid	   maps	   pre-­‐calculated	   by	   AutoGrid,	   for	   each	   atom	   type	   of	   the	   ligands.	   A	   grid	   map	   is	   a	   cubic	  lattice	   composed	   of	   grid	   points	  with	   designated	   spacing.	   	   For	   each	   atom	   type	   the	  potential	  energy	  at	  each	  grid	  point	  is	  determined	  by	  the	  set	  of	  parameters	  used	  for	  that	  particular	  atom	  type.	  In	   our	   docking	   for	   DHOase,	   The	   grid	   box	  was	   set	   at	   40	   Å3	   centered	   at	   the	  middle	  of	  the	  active	  site	  with	  a	  grid	  spacing	  of	  0.275	  Å	  between	  grid	  points.	  For	  each	  ligand,	  25	  Lamarckian	  genetic	  algorithm	  runs	  were	  carried	  out	  with	  a	  maximum	  of	  500,000	  energy	  evaluations	  performed	  on	  a	  single	  population	  of	  50	  individuals.	  For	  the	  zinc	  atoms	  located	  in	  the	  active	  site	  of	  DHOase,	  atomic	  affinity	  grid	  maps	  were	  generated	  with	  equilibrium	  internuclear	  separation	  Rij	  and	  energy	  well	  depth	  εij	   at	  Rij	  set	  as	  1.95	  Å	  and	  0.25	  kcal/mol,	  respectively.	  Other	  parameters	  used	  for	  docking	  and	  scoring	  were	  standard.	  	  	  	  
DOCK5.0	  
 In	   DOCK5.0 the	   ligand	  was	   docked	   to	   the	   binding	   site	   of	   the	   protein	   via	   a	  geometric	  matching	  method.29	  In	  this	  method	  both	  ligand	  and	  protein	  are	  treated	  to	  be	  rigid.	  The	  solvent	  accessible	  protein	  surface	  area	  of	  binding	  site	  is	  calculated	  and	  spheres	  are	  created	  to	  fill	  the	  empty	  space	  complementary	  to	  this	  calculated	  binding	  surface.	  Prior	  to	  docking	  the	  energy	  grid	  (a	  cubic	  lattice	  covering	  the	  binding	  site)	  is	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calculated.	  Every	  point	  on	  the	  lattice	  is	  assigned	  a	  score	  on	  the	  basis	  of	  its	  contacts	  with	   protein	   atoms.	   The	   ligand	   atoms	   are	   then	   matched	   to	   sphere	   centers	   and	  scored	  against	  the	  energy	  grid	  by	  mapping	  onto	  the	  nearest	  points	  on	  the	  lattice.	  	  In	   our	   docking	   for	   DHOase,	   a	   maximum	   of	   1000	   orientations	   were	   cycled	  through	  the	  matching	  to	  the	  receptor	  spheres	  for	  each	  ligand.	  Once	  the	  largest	  rigid	  substructure	   of	   the	   ligand	   was	   fixed	   by	   matching	   to	   the	   receptor	   spheres,	   10	  conformations	   of	   the	   remaining	   portion	   of	   the	   ligand	   with	   altered	   torsion	   angles	  were	  tested	  and	  scored.	  The	  best-­‐scored	  conformation	  was	  carried	  to	  the	  next	  cycle.	  	  The	  search	  cycled	  until	  the	  top	  three	  solutions	  were	  within	  1.5	  Å	  rmsd	  of	  each	  other.	  Other	  parameters	  used	  for	  docking	  and	  scoring	  were	  standard.	  
Surflex	  	   Surflex	  operates	  by	  a	  surface	  shape-­‐based	  method,	  aligning	  each	  test	   ligand	  to	  the	  idealized	  binding	  site	   ligand	  (called	  a	  protomol)	  generated	  from	  the	  protein	  structure.30	   Each	   ligand	   being	   docked	   is	   first	   divided	   into	   1	   to	   10	   molecular	  fragments.	   Alignment	   of	   each	   conformation	   of	   each	   fragment	   is	   performed	   to	  identify	   the	   poses	   that	   have	   the	   most	   molecular	   similarity	   to	   the	   protomol.	   The	  aligned	  fragments	  are	  scored	  and	  the	  whole	  molecule	  approach	  is	  used	  to	  construct	  full	   molecules	   from	   the	   aligned	   fragments.	   The	   poses	   with	   best	   score	   are	   then	  output	   along	  with	   their	   scores.	   The	   function	   used	   to	   score	   the	   docking	   poses	   is	   a	  continuous	   differentiable	   function33	   which	   contains	   a	   hydrophobic	   term,	   polar	  terms	   (hydrogen	   bonding	   and	   electrostatics),	   entropic	   terms	   and	   solvation	   terms.	  
	   201	  
The	  coefficients	  of	  a	   linear	  combination	  of	  these	  terms	  are	  empirically	  determined	  by	  a	  set	  of	  34	  protein-­‐ligand	  complexes	  with	  known	  binding	  affinities.33	  	  	  	  	  	   In	   our	   docking	   for	   DHOase,	   because	   the	   active	   site	   volume	   of	   DHO-­‐bound	  subunit	  is	  larger	  than	  that	  of	  the	  CA-­‐bound	  subunit,	  “protomol”	  was	  generated	  using	  two	  different	  methods.	  The	  “protomol”	  for	  the	  screening	  of	   inhibitors	  against	  DHO	  was	   generated	   using	   the	   residue-­‐based	   method.	   The	   residues	   Tyr104,	   Pro105,	  Glu141,	   His139	   and	   Leu222	   in	   the	   active	   site	   of	   the	   DHO-­‐bound	   subunit	   were	  selected.	  The	   “protomol”	   for	   the	   screening	  of	   inhibitors	   against	  CA	  was	   generated	  using	  the	  ligand-­‐based	  method,	  where	  the	  crystal	  structure	  of	  CA	  bound	  in	  the	  active	  site	  was	  served	  as	  ligand.	  Standard	  parameters	  were	  used	  for	  docking	  and	  scoring.	  
GOLD	   	   GOLD,	  standing	  for	  “Genetic	  Optimisation	  for	  Ligand	  Docking”,	  uses	  a	  genetic	  algorithm	  method	   to	  search	   for	   the	  optimized	  binding	  mode	  of	   ligand	  and	  protein	  with	  the	  allowance	  of	  full	  range	  flexibility	  of	  ligand	  and	  limited	  protein	  flexibility	  in	  the	  binding	  site.31	  The	  search	  process	  employed	  genetic	  algorithm	  imitates	  natural	  evolution.	   This	   method	   starts	   with	   a	   randomly	   created	   population	   of	   solutions	  represented	  by	  chromosomes.	  Each	  chromosome	  codes	  for	  the	  values	  of	  a	  possible	  docking	   pose	   of	   ligand	  within	   the	   binding	   site	   of	   protein,	   such	   as	   the	   translation,	  orientation	   and	   conformation	   information	  of	   the	   ligand.	  A	   scoring	   function,	  which	  measures	   the	   energy	   of	   hydrogen	   bonding	   and	   the	   hydrophobic	   interactions	  involved	   in	   binding	   and	   the	   internal	   energy	   of	   the	   ligand,	   is	   used	   to	   evaluate	   the	  fitness	  of	  each	  docking	  solution.	  A	  new	  population	   is	   then	  created	   following	   these	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steps:	   parent	   chromosomes	   are	   selected	   based	   on	   the	   linear-­‐normalized	   fitness	  scores;	  genetic	  operators	  are	  applied	  to	   form	  child	  chromosomes,	   fitness	  scores	  of	  which	  are	  then	  calculated.	  If	  the	  solution	  is	  new	  to	  the	  population,	  then	  it	  replaces	  the	  least	  fit	  solution	  in	  the	  population.	  The	  search	  cycles	  until	  a	  designated	  number	  of	  operations	  are	  applied.	  The	  most	  important	  factor	  in	  generating	  the	  new	  solution	  is	   the	   genetic	   operator.	   In	   GOLD	   three	   genetic	   operators,	   crossover	   (or	  recombination),	   mutation	   and	   migration,	   are	   used.	   Crossover	   selects	   genes	   from	  parent	   chromosomes	   and	   recombines	   to	   form	   child	   chromosomes.	   Mutation	  changes	   any	   site	   on	   the	   chromosomes.	   Migration	   copies	   and	   moves	   individual	  chromosomes	  among	  the	  subpopulations.	  In	   our	   docking	   for	   DHOase,	   there	   were	   10	   independent	   genetic	   algorithm	  (GA)	   searches	   for	  each	   ligand.	  Algorithm	  performed	  on	  a	   single	  population	  of	  100	  solutions	   and	   terminated	   after	   the	   application	   of	   10,000	   genetic	   operations，	  outputting	   the	  docking	  poses	  with	  best	   fitness	  scores. Operator	  weights,	  based	  on	  which	   the	   operators	   were	   chosen,	   were	   set	   to	   100,	   100	   and	   0	   respectively	   for	  crossover,	  mutation	  and	  migration.	  The	  common	  metal	  ion	  coordination	  parameters	  have	  already	  been	  incorporated	  into	  the	  GOLD	  docking	  program.	  The	  coordination	  geometries	  of	  two	  zinc	  atoms	  in	  the	  active	  site	  of	  DHOase	  were	  set	  to	  4	  (tetrahedral)	  and	   5	   (trigonal	   bipyramidal)	   respectively	   according	   to	   their	   interactions	   found	   in	  the	   crystal	   structure	  of	  DHOase.27	  Other	  parameters	  used	   for	  docking	   and	   scoring	  were	  standard.	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Here, we present a study of the conformational changes of the quaternary
structure of Escherichia coli aspartate transcarbamoylase, as monitored by
time-resolved small-angle X-ray scattering, upon combining with sub-
strates, substrate analogs, and nucleotide effectors at temperatures between
5 and 22 °C, obviating the need for ethylene glycol. Time-resolved small-
angle X-ray scattering time courses tracking the T→R structural change
after mixing with substrates or substrate analogs appeared to be a single
phase under some conditions and biphasic under other conditions, which
we ascribe to multiple ligation states producing a time course composed of
multiple rates. Increasing the concentration of substrates up to a certain
point increased the T→R transition rate, with no further increase in rate
beyond that point. Most strikingly, after addition of N-phosphonacetyl-L-
aspartate to the enzyme, the transition rate was more than 1 order of
magnitude slower than with the natural substrates. These results on the
homotropic mechanism are consistent with a concerted transition between
structural and functional states of either low affinity, low activity or high
affinity, high activity for aspartate. Addition of ATP along with the
substrates increased the rate of the transition from the T to the R state and
also decreased the duration of the R-state steady-state phase. Addition of
CTP or the combination of CTP/UTP to the substrates significantly
decreased the rate of the T→R transition and caused a shift in the enzyme
population towards the T state even at saturating substrate concentrations.
These results on the heterotropic mechanism suggest a destabilization of the
T state by ATP and a destabilization of the R state by CTP and CTP/UTP,
consistent with the T and R state crystallographic structures of aspartate
transcarbamoylase in the presence of the heterotropic effectors.
© 2008 Elsevier Ltd. All rights reserved.
Edited by R. Huber
Keywords: cooperativity; quaternary structure; allosteric transition; small-
angle X-ray scattering
Introduction
Aspartate transcarbamoylase (E.C.2.1.3.2, ATCase)
catalyzes one of the first steps in pyrimidine nucleo-
tide biosynthesis, the reaction of carbamoyl phos-
phate (CP), with L-aspartate (Asp) to form N-
carbamoyl-L-aspartate and inorganic phosphate
(Pi).
1 In many prokaryotes such as Escherichia coli,
this reaction is the committed step in pyrimidine
nucleotide biosynthesis. E. coli ATCase is composed
of two types of subunits. The two larger or catalytic
subunits are each composed of three identical poly-
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peptide chains (Mr=34,000), while the three smaller
or regulatory subunits are each composed of two
identical polypeptide chains (Mr=17,000). Each of
the six active sites is located at the interface between
two adjacent catalytic chains, and side chains re-
quired for catalysis are recruited to the active site
from both chains.2 The enzyme demonstrates homo-
tropic cooperativity for the substrate Asp and is
heterotropically regulated by the effectorsATP, CTP,3
and UTP in the presence of CTP.4
The structures of the low-activity T state (in the
absence of substrates)5,6 and high-activity R state [in
the presence of substrates or substrate analogs such
as N-phosphonacetyl-L-aspartate (PALA)]7–9 have
been determined by X-ray crystallography. A
comparison of the T and R structures reveals that
during the T→R transition, the two catalytic trimers
increase their separation along the 3-fold axis by
about 11 Å and rotate about 5° around the same axis,
while the regulatory dimers rotate about 15° around
their respective 2-fold axes.10 The 11-Å expansion of
the enzyme observed during the T→R transition is
easily monitored by small-angle X-ray scattering
(SAXS).11 Thus, the SAXS pattern is a sensitive and
specific probe to study the quaternary conforma-
tional changes of the enzyme.
By using SAXS as a structural probe in stopped-
flow experiments, the time evolution of the qua-
ternary conformational changes of ATCase has been
monitored.12,13 These studies showed that the
enzyme when mixed with substrates is very quickly
converted from the T to the R state, the enzyme
remains in the R state until substrates are exhausted,
and then the enzyme reverts to the T state. These
early studies required integration of the signal over
time intervals of 100–200 ms and averaging over
many runs to improve the signal-to-noise ratio.12,13
Because of the relatively long time window for each
point, it was necessary to slow the reaction rate,
which was done by performing the reaction at −5 °C
in a buffer containing 20% ethylene glycol.
Dreyfus et al. showed that a variety of alcohols
such as methanol, ethanol, 1-propanol, 2-propanol,
1-butanol, and 2-methyl-2-propanol have a signifi-
cant influence on the activity and homotropic coope-
rativity of ATCase.14 For example, 20% methanol or
ethanol reduced the activity of ATCase by approxi-
mately 90%. Additional studies with 15% ethanol
showed a shift in the pH optimum of the reaction
and an alteration in the Hill coefficient. Their inter-
pretation of these solvent effects was that the
cosolvent preferentially stabilized the T or R state
of the enzyme depending upon the relative concen-
tration and polarity of the cosolvent. For the simple
alcohols, the primary effect was stabilization of the T
state. Although ethylene glycol was not investigated
by Dreyfus et al., one would predict that ethylene
glycol with its two hydroxyl groups would behave
similarly to methanol and ethanol.14
Here, we reinvestigate the time evolution of the
quaternary conformational changes of ATCase in the
absence of ethylene glycol. This was made possible
by significant instrumental developments including
a fast CCD X-ray detector and a high-flux X-ray
beam via a multilayer monochromator,15 with an
increase in beam brightness due to the update of the
synchrotron storage ring at Stanford Synchrotron
Radiation Laboratory (SSRL) to SPEAR3, a third-
generation source. These improvements allowed the
collection of time-resolved SAXS (TR-SAXS) data at
a time resolution as short as 5 ms. Using this system,
we were able to study the quaternary conforma-
tional changes of ATCase in the temperature range
of 5–22 °C in the absence of ethylene glycol.
Results
Kinetics of the ATCase reaction in the presence
of ethylene glycol
Since previous TR-SAXS experiments were per-
formed in the presence of 20% ethylene glycol,12,13
and Dreyfus et al. showed that a variety of alcohols
at concentrations of 20% or less can dramatically
alter the catalytic turnover rate and cooperativity of
Fig. 1. (a) The dependence of activity of ATCase on the
concentration of ethylene glycol. All measurements were
made at 5 °C in the presence of 50 mMTris and 2mMDTT,
pH8.3. (b) Influence of the nucleotide effectors ATP and
CTP on the activity of ATCase in the presence and absence
of 20% ethylene glycol. Colorimetric assays were per-
formed at 5 °C in 50 mM Tris acetate buffer (pH8.3) at a
subsaturating concentration of L-Asp (2.4 mM) and
saturating CP concentration (4.8 mM), in the presence of
ATP and 20% ethylene glycol (v/v) (○), in the presence of
ATP and in the absence of ethylene glycol (●), in the
presence of CTP and 20% ethylene glycol (v/v) (□), and in
the presence of CTP and in the absence of ethylene glycol
(v/v) (▪).
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ATCase,14 kinetic assays were performed in the
presence of ethylene glycol to determine if it had
any influence on the ATCase reaction. As shown in
Fig. 1a, ethylene glycol dramatically reduced the
activity of ATCase at 5 °C. In the presence of 20%
ethylene glycol, the activity of the enzyme was re-
duced by 75%. In addition to reducing the activity
of the enzyme, ethylene glycol had a small influence
on homotropic cooperativity (data not shown).
Ethylene glycol also has a significant influence on
the ability of the heterotropic effectors to modulate
enzyme activity. As shown in Fig. 1b at 5 °C, the
presence of 20% ethylene glycol increased the acti-
vation of the enzyme by ATP while reducing the
inhibition by CTP. The maximal activation by ATP
increased from 220% to 274% in the presence of 20%
ethylene glycol. The residual activity at a saturating
concentration of CTPwas 29% as compared to 48% in
the presence of ethylene glycol. The value of KATP (K
is the nucleotide concentration required at 50%
maximal activation or inhibition of the enzyme)
increased from0.47 to 0.72mM in the presence of 20%
ethylene glycol. The value of KCTP increased from 7.8
to 14.5 μM in the presence of 20% ethylene glycol.
The ability of UTP to act as a synergistic inhibitor
of ATCase in the presence of CTP4 was also tested at
5 °C in the absence and presence of 20% ethylene
glycol. In the absence of ethylene glycol, the
combination of 4 mM CTP and 4 mM UTP (CTP/
UTP) yielded a residual activity of the enzyme of
22%, whereas in the presence of ethylene glycol, the
combination of CTP/UTP yielded a residual activity
of the enzyme of 28%.
Kinetics of the ATCase reaction at 5 °C
Because the TR-SAXS experiments reported here
were performed at temperatures as low as 5 °C, the
kinetic properties of ATCase were fully character-
ized at 5 °C in the same buffers used for the TR-
SAXS experiments (Fig. 2). As shown in Table 1,
many aspects of catalysis at 25 °C are not only
quantitatively different at 5 °C but also, in some
cases, qualitatively different. As would be expected,
the maximal observed velocity was reduced by
nearly 5-fold. This reduction in velocity was
accompanied by an almost 3-fold decrease in the
concentration of Asp required for half-maximal
activity ([Asp]0.5) and a decease in the Hill coeffi-
cient (nH) from 2.6 to 2.0. The observed changes in
[Asp]0.5 and nH are similar to the changes observed
when Asp saturating curves are determined in the
presence of ATP, suggesting that, similar to ATP,
lower temperatures shift the equilibrium towards
the R state. This phenomenon was demonstrated in
a previous SAXS study by the shift in the structural
equilibriumof themutantD236Aenzyme in thedirec-
tion of the R state with decreasing temperature.16 At
5 °C, the [Asp]0.5 decreased nearly 2-fold in the
presence of ATP, increased 20% in the presence of
UTP, increased more than 2-fold in the presence of
CTP, and increased by a factor of 2.5 in the presence
of CTP/UTP. A similar trend was also observed at
25 °C. The [Asp]0.5 decreased more than 2-fold in
the presence of ATP, increased 10% in the presence
of UTP, increased nearly 2-fold in the presence of
Fig. 2. L-Asp saturation kinetics in the absence and
presence of the nucleotide effectors at (a) 5 °C and (b)
25 °C. Reactions were carried out in 50 mM Tris buffer,
pH8.3. The kinetic curves were determined in the pre-
sence of 5 mM ATP (▵), 4 mM CTP (□), 4 mM UTP (▪),and 4 mM CTP and 4 mM UTP (▴) as compared to the
saturation kinetics in the absence of nucleotide (●).
Specific activity is reported in units of millimoles of CA
formed per milligram per hour.












No NTPs 19.1±0.3 12.7 2.6±0.2 4.2±0.5 5.1 2.0±0.1
5 mM ATP 19.8±0.7 6.1 1.4±0.1 5.4±0.2 2.9 1.6±0.2
4 mM CTP 17.9±0.9 21.2 2.4±0.1 3.6±0.2 11.3 3.0±0.1
4 mM UTP 18.4±0.2 13.5 2.3±0.1 4.1±0.6 5.9 2.2±0.1
4 mM CTP/UTP 17.3±0.4 28.6 2.9±0.1 3.0±0.4 12.5 3.0±0.1
a All experiments were performed in 50 mM Tris–acetate buffer (pH8.3) at a saturating CP concentration (4.8 mM).
b The maximal observed velocity (in millimoles per hour per milligram).
c The observed concentration of L-Asp (in millimolar) that produces one-half the observed maximal velocity.
d Hill coefficient.
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CTP, and increased by 2.3-fold in the presence of
CTP/UTP.
The kinetic data at 5 °C were plotted as v/Vmax
versus [Asp] as shown in Fig. 3 and fitted by the
theoretical curve of YAsp (fraction of active sites occu-
pied by Asp) versus αKR(Asp), which is derived from
the equations of the theoretical two-state allosteric
transition model proposed by Monod et al.17,18
YAsp ¼
a 1þ að Þn1þLVacAsp 1þ acAsp
 n1
1þ að ÞnþLV 1þ acAsp
 n
where α=[Asp]/KR(Asp), L′ is the allosteric equili-
brium constant in the presence of saturating CP, and
cAsp=KR(Asp)/KT(Asp). KT(Asp) and KR(Asp) are the
dissociation constants of Asp for the Tand R allosteric
states, respectively. A value of L′=10 was obtained
from the static SAXSdata shown in Fig. 4, according to
the methods of Tsuruta et al.13 The starting point used
for KR(Asp) was the [Asp]0.5=5.1 mM value obtained
from the kinetic data. After obtaining a suitable fit
for the data, the values of KR(Asp)=3.5±0.5 mM and
KT(Asp)=40±10 mM were derived.
Time-resolved X-ray scattering: Effect of
substrates and substrate analogs
TR-SAXS was used to monitor the quaternary con-
formational changes that ATCase undergoes when
the enzyme is mixed with substrates. Using the high
beam flux obtained by the multilayer monochroma-
tor and fast CCD detector at SSRL, practical time
resolution of the TR-SAXS data collection was
improved from 100–200 ms19 to as low as 5 ms in a
single mixing event. However, the rate constants for
the T→R transition presented here were obtained
from the 19-ms collection rate data, because at this
rate, the signal-to-noise ratio was significantly better
and fast enough to recordmuch of the transition. This
improvement in detection allowed reactions to be
monitored in the temperature range between 5 and
22 °C, rather than at −5 °C as previously reported.19
Shown in Fig. 5a are a series of SAXS patterns
recorded upon mixing 1.5 mM ATCase (in active
sites) plus 50 mM CP in one syringe with 100 mM
Fig. 3. L-Asp saturation kinetics at 5 °C fitted by a
theoretical curve calculated from a modified Monod et al.
equation and using parameters listed in the text. Reactions
were carried out in 50 mM Tris buffer, pH8.3.
Fig. 4. Steady-state SAXS patterns of ATCase without
ligands (○), with 50 mM CP (●), and with 5 mM PALA
(□). The allosteric equilibrium constant was calculated
from these curves as L′=10.
Fig. 5. (a) A time series of SAXS patterns of 0.75 mM
ATCase (in active sites) mixed with 50 mM substrates (CP
and L-Asp) and 50 mM CP plus 50 mM D-Asp as a T-state
control, at 5 °C. The SAXS patterns of the enzyme with the
substrates are shown for 38 ms (○), 380 ms (□), and
3800 ms (●) after mixing. The SAXS pattern of the enzyme
with CP and D-asp is shown for 3800 ms (△, short dashed
curve) after mixing. The long dashed curve (▪) iscalculated for an L=0.5, from the sum of 0.33×(T-state
curve) and 0.67×(R-state curve). (b) Time courses of the
quaternary structure change after mixing with substrates
(continuous line) and 50mMCPplus 50mMD-Asp (broken
line), as monitored by the scattering intensity integrated
over the s-range 0.01–0.02 Å−1. Inset: First 300 ms of the
structural change after mixing with substrates shown
along with the curve fit (two-exponential) to the data.
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Asp plus 50 mM CP in the second syringe at 5 °C.
Immediately after mixing, the enzyme concentration
was 0.75 mM in active sites (37.5 mg/ml), while the
CP and Asp concentrations were each 50 mM. The
SAXS patterns shown in Fig. 5a are at 38, 380, and
3800 ms. The scattering pattern at 38 ms does not
correspond to either the T or R states as the enzyme
population is in the process of undergoing the
quaternary conformational change. The pattern at
380 ms is essentially identical with the curve of the
enzyme in the presence of PALA (R state), while the
curve at 3800 ms is essentially the same as that
observed in the presence of D-Asp and CP (T state).
To determine if the curve at 38 ms corresponded to
the formation of a transient intermediate on the
pathway between the T and R states, we generated a
curve from a sum of fractions of the T-state (33%) and
R-state (67%) curves corresponding to a value of
L=0.5.13 This generated curve is a near match to the
X-ray scattering curve recorded at t=38 ms after
mixing the enzyme with substrates.
The area under the curves between s=0.01 Å−1
and s=0.02 Å−1 was integrated and plotted as a
function of time in order to help visualize the time
course of structural change. This integration con-
verts observed scattering intensity to relative con-
centration of the enzyme species on the basis that
solution scattering intensity reflects relative concen-
tration of each species linearly, in the absence of
oligomeric state changes. Figure 5b shows the time-
dependent change in the integrated intensity of the
SAXS pattern for this experiment. At t≅5–10 ms
(t=0 as shown on the plot; the dead time of the
stopped-flow mixer is approximately 5–10 ms), the
enzyme population is nearly an equal mixture of T
and R state molecules. Between t=100 ms and
t=1500 ms, 95% of the enzyme population is in the R
state as the enzyme catalyzes the reaction converting
Asp and CP into carbamoyl aspartate (CA) and Pi.
After t=1500 ms, the enzyme population returns to
the T state as the substrates are depleted, and after
3000 ms, virtually the entire enzyme population is
back in the T state. At 5 °C, the turnover rate at
maximal velocity of the holoenzyme is 350±40 s−1.
At a substrate concentration of 50 mM and an active-
site concentration of 0.75 mM, the substrate:holoen-
zyme ratio is 400; hence, it should take 1–1.3 s to
consume the substrate. The R-state plateau, defined
here as the region of N95% of the peak amplitude of
the integrated scattering curve, has a total duration
of 1.4 s, which demonstrates that enzyme quickly
reverts to the T state after depleting the substrates.
When ATCase is mixed with D-Asp and CP (final
concentrations, 0.75 mM active sites; [D-Asp]=[CP]=
50 mM), the TR-SAXS curve showed virtually no
change (see Figs. 5 and 6). The use of D-Asp thus
provides a control for the L-Asp experiments with a
compound with equal scattering potential or elec-
tron density and as a control for the T-state
scattering curve as previously described.19 The
integrated intensity at the end of the experiment
when L-Asp and CP are mixed was practically
identical with that observed when D-Asp and CP are
mixed with enzyme. Because the TR-SAXS curve
returns to the level observed in the presence of D-
Asp and CP, it is clear that virtually the entire
enzyme population has reverted to the T state after
the substrates have been depleted.
The initial time course of the structural change
after combining the enzyme with substrates or
substrate analogs appeared to fit to either a single
or double exponential depending upon the experi-
mental conditions. Therefore, each set of data was fit
to both exponential fits and the number of rate
constants [represented as kT→R(1) for the first or fast
Fig. 6. Time course of the quaternary structure change
of 0.75 mM ATCase (in active sites) as monitored by the
scattering intensity integrated over the s-range 0.01–
0.02 Å−1. The final substrate or substrate analog con-
centrations after mixing were [CP]=[L-Asp]=50 mM (○),
[CP]=50 mM and [PALA]=5 mM (●), and [CP]=[D-Asp]
=50 mM (□). Data displayed are from a 36-ms collection
rate. Inset: First 1000 ms of the structural change after
mixing with substrates or substrate analogs. Data dis-
played are from a 19-ms collection rate.
Table 2. Kinetic parameters for the T-to-R allosteric








25 mM substratesd 18.3±0.6
50 mM substrates 51±4 7.6±1
100 mM substrates 51±5 6.3±0.9
50 mM substrates+5 mM ATP 89±20 7.9±1
50 mM substrates+4 mM UTP 52±8 14.8±1.8
50 mM substrates+4 mM CTP 12±0.3
50 mM substrates+4 mM CTP 10.3±0.3
+4 mM UTP
50 mM succinate+50 mM CP 38±1
5 mM PALA+50 mM CP 1.53±0.19 0.31±0.05
a These experiments were performed in 50 mM Tris–acetate
buffer (pH8.3), with a final enzyme concentration of 37.5 mg/ml
after mixing, equal concentrations of substrates ([L-Asp]=[CP])
unless otherwise stated, and data points recorded at 19-ms
intervals.
b Rate constant of fast phase or first phase of two-exponential
fit.
c Rate constant of slow phase or second phase of two-
exponential fit, where applicable.
d Final enzyme concentration used was 18.75 mg/ml, because
at this low substrate concentration (and a relatively high enzyme
concentration), the substrates were exhausted before the enzyme
fully attained the R state.
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phase and kT→R(2) for the second or slow phase,
where applicable] reported reflects which fit was
superior. As demonstrated by the rate constant data
for the quaternary structural change in Table 2,
increasing the substrate concentration from 25 to
50 mM and doubling the enzyme concentration
increased the rate of the fast phase of the transition
from 18.3 to 51 s−1. In this experiment, it was
necessary to use a lower enzyme concentration at
the lower substrate concentration in order to
observe the full T-to-R conversion of the enzyme
population before significant depletion of the sub-
strates. Lowering the enzyme concentration by one-
half, to 18 mg/ml, and half again, to 9 mg/ml, while
keeping the substrate concentration at 50 mM, did
not change the rate of the fast or slow phase, within
error, of the T→R transition (data not shown).
Therefore, an enzyme concentration of 37.5 mg/ml
was used for all experiments, with the previous
exception, for a superior signal-to-noise ratio for the
scattering data. Increasing the substrate concentra-
tion further to 100 mM while maintaining the same
enzyme concentration (37.5 mg/ml) did not change
the rate of transition for the fast or slow phases, as
might be expected since this concentration was
much higher than the [Asp]0.5 value of 5.1 mM.
In order to establish the value for the integrated
intensity and scattering pattern of the R-state struc-
ture of ATCase in a TR-SAXS experiment, we mixed
PALA with enzyme and CP (final concentrations,
0.75 mM active sites, 5 mM PALA, 50 mM CP). As
seen in Fig. 6, the integrated intensity observed
immediately after mixing was shifted towards the
R-state value. The rate constants for the fast and slow
phases aftermixingwith PALAwere bothmore than 1
order of magnitude slower than the corresponding
T→R transition rate constants observed in the pre-
sence of a saturating concentration of the natural
substrates, L-Asp and CP. The single fast phase rate
constant for the structural change with 50 mM
succinate and 50 mM CP was 38 s−1, similar to the
rate of the fast phase with the natural substrates at a
saturating concentration.
Effect of nucleotides
The time course of the quaternary structural
change in the presence of ATP is shown in Fig. 7
and is similar to that observed in the absence of
nucleotides. However, in the presence of ATP, the
duration that the enzyme remains in the R-state
plateau is shorter than that in the absence of
nucleotides and the kT→R(1) increased from 51 to
89 s−1. The time course of the structural change for
ATCase in the presence of the nucleotide inhibitors is
shown in Fig. 8. The rate of T→R transition in the
presence of CTP and CTP/UTP decreased signifi-
cantly to 12 and 10.3 s−1, respectively. The inte-
grated scattering intensity of the R-state plateau in
the presence of CTP and CTP/UTP is lower than
that observed in the absence of nucleotides, and the
duration of the plateau in the presence of CTP and
CTP/UTP is much shorter than that in the absence
of nucleotides.
The results with UTP alone were unexpected. The
rate of the fast phase of the T→R transition in the
presence of UTP was identical with that in the
absence of nucleotides. The integrated scattering
intensity of the R-state plateau in the presence of
UTP is also the same as that in the absence of
nucleotides. However, the duration of the R-state
plateau phase in the presence of UTP is only half of
that observed in the absence of nucleotides, suggest-
ing a slight destabilization of the R state by UTP.
Determination of the activation energy of
ATCase
The kinetics of the quaternary structural change
was observed at a series of temperatures between 5
and 22 °C in order to calculate the activation energy
Fig. 7. Time evolution of the quaternary structure
change of 0.75 mM ATCase (in active sites) as monitored
by the scattering intensity integrated over the s-range
0.01–0.02 Å−1 after mixing with 50 mM substrates (Asp
and CP) and without nucleotides (○) and with [ATP]=
5 mM (●). Inset: First 300 ms of the structural change after
mixing with substrates shown along with the curve fits
(two-exponential) to the data.
Fig. 8. Time evolution of the quaternary structure
change of 0.75 mM ATCase (in active sites) as monitored
by the scattering intensity integrated over the s-range
0.01–0.02 Å− 1 after mixing with 50 mM substrates
(Asp and CP) and without nucleotides (○), with [CTP]=
4 mM (◊), with [UTP]=4 mM (□, dashed curve), and with
[CTP]= [UTP]=4 mM (▪, dashed curve). Inset: First500 ms of the structural change shown after mixing with
substrates along with the curve fits to the following data:
without nucleotides (○, two-exponential) and with CTP
and UTP (▪, one-exponential).
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of the quaternary conformational changes of ATCase
both from the T to the R state and from the R to the T
state. Unfortunately, above 10 °C, the T→R transi-
tion rate is so fast that our instrumentation was
unable to follow it. However, the rate constants for
the R0→T0 (unliganded states) transition after the
substrates were exhausted were obtained by fitting
the lower half of the return phase to a single
exponential fit. The rate constants for the R0→T0
transition (kR→T) at 5, 10, 16, and 22 °C were
2.08±0.03, 3.7±0.1, 5.1±0.1, and 8.3±0.1 s−1, respec-
tively. An Arrhenius plot of these data is shown in
Fig. 9, which yielded an activation energy for the
R0→T0 transition of 13.0±1.4 kcal/mol.
Discussion
TR-SAXS experiments investigating the time
evolution of the quaternary structural change of
ATCase induced by the binding of the natural
substrates CP and L-Asp were performed here in
the absence of ethylene glycol. In previous studies,19
20% ethylene glycol was added to all solutions to
allow the experiment to be performed at −5 °C.
Here, we demonstrate that ethylene glycol drama-
tically alters the homotropic and heterotropic
kinetics of the enzyme, as is the case with many
other alcohols.14 Therefore, these new studies were
important not only in monitoring the quaternary
structural change at temperatures closer to physiolo-
gical but also because ethylene glycol was elimi-
nated from the reaction.
In order to better correlate the time-resolved
structural results reported here at 5 °C to the
functional characteristics of ATCase at this tempera-
ture, we performed a complete kinetic characteriza-
tion of the enzyme at 5 °C. As would be expected,
the maximal velocity of the enzyme at 5 °C in the
absence and presence of the nucleotide effectors was
reduced nearly fivefold as compared to the maximal
velocity at 25 °C. The [Asp]0.5 at 5 °C in the absence
of nucleotides was also reduced nearly threefold,
with a concomitant reduction in the cooperativity
for Asp (see Table 1). Similarly, in the presence of
nucleotides at 5 °C, the [Asp]0.5 was reduced but
with no change in cooperativity, except when CTP
was present, where the cooperativity increased. The
results of these kinetic experiments suggest that the
structural results obtained from the TR-SAXS
experiments performed at 5 °C should strongly
correlate with the structure and function of the
enzyme at higher temperatures.
In agreementwith previous results,19 whenATCase
is mixed with its natural substrates, CP and L-Asp,
there is a rapid structural transition of the enzyme
from the T to the R state. The preponderance of the
enzyme population remains in the R state as the
enzyme reacts with the substrates and then reverts
to the T state when the substrates are exhausted (see
Fig. 5b). This clearly demonstrates that the allosteric
transition is not the rate-limiting step in catalysis, as
has been previously suggested.20 Therefore, under
conditions of saturating substrates, the enzyme
remains in the R-quaternary structure until the
substrates are essentially exhausted and then reverts
to the T-quaternary structure.
As shown in the inset to Fig. 5b, the T→R struc-
tural transition upon addition of the natural sub-
strates to the enzyme appears to be a biphasic
exponential process, with a fast and slow phase. In
this particular case, the fast phase accounts for
approximately 75% of the total amplitude of the
curve, representing the change in integrated inten-
sity between the mixture of T and R states at the first
recorded time point and R state at the curve plateau.
Considering the evidence against the formation of a
structural intermediate as demonstrated in Fig. 5a,
along with the structural transition being a single-
phase exponential process in the presence of
allosteric inhibitors, as shown in Fig. 8, we deter-
mined that the curve monitoring the structural
change may represent a composite of T-state species
with different ligation states, each with its own
particular rate of transition to the R state, as has been
previously suggested in studies of the rate of the
structural change in ATCase.13,21 In the case of the
allosteric protein hemoglobin, it is well documented
that not only different ligation states but also
configurational isomers, or asymmetric ligation
states, exhibit a wide range of structural transition
rates that originate from different activation ener-
gies for the structural change.22,23 When all the CP
binding sites of T-state ATCase are saturated, as they
are under our experimental conditions, there are 13
possible species or ligation states with aspartate
bound in the six binding sites when taking into
account the T-state interactions between the C1 and
C4 chains on opposing catalytic trimers. Therefore,
the two rates we observe are the composites of up to
13 or more individual rates for the T→R transition
when accounting for these configurational isomers.
The observed rate of the T→R transition increases
about threefold when doubling the aspartate con-
centration from 25 mM, a concentration well in ex-
Fig. 9. Arrhenius plot of the temperature dependence
of the R→T transition. The rate constants for the R-to-T
transition (kR→T) at 5, 10, 16, and 22 °C were 2.08±0.03,
3.7±0.1, 5.1±0.1, and 8.3±0.1 s−1, respectively.
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cess of the KR(Asp) value of 3.5±0.5 mM, to 50 mM,
while also doubling the enzyme concentration.
Therefore, we are confident that the structural
transition is triggered by aspartate binding to the T
state and is not a simple shift in the preexisting
equilibrium between the T and R states towards the
R state caused by aspartate binding only to that state
and “locking” it into that state. If the structural
transition were simply a population shift to the R
state, then the rate would not change or change very
little when the aspartate concentration is increased
from 25 to 50 mM as both concentrations are well in
excess of KR(Asp). This can be accounted for using a
kinetic version of the two-state model, which would
suggest 14 individual rates for the allosteric transi-
tion, defining the T-to-R equilibrium constants at
the 7 ligation states.24 In order to approximate the
average number of aspartate molecules bound to
the T state during the structural transition, we used
the equation derived for the two-state allosteric
model of Monod et al., simplified by assuming a
saturating concentration of CP in the manner
previously described to fit our aspartate saturation
data at 5 °C.17,18 After obtaining a reasonable fit of
the data and extracting the appropriate parameters,
we obtained a KT(Asp) value of 40±10 mM. With an
active-site concentration of 0.75 mM and an aspar-
tate concentration of 25 mM, an average of 33–46%
of the active sites are ligated with aspartate (2–2.5
per holoenzyme). Similarly, at an aspartate concen-
tration of 50 mM, an average of 50–67% of the active
sites are ligated with aspartate (3–4 per holoen-
zyme), and at an aspartate concentration of 100 mM,
an average of 67–77% of the active sites are ligated
with aspartate (4–4.6 per holoenzyme). These
observations compare favorably with the previous
SAXS studies of Fetler et al. that show that two
PALA molecules per ATCase holoenzyme molecule
are necessary to shift the T-to-R equilibrium in favor
of the R state and that four PALA molecules are
necessary to shift the entire enzyme population to
the R state.25 Macol et al. demonstrated that the
binding of one PALA molecule could shift the entire
holoenzyme population to the R state; however, the
holoenzyme was composed of five chains with the
R105A mutation.26 In either case, the enzyme clearly
does not need to be saturated with substrate analogs
or presumably substrates, in order to shift the
equilibrium towards the R state. Our findings
suggest that the faster observed rate is the composite
of rates of the structural transition for the highly
liganded species, with three or more active sites
filled. Likewise, the slower observed rate may be the
composite of structural transition rates of the least
liganded species, with two or fewer active sites
filled. At an aspartate concentration of 25 mM, we
observe only one exponential fit to the data, which,
according to our model, would be the composites of
rates of the least liganded species along with the
rates of the highly liganded species containing three
or more aspartate present as a small fraction of the
mixed population. Increasing the aspartate concen-
tration from 50 to 100 mM yielded identical rates for
both observed phases, suggesting that once three or
more aspartate molecules are bound to the holoen-
zyme, the rate for the structural transition is near a
maximum, or that highly liganded T-state molecules
bound with four or more aspartate are present as
only a small fraction of the population even at high
aspartate concentrations. Further evidence for this
model is provided by comparison of the ratio of the
fast-phase amplitude to the slow-phase amplitude at
50 mM aspartate and 100 mM aspartate concentra-
tions; at the higher aspartate concentration, the ratio
is higher, suggesting a shift in population towards
the highly liganded molecules.
There are some substantial qualitative differences
between these TR-SAXS results and the data
obtained previously in the presence of ethylene
glycol,19 such as the time course of the TR-SAXS
pattern of the enzyme in the presence of ATP, shown
in Fig. 7. We observed that the R-state plateau region
in the presence of ATP, during which most of the
substrates are being converted to products, is
shorter than that in the absence of ATP. This was
not unexpected since ATP, an activator of the en-
zyme, at 5 °C increased the Vmax value from 4.2 to
5.4 mmol h−1 mg−1 (Table 1) as well as the apparent
binding affinity of L-Asp, as the [Asp]0.5 value de-
creased from 5.1 to 2.9 mM. However, in the
presence of 20% ethylene glycol, a longer R-state
plateau was observed in the presence of ATP than
in its absence.19 To explain this, it was proposed that
ATP, in addition to being an activator, may possibly
become an inhibitor by “increasing the chance of
making L-Asp bind to the active site before Pi
leaves and locking the active site into an unproduc-
tive cycle with no alteration of the quaternary
structure”.19 In that experiment, the activity of the
enzyme was dramatically reduced not only by the
presence of 20% ethylene glycol, which, as demon-
strated in Fig. 1a, reduces the activity by 75%, but
also by performing the TR-SAXS at −5 °C. The
similar phenomenon of “substrate inhibition” has
been observed for the isolated catalytic subunit and
for the incomplete complexes C6R4 and C3R6, as well
as for the holoenzyme C6R6,
27–29 where a high
aspartate concentration ostensibly acts as an inhi-
bitor by binding to the CP binding site.
As detailed in Table 2, ATP increased the rate of
the T→R transition, specifically the rate of the fast
phase, by approximately 75%. It should be noted
that in the presence of ATP, the allosteric transition is
so rapid that with the current instrumentation, the
experimental error is somewhat large. As discussed
previously, saturating the enzyme with aspartate
beyond a concentration of 50 mM did not increase
the rate of the structural transition. Therefore, one
possible interpretation is that ATP increases the on
rate of aspartate to the T state,20 suggesting that
aspartate binding is a rate-limiting step in the
allosteric transition. However, a more elegant expla-
nation, which is in accord with the data from the
inhibitors CTP and CTP/UTP and numerous studies
on the effects of the heterotropic nucleotides,30–32
can be derived using some aspects of the two-state
213Quaternary Change of E. coli ATCase
model of Monod et al.17,18 At pH7.0, Howlett et al.
observed that ATP increases the stability of the R
state relative to the T state by 0.8 kcal and reduces
the T-to-R equilibrium constant from 250 to 7 in the
absence of substrates.17,31 The R-to-T transition rate
with ATP was reduced by only approximately 15%
(Fig. 7), suggesting a slight stabilization of the R
state; therefore, the large increase in the T→R rate
would suggest a significant T state destabilization
by ATP. Here, the two-state model suggests that ATP
binds more tightly to the R state and therefore shifts
the structural equilibrium in favor of the R state.17,31
However, our observation of a possibly different
mechanism for ATP was suggested by the crystal
structures of the T and R states of the enzyme in the
presence of ATP; the T-state structure showed a
slight shift towards the R state with ATP present,5
whereas, globally, the R-state structure was un-
changed in the presence of ATP.33 It should be noted
that under these conditions with ATP, the Vmax did
increase even though the structural state at saturat-
ing substrate levels appears to be the same R state as
that with no ATP present, with the caveat that the
Vmax value is difficult to obtain precisely from
steady-state kinetics curves that exhibit substrate
inhibition. This suggests that the previously
observed increase in the Asp to CA exchange rate
with ATP may influence the catalytic mechanism to
a modest degree.20 However, our time-resolved
structural study indicates that perturbation of the
T-to-R equilibrium specifically via T-state destabili-
zation may be the most significant mechanism of
ATP activation of ATCase.
The time courses of the quaternary structural
change in the presence of CTP or CTP/UTP are
similar in the presence and absence of ethylene
glycol (see Fig. 8). For both cases, in the presence of
CTP or CTP/UTP, the duration of the R-state-shifted
plateau is shorter and the integrated intensity of the
plateau is lower than that in the absence of
nucleotides, and the observed return to the T-state
quaternary structure is a slow exponential decline as
the remaining substrates are consumed as the
enzyme population shifts towards the T state. The
integrated intensity of the peak with CTP present
and with CTP/UTP present was approximately 80%
and 75%, respectively, of that when no nucleotides
were present, indicative that the percentage of high-
activity R-state molecules at a saturating substrate
concentration was reduced to a similar value. This is
in excellent agreement with the enzymatic kinetic
data, in which the Vmax was, within error, reduced
by the same amount as the integrated scattering
peak in the presence of CTP and CTP/UTP as com-
pared to when no nucleotides were present. These
allosteric inhibitors also reduced the rate of the
structural transition by more than fourfold. Similar
to the condition when no nucleotides were present
and the substrate concentration was 25 mM, the
initial time course of the structural change fits to a
single exponential. This suggests that the least
liganded species have a rate that is so reduced that
we do not observe them before the shortened pla-
teau starts its reversion towards the T state or that
the R→T rate for these species is nearly equal to the
T→R transition rate. As with the case of ATP, our
experimental observations are not in complete
agreement with some of the tenets of the two-state
model; the much reduced T→R transition rate
suggests that the nucleotide inhibitors stabilize the
T state, and the incomplete conversion of the
enzyme population to the R state at a saturating
substrate concentration and shift in equilibrium
towards the T state long before the substrates are
exhausted caused by the collective R→T rates
becoming greater than the T→R rates suggest that
they destabilize the R state. Using the two-state
model as a theoretical framework, Howlett et al.
observed that CTP increases the stability of the T
state relative to the R state by 0.9 kcal and increases
the T-to-R equilibrium constant from 250 to 1250 in
the absence of substrates.17,31 In addition, the two-
state model suggests that CTP and UTP exert their
influence by binding more tightly to the T state and
shifting the structural equilibrium in favor of the T
state. However, again as with ATP, our observations
are somewhat at variance with this model but are
supported by the crystal structures of the T and R
states of the enzyme in the presence of CTP; the T-
state structure globally was unchanged in the
presence of CTP,5 and the R-state structure was
shifted slightly in the direction of the T state with
CTP present.33
In the case of UTP, by itself, it had no influence on
the kinetics of the enzyme with the exception of
raising the [Asp]0.5 slightly. It also had no influence
on the kinetics of the T→R transition, except for
increasing the rate of the slow phase for reasons that
are unclear. However, UTP did have a noticeable
effect on the length of time the enzyme spent in the
R-state plateau region, causing the enzyme popula-
tion to begin reverting to the T state before the
substrates were exhausted. This indicates that UTP
may slightly destabilize the R state but otherwise
does not have an appreciable effect on the allosteric
behavior of ATCase under these conditions.
The activation energy of the R→T transition was
determined by fitting the bottom half of the return
curve, after the enzyme had exhausted the sub-
strates, to a single exponential rate, as opposed to
the upper half of the curve where presumably not all
enzyme molecules have completely exhausted the
substrate bound to the active sites. By fitting the
bottom half of the return curve, mainly the rate of
R0→T0 should be observed, which is supported
by the very low error in the kR→T values obtained.
As shown in Fig. 9, the EaR→T was calculated to be
13.0±1.4 kcal/mol from the slope of the Arrhenius
plot. At temperatures above 10 °C, the T→R rate
was so rapid that the data could not give rates with a
reasonable error. Moreover, these rates are compo-
sites of the multiple species with different ligation
states, making interpretation of a single activation
energy value problematic. However, by making
some assumptions, an approximate value for the
T→R activation energy was derived for the unli-
214 Quaternary Change of E. coli ATCase
ganded T and R states. Assuming that the respective
transition states in both the T→R transition and
R→T transition are the same, and the free energy
difference between the T and R states is 3.3 kcal/
mol,17,31 then the activation energy for the T→R
transition should be in the range of 15–18 kcal/mol.
The charged–charged hydrogen bonds between
Glu239 and Lys164 and noncharged hydrogen
bonds between Glu239 and Tyr165 are critical for
the stabilization of both the T and R state conforma-
tions of the enzyme, which are interchain in the T
state and intrachain in the R state.7 Sakash et al.
showed that three of the six stabilizing interactions
between catalytic chains on opposing subunits
involving Glu239 are sufficient to stabilize the
enzyme in the T-state conformation.34 Thus, at
least three of the hydrogen bonds involving
Glu239 must be broken during the allosteric transi-
tion. Considering a typical charged–charged hydro-
gen bond energy is approximately 4 kcal/mol and a
noncharged hydrogen bond energy is approxi-
mately 0.5–1.5 kcal/mol,35,36 the minimal energy
required for the allosteric transition of the enzyme is
13.5–16.5 kcal/mol. The results reported here are
consistent with these calculations.
The rate of the allosteric transition was also
measured when ATCase is mixed with two substrate
analogs: succinate, an aspartate analog that pro-
motes the T→R state transition when combined
with CP, and PALA, a bisubstrate analog that
binds at nanomolar affinity and also causes the
T→R state transition. The structural transition rate
with succinate and CP at a concentration of 50 mM
each was slightly lower than the rate with the
natural substrates at equivalent concentration and
was observed to be a single exponential process.
This may be because succinate binds approxi-
mately 1 order of magnitude more tightly than
aspartate,17,37,38 and therefore, the bulk of the T-state
molecules should be highly liganded during the
transition to the R state. However, the structural
transition rate with PALAwas more than 1 order of
magnitude slower than that with the natural
substrates. The kinetics of the interaction of PALA
with the isolated catalytic subunit at pH7.0 and
25 °C has been studied using stopped-flow kinetics
and 31P saturation transfer NMR by Cohen and
Schachman.39 They observed a rapid binding of
PALA followed by a much slower isomerization of
the complex with a forward rate constant of 0.18 s−1,
similar to the rate constant of the slow phase we
observed by TR-SAXS of 0.31 s−1. However, the
catalytic subunit by itself does not undergo a T→R
transition; hence, it is unclear whether the similarity
of these values implies a similar mechanism
between the change in the tertiary structure follow-
ing PALA binding to the catalytic subunit and the
change in the quaternary structure following PALA
binding to the holoenzyme. The rate constant data
and integrated scattering intensity presented here
were obtained after mixing PALA with enzyme
premixed with CP, to be consistent with the other
experimental conditions. In addition, experiments
were performed where PALAwas mixed with only
the enzyme and the rate constants for the T→R
transition were essentially identical (data not
shown), which suggests that the slow allosteric
transition after PALA binding is not caused by
having to displace CP from the active site. Because
PALA combines elements of both substrates into one
covalently linked bisubstrate analog, when the CP
moiety of PALA initially binds, the aspartate moiety
may not be able to bind well to the aspartate binding
site with the domains open, as they are in the T state.
Subsequently, the enzyme may undergo a slow
conformational change in order for the aspartate
moiety to bind tightly and then complete the T→R
structural conversion. In this regard, PALA appears
to fit in the category of a slow, tight-binding
inhibitor.40 However, the phenomenon of PALA
being a very tight-binding bisubstrate analog that
causes an initial conformational change followed by
a much slower conformational change needs further
investigation to be better understood.
In summary, our data showed that ethylene glycol
had a profound influence on the kinetics and
behavior of ATCase; therefore, the time evolution
of the allosteric transition of ATCase was reinvesti-
gated in the absence of ethylene glycol by SAXS,
revealing several important new insights. Experi-
mentally, these studies demonstrate that SAXS is
now capable of monitoring relatively rapid struc-
tural changes at temperatures approaching physio-
logical. The allosteric transition is not the rate-
limiting step in ATCase catalysis, and the rate of
allosteric transition is increased with increasing
substrate concentration up to 50 mM. ATP appears
to destabilize the T state and to have little effect on
the R state. CTP and the combination of CTP/UTP
appear to destabilize the R state and stabilize the T
state. PALA causes a very slow conformational
change as compared to the natural substrates. In the
future, novel TR-SAXS experiments could be per-
formed with hybrid ATCase molecules that bind
one, two, three, four, or five aspartate molecules to
determine the individual rate constants and activa-
tion energies for each one of these species. Such
studies will be facilitated by further instrumental
upgrades that are being made to improve time
resolution. We believe that we have begun to arrive
at a clear understanding of the allosteric mechanism
of ATCase, and further studies into its dynamic
behavior utilizing such time-resolved techniques as
employed here will be invaluable in this.
Experimental Procedures
Materials
ATP, CTP,UTP, CP, L-aspartate, D-aspartate,N-carbamoyl-
L-aspartate, potassium dihydrogen phosphate, sodium
azide, succinate, and uracil were obtained from Sigma
Chemical Co. (St. Louis, MO). Ammonium sulfate, electro-
phoresis-grade acrylamide, and trishydroxymethylamino-
methane (Tris)were purchased from ICN (CostaMesa, CA).
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PALA was obtained from the National Cancer Institute,
National Institutes of Health (NIH). All commercially avail-
able starting materials and solvents were reagent grade or
better and used without further purification. CP dilithium
salt was purified before use by precipitation from 50% (v/v)
ethanol and was stored desiccated at −20 °C.
Enzyme preparation
The E. coli ATCase was overexpressed utilizing E. coli
strain EK110441 containing plasmid pEK152.42 The isola-
tion and purification were as described previously.41 The
purity of the enzyme was checked by SDS-PAGE43 and
nondenaturing PAGE.44,45 The concentration of wild-type
enzyme was determined by absorbance measurements at
280 nm with an extinction coefficient of 0.59 cm2/mg.46
The purified enzyme was dialyzed into a buffer solution
containing 50 mM Tris and 2 mM DTT, pH8.3, and con-
centrated to approximately 75mg/ml. The pHof the buffer
solution was readjusted to be approximately 8.3 at 5 °C.
Enzyme kinetics
The activity of the enzyme was measured by the colori-
metric47 method at either 5 or 25 °C. Colorimetric assays
were performed at a pH of 8.3, in 50 mM Tris acetate
buffer. All of the saturation kinetics was performed in
duplicate, and the data points shown are the average
values. Data analysis for the steady-state kinetics was
carried out as previously described.48 The experimental
data were fit to theoretical equations using nonlinear
regression. When significant substrate inhibition was pre-
sent, the data were analyzed using an extension of the Hill
equation that includes a term for substrate inhibition.28
The nucleotide saturation curves were fit to a hyperbolic
binding isotherm by nonlinear regression.
Small-angle X-ray scattering
Time-resolved X-ray scattering experiments were per-
formed on beamline 4-2 at SSRL, Menlo Park, CA. Syn-
chrotron radiation from a 20-pole 2-Twiggler was focused
by a bent cylinder mirror and monochromatized (X-ray
wavelength, 1.38 Å) by a pair of synthetic W/B4C multi-
layer diffraction elements.15 A stopped-flow mixer injected
0.1 ml of enzyme solution and an equal volume of another
solution, typically containing substrates or substrate ana-
logs, into an observation cell via a mixing chamber. The
observation cell was kept at a constant temperature within
an error of ±0.5 °C. The dead time of our stopped-flow
apparatus for X-ray scattering is approximately 5–10 ms,
which is the earliest time point that one can obtain after
initiation of the enzyme reaction. All stopped-flow experi-
ments were performed at a pH of 8.3, in 50 mMTris acetate
buffer containing 2 mM DTT. The time-resolved measure-
ments were done by mixing solutions from two syringes:
one syringe containing the substrate CP, nucleotides where
applicable, and enzyme and the other containing the sub-
strates CP and L-Asp (or substrate analogs where applic-
able) and nucleotides where applicable. D-Asp was
substituted for L-Asp for recording the T-state scattering
curves without enzyme catalysis as well as for the back-
ground correction with identical electron density contrast.
A series of successive measurements of 2D scattering
data and corresponding beam intensities were synchro-
nized with the completion of sample mixing. The data
sampling rate for all experiments was 19 ms, with the
exception of the curves displayed in Fig. 5, in which the
rate was 36 ms. The scattering data were recorded by an
image-intensified interline CCD X-ray detector system
(Hamamatsu Photonics C4880-80-14A & V5445P),49
located at ∼85 cm from the observation cell. The beam
intensities incident on the sample were integrated during
a series of CCD exposures by the European Molecular
Biology Laboratory data collection system.49 The detector
channel numbers were converted to s=2sinθ/λ, where 2θ
is the scattering angle and λ is the X-ray wavelength
(1.38 Å), by recording the position of the (100) and related
reflections of a cholesterol myristate powder sample
placed at the sample position. Image distortion correction
of 2D data was performed using the program Fit2D.50
Radial integration, intensity scaling, background subtrac-
tion, and correction for nonuniformity of detector
response were done by MarParse, developed at SSRL.51
Each reported set of T→R rate constants was obtained
from averaging three individual runs under the same
conditions, with each run inspected for consistency and
any experimental anomalies. The time courses of the initial
quaternary structural change were subject to both one-
exponential curve fits and two-exponential curve fits with
terms for separate amplitudes and time constants. The
number of reported rate constants reflects which least-
squares fit yielded the highest R value (correlation
coefficient) or goodness of fit under each experimental
condition. The time evolution of the structural change
displayed in Figs. 4–7 is from individual single-mixing
runs, and the reported R→T rate constants were obtained
from the same individual runs.
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X-ray crystallography and small-angle X-ray scattering (SAXS) in
solution have been used to show that a mutant aspartate trans-
carbamoylase exists in an intermediate quaternary structure be-
tween the canonical T and R structures. Additionally, the SAXS
data indicate a pH-dependent structural alteration consistent with
either a pH-induced conformational change or a pH-induced alter-
ation in the T to R equilibrium. These data indicate that this mutant
is not a model for the R state, as has been proposed, but rather
represents the enzyme trapped along the path of the allosteric
transition between the T and R states.
allostery | cooperativity | intermediate structure | structural stabilization
Although many aspects of allosteric regulation and coopera-tivity have been established for Escherichia coli aspartate
transcarbamoylase (ATCase), the enzyme that catalyzes the
committed step in pyrimidine nucleotide biosynthesis, many of
the details of how the active sites change from low-activity, low-
afﬁnity to high-activity, high-afﬁnity during the T to R transition
have not been delineated (1). The major limitation has been that
stabilization of the enzyme in the R state requires the presence
of active site ligands, thus making interpretation of the structural
rearrangements upon the T to R transition, in the absence of
ligands, difﬁcult. Newell and Schachman (2) have concluded,
from sedimentation velocity experiments, that the quaternary
structures of ATCase with the catalytic chain mutation K164E
and the catalytic chain double-mutation K164E and E239K exist
in the R state, irrespective of the presence of active site ligands.
The enzymatic properties of the double mutant (K164E/E239K
ATCase) include a lack of homotropic cooperativity and an in-
ability to be activated by ATP or inhibited by CTP: properties
coincident of an enzyme that cannot transition between the two
allosteric states (2). More recently, Velyvis et al. (3) demon-
strated that the partially labeled K164E/E239K ATCase exhibi-
ted certain chemical shifts in solution NMR studies that they
conclude are characteristic of the R state of the enzyme. These
same chemical shifts were also observed when the wild-type
enzyme was bound with the bisubstrate analog N-phosphonace-
tyl-L-aspartate (PALA) (3), which is known to stabilize fully the
R state of the enzyme (4). Thus, a crystal structure of K164E/
E239K ATCase should provide us a means to obtain the struc-
tural details of an R-state active site in the absence of ligands.
However, here we report the X-ray crystal structure and the so-
lution small-angle X-ray scattering (SAXS) data for the K164E/
E239K ATCase, which clearly demonstrate that this double-
mutant enzyme is not in the R-quaternary structure. Instead this
mutant enzyme is in a unique intermediate state on the path
between the T and R structural states.
Results and Discussion
Crystal Structure of K164E/E239K ATCase Is Different from the Wild-
Type R State Structure. The K164E/E239K ATCase was puriﬁed
and subsequently crystallized in the absence of ligands as de-
scribed in Methods. The crystals were determined to be in the
P212121 space group with unit cell dimensions of a = 124.1 Å,
b= 144.8 Å, and c= 203.4 Å with α = β = γ = 90°. A previously
determined structure of R-state ATCase in the presence of the
PALA has also been solved in the P212121 space group (5).
However, the unit cell dimensions (a = 125.5 Å, b = 153.5 Å,
c = 185.7 Å with α = β = γ = 90°) vary signiﬁcantly from those
determined for the K164E/E239K ATCase. In the crystal of the
PALA–ATCase complex the molecular threefold axis is parallel
to the crystallographic b-axis (5). The almost 9 Å shorter b-axis
of the K164E/E239K ATCase crystals was the ﬁrst indication
that the structure of this double-mutant enzyme may not be an
R-state structure.
To quantitatively compare the quaternary conformation of
the K164E/E239K structure with the canonical ATCase T and R
structures, the vertical separation (6) between the upper and
lower catalytic subunits, planar angle between allosteric domains
of the regulatory dimer, and the rotation about the threefold axis
(Fig. 1) of the K164E/E239K structure were determined and
compared with the corresponding values for the published T
and R structures (Fig. 2). The vertical separation for the K164E/
E239K structure was 50.5 Å, compared with 47.3 Å and 57.9 Å
for the T state [Protein Data Bank (PDB) ID 1ZA1 used
throughout] and R state (PDB ID 1D09 used throughout), re-
spectively. The average planar angle between allosteric domains
of the regulatory dimer in the K164E/E239K structure was 153°,
which compares to 152.0° and 155.8° for the T and R structures,
respectively, of the wild-type enzyme. For the wild-type enzyme
the relative rotation around the molecular threefold axis be-
tween the T and R structures is 12°, whereas the rotation from
the wild-type T structure to the K164E/E239K structure is only
4.8°. The vertical separation, the angle between the allosteric
domains of the regulatory dimer, and the rotation of the catalytic
subunits about the threefold axis all indicate that the K164E/
E239K structure is not globally in either the wild-type T or R
structure.
The analysis of the global conformation of the K164E/E239K
structure by means of X-ray crystallography does not agree with
the previously reported data as determined by sedimentation
velocity (2). Therefore, we used the program HydroPRO (7) to
calculate the radius of gyration (Rg) on the basis of the wild-type
and K164E/E239K structures. These values have some uncer-
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tainty because the highly mobile portions of the structures are
not reported in the structural data. The Rg values of the wild-
type T and R states were calculated to be 46.4 and 49.1 Å, re-
spectively, which compares well with the reported values of 46.6 ±
0.3 Å and 49.3 ± 0.2 Å, respectively (8). The calculated Rg for the
K164E/E239K structure was 47.2 Å, a value closer to the T than
the R state of the wild-type enzyme.
K164E/E239K ATCase Exists in a Structural State Different from the
Wild-Type R State in Solution. For the wild-type enzyme, the per-
cent change in the sedimentation coefﬁcient between the T- and
R-state structures has been reported to be −3.8% (2). The cor-
responding percent difference calculated between the K164E/
E239K and wild-type R-state structures was −0.4% (2). These
data suggest that the structure of K164E/E239K enzyme may be
different in solution than it is in the crystal. Therefore, we used
SAXS to obtain additional structural data on the K164E/E239K
ATCase in solution (9, 10).
SAXS data were recorded using Beamline 4-2 at the Stanford
Synchrotron Research Laboratory at pH values 8.3, 7.5, and 7.0.
In addition to recording SAXS data for the K164E/E239K en-
zyme, data were also recorded for the wild-type ATCase in the
absence of ligands (T-state control) and in the presence of PALA
(R-state control). The SAXS patterns (Fig. 3), plotted as nor-
malized Kratky Plots (11), for the T and R states of the wild-type
enzyme are dramatically different. The SAXS pattern for the
K164E/E239K enzyme at pH 8.3 (Fig. 3A) is intermediate be-
tween the T and R states observed for the wild-type enzyme. This
clear difference in the scattering patterns between the T and R
states and the K164E/E239K enzyme can also be visualized when
the data are plotted as I(q) vs. I (Fig. S1A) and as log I(q) vs. I
(Fig. S2A). The intermediate curve observed for the K164E/
E239K enzyme can be explained in at least two ways. First, the
K164E/E239K enzyme exists in a new structural state that is
different from the wild-type T or R states; or second, in solution
the K164E/E239K enzyme is a mixture of two or more structures.
The second explanation is consistent with the K164E/E239K
enzyme having a T to R equilibrium shifted from the T state-
dominated equilibrium observed for the wild-type enzyme.
If the SAXS pattern of the K164E/E239K enzyme is a mixture
of wild-type T and R structures, it should be possible to generate
the SAXS pattern of the double-mutant enzyme by a linear
combination of the wild-type T- and R-state patterns. The dotted
line in Fig. 3 A–C corresponds to the best ﬁt of the SAXS pattern
of the K164E/E239K enzyme using the wild-type T and R curves.
At each pH, the best-ﬁt curve does not match that observed for
the K164E/E239K enzyme. In particular, the position and am-
plitude of the ﬁrst subsidiary minimum is not predicted correctly.
The inability to deconvolute the curve into T and R components
suggests that in solution the K164E/E239K enzyme is neither the
Fig. 1. ATCase holoenzyme showing the threefold and twofold axes. One-
third of the molecule (c1-r1-r6-c6) is represented as a ribbon diagram. The
other two-thirds of the molecule is shown without secondary structure.
Planar angles between the CP and ASP domains of the catalytic chain (PA1)
and the allosteric domains of the r1–r6 regulatory chains (PA2) are also
shown. Insets: The c1 and r1–r6 chains with the corresponding PA1 and PA2
are shown in an orientation to better visualize the planar angle between
the domains as well as the centers of gravity of these domains. Also in-
dicated is the vertical separation between the centers of gravity of an upper
and lower catalytic chain. This ﬁgure was produced using MOLSCRIPT (32)
and RASTER3D (33).
Fig. 2. Comparison of the structures of (A) wild-type ATCase in the T state (PDB ID 1ZA1), (B) wild-type ATCase in the R state (PDB ID 1D09), and (C) the
K164E/E239K mutant ATCase (PDB ID 4E2F). The vertical separations between the center of masses of the upper and lower catalytic trimers are indicated. The
catalytic chains are dark and the regulatory chains light in color. This ﬁgure was drawn with PyMol (34).
7742 | www.pnas.org/cgi/doi/10.1073/pnas.1119683109 Guo et al.
T nor R quaternary structure of the wild-type enzyme or a mix-
ture thereof.
As opposed to the wild-type enzyme in the absence or pres-
ence of PALA, the SAXS pattern for the K164E/E239K enzyme
is pH dependent (compare Fig. 3 A–C). Thus, by altering the pH
either the quaternary structure of the K164E/E239K enzyme is
shifting, or the population of molecules in the R state is in-
creasing relative to the T state. According to these SAXS data, at
no pH between 7.0 and 8.3 does the unliganded K164E/E239K
enzyme exist in a structure that would be considered the same as
the R structure of the wild-type enzyme. As the pH is varied
from 8.3 to 7.0 the SAXS pattern of the unliganded K164E/
E239K enzyme shifts toward the wild-type R structure. This shift
in structure could be modeled on the basis of the SAXS pattern
of the K164E/E239K enzyme at pH 8.3 in the presence and
absence of PALA, suggesting that this shift in the SAXS pattern
was due to a change in the relative population of the two
structures in solution. The SAXS data for the wild-type and the
K164E/E239K enzymes are also plotted as scattering intensity
and the log of the scattering intensity vs. the momentum transfer
(q) (Figs. S1 and S2).
The Rg values can be determined directly from the SAXS data
using the Guinier plot (Table S1). The values for the wild-type
enzyme, 48.1 ± 0.1 Å and 51.9 ± 0.1 Å for the T and R states,
respectively, are similar to the previously determined Rg values
in solution of 47.3 ± 0.2 Å and 49.9 ± 0.2 Å for the T and R
states (12). Most strikingly, we found that in solution the K164E/
E239K enzyme has a slightly greater Rg than the PALA liganded
wild-type or mutant enzymes. At the two other pHs tested this
trend was the same: the Rg was greater (0.5–0.6 Å) for the
unliganded mutant before the addition of PALA and conversion
to the R state. This discrepancy between the Rg as determined in
solution by SAXS and the crystal structure suggest that the
ground state structure of the mutant enzyme is much more
ﬂexible than that of the wild-type; however, whatever the ex-
planation may be the crystal structure and SAXS data both
support the conclusion that the mutant without ligands is not in
an R-state structure.
These results suggest that the previously reported ﬁndings that
the K164E/E239K ATCase is in the R state may need to be
reevaluated (2, 3). The evidence presented here clearly demon-
strates that the quaternary structure of the K164E/E239K ATCase
is not identical to the wild-type ATCase–PALA complex, the
typical structure used to deﬁne the R state. The sedimentation
velocity experiments on the K164E/E239K ATCase, which indi-
cated R state-like sedimentation values, were performed at 20 °C
and pH 7.0 (2), a temperature and pH that may perturb the
enzyme toward a more R-like structure. The SAXS data in Fig. 3
show that lowering the pH from 8.3 to 7.0 causes a shift in the
structure toward the R state. The solution NMR report by
Velyvis et al. (3) also asserts the K164E/E239K ATCase is in the
R state and concludes that the Monod, Wyman, and Changeux
model (13) can fully account for the allosteric properties of
ATCase. The experiments performed by Velyvis et al. (3) were
carried out at 37 °C and pH 7.5. At this pH value and 25 °C, the
K164E/E239K ATCase is not in the canonical R-state structure
(Fig. 3B). Although the higher temperature of the NMR
experiments may cause a shift in the structure toward the R state,
the temperature dependence of SAXS data has been determined
for the wild-type and the D236A enzyme. The wild-type enzyme
showed no change in structure by SAXS through the tempera-
ture range of 4° to 55 °C, whereas the D236A ATCase exhibited
a large shift toward the T state between 4 and 30 °C, with a minor
shift back toward the R state between 30 °C and 45 °C (14).
These data suggest that under the NMR conditions (37 °C) the
Fig. 3. SAXS of the wild-type and the K164E/E239K enzymes at (A) pH 8.3,
(B) pH 7.5, and (C) pH 7.0. At each pH the wild-type enzyme in the absence
of ligands is shown in black and in the presence of PALA in blue. The K164E/
E239K enzyme in the absence of ligands is shown in red and in the presence
of PALA in orange. The data are plotted as normalized Kratky Plots (11). The
green dashed line indicates the best ﬁt of a combination of the wild-type T
pattern and the K164E/E239K PALA R pattern to the K164E/E239K pattern in
the absence of ligands. Each scattering curve corresponds to 140 data points
connected by linear line segments.
Fig. 4. (A) Percent change in quaternary structural properties of the K164E/
E239K ATCase. As reference, the wild-type enzyme characteristics go from
0 (T state) to 100% (R state). (B) T structure of one catalytic chain of wild-
type ATCase (PDB ID 1ZA1). (C) R structure of one catalytic chain of wild-
type ATCase (PDB ID 1D09). In B and C the diameter of the tube corresponds
to the main chain rmsd between the wild-type and the K164E/E239K
structures. The portions of the tube highlighted in black correspond to
those with rmsd >1.5 Å.








K164E/E239K ATCase, which has properties similar to those of
D236A ATCase, would not be shifted toward the R state. This
study underscores the need for extreme caution when making
inferences about the allosteric mechanism of a wild-type protein
when working with a model system, which in this case is the
double-mutant enzyme.
K164E/E239K ATCase Is in an Intermediate State During the Allosteric
Transition from the T to the R State. Both the X-ray crystallo-
graphic and SAXS data indicate that the structure of the K164E/
E239K enzyme in the absence of ligands is not in the R structure,
but rather it is an intermediate structure between the canonical T
and R structures. Instead of providing a model for the R state,
the K164E/E239K enzyme gives us structural information on the
pathway of the T- to R-state transition of ATCase. When wild-
type ATCase undergoes the allosteric transition to the R state,
the enzyme expands 10.6 Å and the upper catalytic trimer rotates
12° relative to the lower trimer along the threefold axis. Com-
pared with the wild-type T-state structure the K164E/E239K
enzyme only expands 2.8 Å and the upper catalytic trimer rotates
only 4.4° relative to the lower trimer (Fig. 4A). Previous studies
revealed that the planar angle between the allosteric domains of
the regulatory dimer changes almost linearly with changes in the
size of the molecule (6), which increases from 152.0° to 155.8° as
the enzyme transitions from the T to the R state. The fact that in
the K164E/E239K structure this planar angle is only 153° sug-
gests that the size of the double mutant is between the size of the
wild-type T- and R-state enzymes. As seen in Fig. 4A, the percent
change in the vertical separation, the angle between the allo-
steric domains of the regulatory dimer, the rotation about the
threefold axis, and the radius of gyration observed in the K164E/
E239K structure are all approximately one-third of the difference
in the parameters observed between the T and R states of the
wild-type enzyme. These data suggest that the K164E/E239K
enzyme exists in an intermediate structure shifted approximately
one-third toward the wild-type R structure from the T structure.
Not only is the quaternary conformation of the K164E/E239K
structure intermediate between the canonical ATCase T and R
Fig. 5. Stereo view of the K164E/E239K ATCase 2 Fo–Fc electron density map of the active site region contoured at 1.3 σ. Overlaid onto the electron density
are the side chains known to be involved in substrate binding and catalysis. Side chains are shown for the K164E/E239K (cyan carbons), wild-type T-state
(magenta carbons), and wild-type R-state (orange carbons) ATCases. The three structures were overlaid on the basis of the α-carbon positions of the active
site residues.
Fig. 6. The c1–c4, c1–r4, and c4–r1 interfaces. (A) T-state residue positions and interactions of the wild-type enzyme (PDB ID 1ZA1), (B) the same residue
positions in the K164E/E239K ATCase reported here, and (C) the R-state residue positions and interactions of the wild-type enzyme (PDB ID 1D09). Shown are
the interactions involving Glu239 [wild-type T state (A) and R state (C) or Lys239 in the K164E/E239K structure (B)]. Also shown are the interactions between
Asp236 of the catalytic chains and Lys143 of the regulatory chains. For clarity Tyr165 is not labeled.
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structures, but also the tertiary structure of the individual chains
are intermediate as well. As seen in Fig. 4 B and C, the rmsd of
the Cα in the catalytic chain between the wild-type and the
K164E/E239K structures is reﬂected in the diameter of the tube.
The catalytic chain of the K164E/E239K structure has less rmsd
to that of the T-state structure than the R-state structure. Thus,
the tertiary structure of the double mutant represents an in-
termediate state closer to the T state.
Another prominent feature of the T to R transition is the
closure of the two domains of each catalytic chain to rearrange
the active site residues so as to push the substrates toward one
another in the bimolecular reaction. However, the active site of
the K164E/E239K ATCase more closely resembles the T-state
than the R-state active site (Fig. 5).
A comparison of the active site region of the K164E/E239K
ATCase with the T and R states of the wild-type enzyme is shown
with electron density in Fig. 5. Key differences include signiﬁcant
alterations in the positions of Arg54 and Arg167, which are two
key residues involved in catalysis. Both Arg54 and Arg167 swing
out of the active site in the K164E/E239K ATCase structure.
These alterations in side chain position may be responsible for the
reduced catalytic activity and increased [Asp]0.5 of the K164E/
E239K compared with the wild-type enzyme (2).
In addition to the K164E/E239K enzyme reported here, SAXS
experiments have shown that the E239Q and D236A enzymes
also exhibit patterns intermediate between the T and R patterns
of the wild-type enzyme (8, 14). These mutations break the T-
state interchain c1–c4 interactions between Glu239 and both
Lys164 and Tyr165 or the c1–r4 interaction between Asp236c
and Lys143r. For ATCase to transition from the T- to the R-
quaternary structure, these interchain interactions must break
(Fig. 6 A and C), although for the wild-type enzyme in the R
state, c1 intrachain interactions are formed between Glu239 to
both Lys164 and Tyr165 (Fig. 6C). In the case of the K164E/
E239K enzyme, the possible salt link between Glu164 and
Lys239 does not form (average distance between Glu164 Oε and
Lys239 Nζ is 4.78 ± 0.7 Å). Furthermore, the salt-link between
Asp236 (c1/c4) and Lys143 (r4/r1) observed in the T-state
structure (Fig. 6A) is broken in the K164E/E239K enzyme, with
an average distance between the Asp236 Oδ and the Lys143 Nζ
of 8.17 ± 3.5 Å (Fig. 6B).
Most interestingly, the scattering curve of the K164E/E239K
ATCase at pH 8.3 is comparable to the intermediate curve of
the structure at the end of the early fast-rising phase of the
time-resolved stop-ﬂow X-ray scattering of ATCase upon mixing
with substrates carbamoyl phosphate and L-aspartate (15).
The elongation of the enzyme is a necessary part of the allosteric
transition, which requires the breaking of the T-state inter-
subunit interactions involving both Glu239 and Asp236; thus the
K164E/E239K structure, lacking these interactions, is a unique
structure along the path of the quaternary structural transition
from the T to the R state. As such, these ﬁndings suggest that
there may be transiently stable intermediate structure(s) that the
protein passes through during the allosteric transition.
Methods
Enzyme Preparation. The mutations K164E/E239K were introduced to the
catalytic chains of ATCase on plasmid pEK152 (16) by site-speciﬁc muta-
genesis using the QuikChange Site-Directed Mutagenesis Kit (Stratagene)
to produce plasmid pEK695. The double mutant was isolated according
to the procedure described by Nowlan and Kantrowitz (17), from over-
producing E. coli strain EK1104 [F− ara, thi, Δ(pro-lac), ΔpyrB, pyrF±, rpsL],
containing the plasmid pEK695. The enzyme was puriﬁed by isoelectric
precipitation (17), ion exchange, and hydrophobic interaction chromatog-
raphy. For the ion-exchange puriﬁcation, a Q-Sepharose Fast Flow (GE
Healthcare) column (11 cm × 2.5 cm) was used. The protein was eluted using
a linear gradient from 0.05 M Tris·acetate, 2 mM 2-mercaptoethanol, pH 8.3
(Low Q buffer) to Low Q buffer plus 0.5 M sodium chloride. For the hy-
drophobic interaction chromatography, a Phenyl Sepharose High Perfor-
mance (GE Healthcare) column (8.5 cm × 2 cm) was used. After the ion-
exchange chromatography, ATCase-containing fractions were dialyzed into
Low Q and brought to 20% saturation with ammonium sulfate and loaded
onto the Phenyl Sepharose column. The protein was eluted using a linear
gradient from Low Q buffer plus 20% saturating ammonium sulfate to Low
Q buffer. The homogeneity of the protein was checked by SDS/PAGE (18),
nondenaturing PAGE (19, 20), and by size-exclusion chromatography (Fig.
S3). The concentration of puriﬁed double-mutant enzyme was determined
by the Bio-Rad version of Bradford’s dye-binding assay using wild-type
ATCase as the standard (21).
Crystallization and Data Collection. A sample of 10 mg/mL puriﬁed K164E/
E239K ATCase was sent to the Hauptman-Woodward Institute for high-
throughput screening of crystallization conditions (22). The ﬁnal crystalli-
zation condition was developed on the basis of one of the screening results.
The mutant enzyme was crystallized by the hanging-drop vapor diffusion
method. Two microliters of enzyme (10 mg/mL) in 50 mM Tris·acetate (pH
8.3) was mixed with 2 μL of crystallization buffer [16% (wt/vol) PEG 4000,
0.04 M Na2MoO4·2H2O, 0.04 M N-cyclohexyl-3-aminopropanesulfonic acid,
and 30 mM Tris·acetate (pH 8.75)] and equilibrated over a reservoir of 1.0 mL
of crystallization buffer at 20 °C. Bar-shaped crystals grew to average
dimensions of 0.3 × 0.3 × 0.4 mm in approximately 2 wk.
Crystals were transferred into a freezing solution containing 20% (vol/vol)
ethylene glycol in crystallization buffer for 1 min before freezing in liquid N2.
Data were collected in the Boston College Crystallography Facility. X-rays
were generated using a Rigaku MicroMax-007HF rotating-anode generator
operating at 40 kV and 30 mA, and data collected using a Rigaku R-axis IV++
detector. The diffraction data were integrated, scaled, and averaged using
d*TREK (23).
Structure Determination. Attempts to solve the structure of the K164E/E239K
ATCase by molecular replacement succeeded using the T-state ATCase
structure (PDB ID 1ZA1) rather than the R-state PALA-ATCase structure in the
same space group (PDB ID 1Q95). First, one catalytic trimer (c3) of the double
mutant was found by using the c3 of the T-state structure (PDB ID 1ZA1) in
MOLREP (24) as implemented in CCP4 (25). MOLREP was also able to locate
the second c3. MOLREP was then used to locate the three regulatory dimers
(r2) by ﬁxing the coordinates of the two c3 subunits. Combining the two c3 and
three r2 subunits positioned by MOLREP the initial model of the holoenzyme
(c6r6) in the asymmetric unit was established. Reﬁnement of the structure was
performed using PHENIX (26). The 80’s loops (residues 77–84) and 240’s loops
(residues 231–245) of all of the catalytic chains were rebuilt into the reﬁned
structure using the Autobuild protocol in PHENIX (26). The loop positions were
further checked using composite omit maps, calculated using RESOLVE (27)
within PHENIX, and displayed in COOT (28, 29) averaging over the sixfold
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noncrystallography symmetry. The 80’s and 240’s loops of the catalytic chains
had elevated b-factors, which were higher than in the T- or R-state structures
of the wild-type enzyme. The higher b-factors are most likely due to loss of
a number of loop-stabilizing interactions. Even though the density of these
loops was weak and the b-factors high, the atomic coordinates have been
included for completeness. Water molecules were added to the structure using
PHENIX (26) on the basis of the Fo–Fc map at or above the 3.0σ level. After
completion of the reﬁnement, the ﬁnal Rwork and Rfree were 0.214 and 0.274,
respectively. The model was checked for errors using PROCHECK (30). The
detailed statistics of data collection and reﬁnement are given in Table 1. Res-
idues 1–9 in the regulatory chains were omitted from the deposited structure
owing to extremely weak electron density. Coordinates for the K164E/E239K
ATCase structure have been deposited with the PDB (PDB ID 4E2F).
Small-Angle X-Ray Scattering. The SAXS experiments were performed at
Beamline 4-2 at the Stanford Synchrotron Radiation Laboratory (3.0 Gev, 50–
100 Ma). The experimental setup and procedures were performed as de-
scribed by Sakash et al. (31). For experiments at pH 8.3 the buffer used was
0.05 M Tris·acetate and 10 mM 2-mercaptoethanol, whereas for pH 7.0 and
pH 7.5 the buffer used was 0.05 M Hepes buffer, 50 mM KCl, and 20 mM
2-mercaptoethanol.
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Fig. S1. Small-angle X-ray scattering of the wild-type and the K164E/E239K enzymes at (A) pH 8.3, (B) pH 7.5, and (C) pH 7.0. The data are plotted as scattering
intensity (I) vs. momentum transfer (q). Scattering intensity was normalized to take into account the small differences in enzyme concentration between
samples. At each pH the wild-type enzyme in the absence of ligands is shown in black and in the presence of PALA in blue. The K164E/E239K enzyme in the
absence of ligands is shown in red and in the presence of PALA in orange. The green dashed line indicates the best ﬁt of a combination of the wild-type T
pattern and the K164E/E239K PALA R pattern to the K164E/E239K pattern in the absence of ligands. Each scattering curve corresponds to 100 data points
connected by linear line segments.
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Fig. S2. Small-angle X-ray scattering of the wild-type and the K164E/E239K enzymes at (A) pH 8.3, (B) pH 7.5, and (C) pH 7.0. The data are plotted as scattering
intensity (I) vs. momentum transfer (q). Scattering intensity was normalized to take into account the small differences in enzyme concentration between
samples. At each pH the wild-type enzyme in the absence of ligands is shown in black and in the presence of PALA in blue. The K164E/E239K enzyme in the
absence of ligands is shown in red and in the presence of PALA in orange. The green dashed line indicates the best ﬁt of a combination of the wild-type T
pattern and the K164E/E239K PALA R pattern to the K164E/E239K pattern in the absence of ligands. Each scattering curve corresponds to 100 data points
connected by linear line segments.
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Table S1. Radius of gyration (Rg) as determined by Guinier
analysis of SAXS data at pH 8.3
Enzyme Ligand Rg (Å)
Wild-type 48.1 ± 0.1
Wild-type PALA 51.9 ± 0.1
K164E/E239K 52.9 ± 0.1
K164E/E239K PALA 52.2 ± 0.1
Fig. S3. Size-exclusion chromatography of the (A) wild-type and the (B) K164E/E239K ATCases on a Bio-Prep SE1000/17 column (BioRad Laboratories). The
column was equilibrated with 0.05 M Tris·acetate buffer (pH 8.3) at a ﬂow rate of 0.25 mL/min. At zero, the sample in a total volume of 300 μL was injected, and
the sample was eluted with the same buffer and at the same ﬂow rate.
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